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Bloodstream trypanosomes initiate differentiation to procyclic forms in response to a 
citrate/ cis-aconitate (CCA) signal.  A cell line was previously selected (“defective in 
differentiation-clone 1”; DiD1) that was unable to differentiate to procyclic forms 
(Tasker et al. (2000)). Additionally, expression profiling of this line in comparison to 
the parental line by macroarray hybridisation identified two differentially-expressed 
transcripts from an 8 gene cluster of highly homologous genes we named PAD genes 
(Proteins Associated with Differentiation).  Members of this family show distinct 
expression profiles throughout the trypanosome lifecycle at both the mRNA and 
protein level, and are localised to the cell surface membrane of the cell.  At least 1 
member of the family (PAD1) shows stumpy form specific RNA and protein 
expression, representing the first useful molecular marker for this stage, and exhibits 
biochemical specificity for citrate.  Additionally, another member of this family 
(PAD2) is upregulated in response to low temperature, a condition reported to cause 
hypersensitivity to CCA.  Finally, RNAi mediated ablation of the PAD gene 
transcripts compromised the capacity of stumpy form trypanosomes to differentiate to 
the procyclic form in response to CCA.  These combined expression, cytological, 
reverse-genetic and biochemical data make PAD proteins excellent candidates for 
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1 Introduction 
In addition to their considerable biomedical importance, trypanosomes are 
intrinsically interesting organisms to study.  With unusual features such as complete 
reliance on post-transcriptional mechanisms for genetic regulation, RNA polymerase 
I mediated transcription of protein coding genes, antigenic variation and RNA 
editing, trypanosomes are subject to intensive research.  Moreover, with the maturity 
of molecular interrogation techniques such as RNA interference and ectopic gene 
expression, researchers are in a position to address many of the biological questions 
that they can ask. 
1.1 Evolution of Trypanosoma brucei spp. 
The genus of Trypanosoma are single celled, parasitic organisms of the phylum 
Euglenozoa, the class Kinetoplastida, and the order Trypanosomatidae.  It is 
proposed that the evolutionary ancestor of trypanosomes was a free living, non-
parasitic organism (Vickerman (1994)) (Simpson et al. (2002)), that parasitized 
insects after their appearance 400 million years ago (Gaunt and Miles (2002)) (Engel 
and Grimaldi (2004)).  A digenetic lifestyle may have subsequently developed, 
whereby a blood sucking insect was able to transfer the early parasite between 
vertebrate hosts (Baker (1994)) (Vickerman et al. (1994)) (Hamilton et al. (2004)): 
the first land based vertebrate appeared approximately 370 million years ago 
(Kardong (2002)), making this the earliest time point for this evolutionary step.  This 
enabled the parasite to massively expand its host range, and in some cases revert to a 
monogenetic lifestyle, or even move away from insect parasitism altogether (for 
example, Trypanosoma cobitis is transmitted between fish by leaches (Lewis and 
Ball (1980)) (Hamilton et al. (2004)) (Gibson et al. (2005))). 
The salivarian trypanosomes, constituting T. brucei, T. evansi, and T. equiperdum, 
are thought to have diverged from the stercocarian trypanosomes (such as T. cruzi 
and T. lewisi) when continental drift isolated Africa from the Americas 
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approximately 100 million years ago (Stevens and Gibson (1999)).  The different 
clades subsequently evolved radically different strategies for parasitizing mammals, 
and in some cases humans and primates. 
1.2 African Sleeping Sickness 
African sleeping sickness, or human African trypanosomiasis (HAT), is caused by 
the parasite Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense 
and is thought to result in between 300,000 to 500,000 deaths each year (WHO 
(2006)) (Smith et al. (1998)).  The ambiguity of these figures is due mostly to the 
difficulties associated with early infection detection, and a lack of a diagnostic 
infrastructure across affected areas.  African sleeping sickness is described as being 
‘neglected’ both by the media and by the pharmaceutical industry (Balasegaram 
(2008)), probably because it affects primarily poor regions with little economic 
power.  Trypanosoma brucei brucei and Trypanosoma congolense cause Nagana in 
cattle which constitutes an enormous economic burden upon the African agriculture 
industry. 
Sleeping sickness is found in sub-Saharan Africa in the tsetse fly belt, with foci of 
occurrences occurring primarily in rural, difficult to access regions, with little or no 
access to health services (Barrett et al. (2003)).  The progression and type of disease 
depends on whether T. b. gambiense or T. b. rhodesiense initiate the infection.  T. b. 
gambiense causes a chronic disease, and often maintains a parasitaemia for years 
prior to human host death; this parasite is responsible for >90% of all reported 
infections (Simarro et al. (2008)). T. b. rhodesiense causes an acute, fluctuating 
parasitaemia, and can be lethal within several months (Barrett et al. (2003)).  The 
disease can be divided into two stages, depending on the phase of infection.  The first 
stage involves infection of the haemolymphatic system, and causes symptoms of 
headaches, aching joints, itching and fever.  As these symptoms are common to a 
number of ailments the first stage of HAT often goes undiagnosed, and therefore 
untreated.  The second, neurological, phase occurs when the parasite crosses the 
blood/ brain barrier and invades the central nervous system; this is when sleeping 
sickness is most clearly diagnosed, and is characterised by confusion, loss of 
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coordination, sensory disturbances and disruption of the circadian rhythm (Buguet et 
al. (1993)).  Sleeping sickness gains its name from the latter of these symptoms, and 
by this stage treatments are dangerous and often unsuccessful. 
1.2.1 Treatments 
Four drugs (see Figure 1.2-1) are currently licensed for HAT treatment that allow 
treatment for both stages of the disease and each of the two different disease causing 
sub-genuses.  However, each is less than ideal due to emerging parasite resistance 
and toxic affects. 
1.2.1.1 Suramin 
Suramin was first synthesised by German chemists in 1916 and is a symmetrical 
polysulfonated naphthylamine derivative of urea (see Figure 1.2-1) and is 
trypanocidal against all types of Trypanosoma (Voogd et al. (1993)).  The 
trypanocidal mechanism is not known, but it is thought that the high number of 
charges on the Suramin molecule cause inhibition of the parasitic enzyme.  Suramin 
is 100 fold more active against blood form parasites than the insect form, possibly 
due to inhibition of glycolysis pathways and the high pinocytic uptake in these 
forms.  Suramin is primarily used against the T. b. rhodesiense form of the disease.  
Due to its more acute nature, this form is more readily diagnosed in the early stages 
of the disease, although treatment failure was first demonstrated in the 1950s.  Poor 
intestinal absorbance means that suramin is commonly given by intravenous 
injection; however, suramin does not cross the blood-brain barrier, and is 
consequently ineffective against the later stage of the disease.  A number of side 
affects are associated with Suramin treatment, including neuropathy, rash, fatigue, 
anaemia, hyperglycaemia, and renal failure (Voogd et al. (1993)) (Figg et al. (1994)) 
(Bowden et al. (1996)).  Despite resistance in the field being rare, cultured 
trypanosomes readily become resistant to acceptable doses of suramin, suggesting 
that extensive field resistance will ultimately be selected for. 
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1.2.1.2 Pentamidine 
Pentamidine is a diamidine (see Figure 1.2-1) currently in therapeutic use against the 
haemolymphatic stage, primarily for the T. b. gambiense form of the disease.  The 
mechanism of pathogenic uptake has been well characterised; P2 equilibrative 
nucleoside transporters (ENTs) (see Section 1.7.2) act to concentrate the drug from 
the extra-cellular environment such that a toxic concentration is achieved.  
Additionally, several P1 transporters (see Section 1.7.2) are also thought to 
contribute to this.  The mechanism of trypanocidal action is largely unknown; studies 
in Leishmania have shown pentamidine accumulation at the mitochondria, and 
associated mitochondrial defects; additionally, treatment of blood form parasites with 
pentamidine has been shown to induce dyskinetoplastidy (Damper and Patton 
(1976)) (Shapiro and Englund (1990)) (Shapiro and Englund (1995)) (Basselin et al. 
(1998)).  It is thought that the DNA binding properties of this chemical prevent 
proper segregation of the kinetoplast DNA, thus causing reduced virulence; however, 
given that a number of naturally occurring, mechanically transmitted, 
dyskinetoplastid trypanosomes occur in the field, and that cells selected for 
dyskinetoplastidy in culture are viable, the exact mechanism of toxicity is not clear.  
A number of pentamidine resistant cell lines have been shown to have reduced 
uptake of pentamidine, through mutations in, or loss of, P2 type transporters (Matovu 
et al. (2003)) (Bridges et al. (2007)).  Other cell lines have been selected for that 
show normal uptake of pentamidine, but increased resistance to high intracellular 
concentrations (Berger et al. (1995)).  All these cell lines appeared to have reduced 
virulence, suggesting that resistance in the field will not be easily selected for. 
Pentamidine, as with suramin, is not well absorbed by the intestinal system, and 
consequently must be intramuscularly injected.  Although highly trypanocidal, 
pentamidine is only effective against the hemolymphatic (and very early neuronal) 
stage of the disease as it does not easily cross the blood-brain-barrier.  Additionally, 
toxic side affects include: hypoglycemia, hypotension, pain and abscess at the site of 
injection, nephrotoxicity, leucopenia, nausea and vomiting, azotemia and liver 
enzyme abnormalities (Sands et al. (1985)) (Doua and Yapo (1993)). 
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1.2.1.3 Melarsoprol 
Melarsoprol is a melaminophenyl based arsenical compound (see Figure 1.2-1) and 
is the mostly widely used drug against the late stage disease; it is the only effective 
drug against T. b. rhodesiense late stage HAT, and the only affordable drug against 
T. b. gambiense late stage HAT.  Despite being in use since 1949, the mechanism of 
action of melarsoprol is not known; the mechanism could be associated with ATP 
depletion (Flynn and Bowman (1974)) or thiol associations (Fairlamb et al. (1989)). 
Nonetheless, parasites exposed to melarsoprol undergo rapid lysis (Meshnick et al. 
(1978)).  However, resistance to melamine based arsenical drugs is rapidly emerging 
in the field (Legros et al. (1999)) (Brun et al. (2001)) (Moore and Richer (2001)) 
(Stanghellini and Josenando (2001)), and cell lines selected for melarsoprol 
resistance in vitro have lost the P2 ENT transporter that is partially responsible to 
drug uptake (Carter and Fairlamb, (1993)) (Barrett and Fairlamb (1999)) (Mäser et 
al. (1999)) (Stewart et al. (2005)).  However, it is thought that secondary routes for 
melarsoprol exist and melarsoprol resistant trypanosomes may have also lost the 
pentamidine transporter HAPT1 (Matovu et al. (2003)).   
Despite its general use, melarsoprol is highly toxic to the patient, and 5 – 10% of 
patients suffer from reactive encephalopathy, often leading to death (Arroz (1987)) 
(Robertson (1963)).  Moreover, even in those patients that survive the toxic affects of 
the drug, side effects include convulsions, headaches, itching, fever, loss of 
consciousness, rashes, bloody stools, nausea, and vomiting (Chappuis et al. (2005)).  
Thus, the mechanism of Melarsoprol trypanocidal activity, with a view to developing 
a safer alternative, is an area of research that requires urgent attention. 
1.2.1.4 Eflornithine (difluoromethylornithine [DFMO]), 
Eflornithine is an analogue of the amino acid ornithine that is the only licensed drug 
effective against the neuronal stage of T. b. gambiense (Burri and Brun (2003)).  
Eflornithine binds to the polyamine biosynthetic enzyme ornithine decarboxylase 
(ODC), resulting in inhibition of putrescine synthesis in the parasite (Bacchi et al. 
(1980)) (Phillips et al. (1987)) (Bacchi and Yarlett (1993)).  The mammalian host 
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enzyme is also affected, but the parasite-specific toxicity is thought to be due to the 
longer half-life of the T. b. gambiense enzyme, such that inhibited host enzymes are 
more quickly re-synthesised (Ghoda et al. (1990)).  The resistance of T. b. 
rhodesiense to DFMO is thought to be due to the faster ODC turnover in this parasite 
(Iten et al. (1997)).  Other mechanisms of action may include trypanothione 
depletion, and a consequent vulnerability to oxidative and immunological stress 
(Fairlamb et al. (1987)).  Uptake of eflornithine is thought to be transporter-mediated 
due to its polar nature, saturable uptake, and that resistance to eflornithine is 
associated with reduced uptake in procyclic forms (Bellofatto et al. (1987)) (Phillips 
and Wang (1987)).  However, the transporter responsible has not yet been identified. 
The pharmacological properties of eflornithine are less than ideal; low absorption 
kinetics means that the drug must be administered in high doses by intravenous 
injection.  However, the high rate of mammalian ODC turnover means that this drug 
is relatively non-toxic in comparison with melarsoprol, and importantly, eflornithine 
is able to cross the blood-brain barrier, possibly though the action of an amino acid 
transporter or passive diffusion (O’Kane et al. (2006)) (de Koning (2001)).  
However, despite being safer than Melarsoprol, eflornithine was nonetheless reported 
to be fatal in 0.8% of cases (Chappuis et al. (2005)), and causes many of the side 
effects associated with Melarsoprol, albeit to a lesser intensity.  Side effects include: 
fever, bleeding, weakness, diarrhea, nausea, stomach pain, and vomiting.  Clearly, 
research into new treatments is of primary importance. 
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Figure 1.2-1  The structure of anti- HAT drugs.  Four drugs are currently licensed for 
use in African Sleeping Sickness treatment.  There is currently a great need for new, non-
toxic, drugs that are effective against the late stage disease. 
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1.3 Lifecycle 
African trypanosomes have a complex lifecycle that exhibits highly regulated 
morphological, metabolic and cellular adaptations to meet the challenges of the host 
and the vector.  Establishment and maintenance of infection, avoidance of the 
immune system in the mammalian host, and subsequent transmission to the tsetse fly 
vector requires two distinct lifecycle stages.  In contrast, there are at least four 
distinct forms in the tsetse fly that are necessary in order to establish tsetse infection 
in the midgut, migrate through a complex and highly specific route to the salivary 
glands, undergo genetic exchange, and complete the lifecycle by infection of a 
mammalian host. 
1.3.1 Bloodstream forms 
The blood of the mammalian host presents a number of challenges to the parasite.  
As extra-cellular pathogens, trypanosomes have evolved a well studied paradigm of 
antigenic variation (Borst et al. (1980)) (Hoeijmakers et al. (1980)) (Borst et al. 
(1981)) (Pays et al. (1981)) (Bernards et al. (1984)) (Cross (1990)) (Cross (1996)) 
(Barry (1997)) (Marcello and Barry (2007)) (Lythgoe et al. (2007)) in order to evade 
the immune system, whereby a single variant surface glycoprotein (VSG) gene is 
expressed on the cell surface of the blood form parasite in very large numbers 
(Muñoz-Jordán et al. (1996)) (Navarro and Gull (2001)), acting to shield the 
invariant surface glycoproteins from antibody detection (Overath et al. (1994)) 
(Cross (1996)).  Antibodies that bind to the VSG are sorted to the flagellar pocket of 
the trypanosome by hydrodynamic flow over the cell surface (Engstler et al. (2007)), 
and removed by endocytosis; this is particularly effective in stumpy form parasites, 
and may not be effective at preventing antibody mediated lysis at higher antibody 
titres.  As the infection progresses, the VSG isotype is ‘switched’ such that a 
different, unrecognised VSG is expressed.  In addition, the dense layer of VSG 
molecules prevent access to the cell surface membrane by components of the 
alternative complement pathway, thus providing protection against complement 
mediated lysis (Ferrante and Allison (1983)) (McLintock et al (1993)). 
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Blood form parasites are trypomastigotes: the kinetoplast is positioned between the 
nucleus and the posterior of the cell.  As with all lifecycle stages, the flagellum 
extends from the kinetoplast and the connected basal body to the anterior of the cell 
in a corkscrew-like pattern (Vaughan and Gull (2003)). 
1.3.1.1 Slender forms 
Upon infection of the mammalian host, the metacyclic form differentiates to the 
slender form (see Figure 1.3-1), re-enters the cell cycle, and expresses a VSG antigen 
from a bloodstream-specific active expression site (Nagoshi et al. 1995)) (Borst et al. 
(1998)) (Cross et al. (1998)) (Borst and Ulbert (2001)). The blood of the mammal 
provides a high extra-cellular concentration of glucose which the trypanosomes 
utilise as a carbon and energy source.  All energy generation in the blood forms is 
provided by glycolysis in the glycosomes and, as such, the single mitochondrion is 
simple and tubular, with no cristae or elaborations (Vickerman et al. (1988)).  The 
pyruvate end-product is excreted.  Stains for mitochondrial enzyme activity are 
negative on the slender mitochondrion (Vickerman (1965)) (Brown et al. (1973)) 
(Hamm et al. (1990)) (Bass and Wang (1991)) (Vassella and Boshart (1996)), and 
antibodies against mitochondrial enzymes show that these proteins are not 
significantly present (Tyler et al. (1997)). 
The slender forms are approximately 25µm long and 5µm wide (Robertson (1913)).  
The kinetoplast is positioned approximately equidistant between the nucleus and the 
posterior of the cell, and the flagellum extend from this point past the anterior of the 
cell, where it becomes free and gives the parasite directional motility. 
Perhaps most importantly, the slender form trypanosome is proliferative and forms 
the infection in the mammalian host.  However, there is debate as to whether slender 
forms are able to complete the trypanosome lifecycle without first differentiating to 
the stumpy form (see Section 1.6 for more detail on this debate). 
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Slender forms are quickly killed by proteolytic stress (Sbicego et al. (1999)) and are 
unable to express procyclin on their cell surface in response to a cold shock of 20°C 
in vitro (Engstler et al. (2004)). 
1.3.1.2 Stumpy forms 
Slender forms differentiate to the stumpy forms (see Figure 1.3-1) in response to a 
high parasitaemia (Reuner et al. (1997)).  The transforming factor, termed stumpy 
induction factor (SIF), has not yet been identified, but has been characterised as a 
soluble, heat stable, low molecular mass molecule that is secreted into the blood by 
the parasite, and may operate through a cAMP associated signalling pathway 
(Vassella et al. (1997)) (see 1.4.1 for further discussion). 
Stumpy forms have a shortened morphology of approximately 15µm and are broader 
than slender forms (Robertson (1913)) (Vickerman (1985)).  Additionally, stumpy 
forms do not have a free, anterior flagellum, are less motile than the slender form, 
and the nucleus often re-positions such that the kinetoplast is posteronuclear, 
although still in the trypomastigote arrangement (Vickerman (1985)). 
The stumpy form mitochondrion is active as a pre-adaptation to life in the tsetse, and 
has a more elaborated structure than the slender form (Vickerman (1965)) 
(Vickerman (1988)).  Moreover, the stumpy form mitochondrion stains positive for 
mitochondrial activity (Vickerman (1965)) (Brown et al. (1973)) (Hamm et al. 
(1990)) (McLintock et al. (1993) (Bass and Wang (1991)) (Vassella and Boshart 
(1996)) (Vassella et al. (1997)) and immunofluorescence microscopy shows that 
dihydrolipoamide dehydrogenase DHLADH is present (Tyler et al. (1997)). 
Stumpy forms serve two crucial functions in the parasite lifecycle.  Firstly, stumpy 
form cells are cell cycle arrested in G1/0 (Shapiro et al. (1984)) (Czichos et al. 
(1986)) (Ziegelbauer et al. (1990)) (Pays et al. (1993)) (Matthews and Gull (1994)) 
which has the consequence of limiting the parasitaemia and prolonging the life of the 
host, and thus increasing the chance of transmission to the tsetse.  Differentiation to 
the arrested stumpy forms, and subsequent clearance of the prevalent VSG isotype in 
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the parasitaemia gives rise to the characteristic ‘waves’ of parasitaemia associated 
with Trypanosoma brucei spp. infection (Lythgoe et al. (2007)).  Secondly, it has 
been proposed that stumpy forms and not slender forms are capable of differentiation 
to the procyclic form and thus transmission to the tsetse fly (Robertson (1913)) 
(Wijers and Willett (1960)) (Vickerman (1965)) (Vickerman (1985)) (Matthews and 
Gull (1994)) (Tasker et al. (2000)).  Stumpy forms are terminally differentiated 
unless they progress to the procyclic form, and do not appear to be able to revert to 
the slender form (Vickerman (1985)) (Matthews and Gull (1994)). 
Analysis of the slender to stumpy transition, and the precise ordering of events, has 
been complicated due to the presence of intermediate forms within a natural 
infection.  Intermediate forms appear to have many of the characteristics of both 
slender and stumpy forms, and are probably competent to progress to the insect 
stage, but without an unambiguous marker for ‘stumpiness’ it is difficult to designate 
an individual parasite as slender, intermediate or stumpy. 
1.3.2 Insect forms 
The insect represents a radically different nutritional environment to the bloodstream.  
Additionally, the parasite must overcome the tsetse immune system, traverse from 
the insect midgut, across the peritrophic membrane and swim towards the anterior 
midgut, whereupon it re-crosses the peritrophic membrane at the proventriculus, and 
swims through the labrum and the hypopharynx into the salivary glands (see Figure 
1.3-1) (Vickerman (1988)).  Once at the salivary glands, the cell must undergo 
genetic exchange prior to attaching to the salivary gland and differentiating to a form 
pre-adapted to life in the mammalian immune system.  This journey necessitates a 
number of proliferative stages and cell cycle arrested stages.  Much about this 
journey is not known, such as how the parasite is able to navigate the tsetse anatomy, 
the triggers for differentiation at each stage, and the significance of lifecycle stage 
differences that have been identified.  Additionally, although it has been conclusively 
shown that trypanosomes exchange genetic material (Sternberg et al. (1988)) 
(Gibson (2001)) (Gibson et al. (2006)) (Gibson et al. (2008)), trypanosome sex has 
not been observed and there is much speculation as to the exact mechanism of DNA 
transfer. 
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1.3.3 Stumpy to Procyclic form differentiation 
Blood form trypanosomes are taken up into the crop, and then the midgut of the 
tsetse fly vector as it feeds on the mammalian host (see Figure 1.3-1) (Vickerman 
(1988)).  Stumpy form trypanosomes subsequently initiate differentiation to the 
procyclic form primarily in the posterior midgut (Robertson (1913)) (Turner et al. 
(1988)) in response to a number of environmental cues (see Section 1.4 for details), 
and slender forms are either lysed by tsetse lectins and proteases (Sbicego et al. 
(1999)), or differentiate to the stumpy form and then the procyclic form.  The 
differentiation events of this transition are well characterised because it has been 
possible to induce the synchronous differentiation of stumpy forms cells to procyclic 
form cells with high efficiency (Brun and Schönenberger (1981)) (Ziegelbauer et al. 
(1990)) (Matthews and Gull (1994)).  Thus, a number of morphological, metabolic 
and surface coat changes have been described as part of a strictly ordered series of 
events. 
1.3.3.1 Surface coat remodelling 
The VSG homodimer is shed from the surface of the stumpy form parasite through 
the combined effect of glycosylphosphatidylinositol (GPI) -anchor hydrolysis and 
VSG homodimer proteolysis (Ziegelbauer et al. (1993)) (Gruszynski et al. (2006)) 
(Grandgenett (2007)).  The GPI hydrolysis enzyme, glycosylphosphatidylinositol-
specific phospholipase C (GPI-PLC) is expressed in blood forms but not procyclic 
forms (Bülow and Overath (1985)) (Carrington et al. (1989)) (Mensa-Wilmot et al. 
(1990)) (Webb et al. (2005)), present on the extracellular side of the cell surface 
membrane in stumpy forms (Gruszynski et al. (2003)) but not monomorphic slender 
forms (Bülow et al. (1989)), and contributes to the initial release of VSG upon 
initiation of differentiation.  This enzyme is subsequently down-regulated as 
differentiation progresses, after which proteolysis of the VSG molecule by the zinc 
specific metalloprotease MSP-B is thought to complete VSG shedding (Gruszynski 
et al. (2006)).  VSG shedding is complete within 8 hours of the initiation of 
differentiation (Gruszynski et al. (2003)) and as a consequence, endocytosis is 
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reduced in the procyclic form by a factor of 10 (Natesan et al (2007)) because the 
VSG surface molecule no longer recycles through the endocytic apparatus. 
Within 2 hours of exposure to cis-aconitate, stumpy form parasites express EP 
procyclins on their cell surface (Ziegelbauer et al. (1990)) (Rolin et al. (1993)) 
(Matthews and Gull (1994)) (Vassella et al. (1997)), and within 6 – 12 hours GPEET 
procyclin is detectable (Vassella et al. (2000)).  Similarly to VSG, these procyclins 
are bound to the cell surface membrane by a GPI-anchor; however, procyclins do not 
form homodimers and this GPI anchor is distinct from the blood form GPI-anchor in 
that it is insensitive to GPI-PLC, and is modified by the addition of different 
carbohydrate side chains such as polylactosamine (Ferguson et al. (1993)) 
(Treumann et al. (1997)) (Mehlert et al. (1998)). The function of these surface 
proteins are unknown.  However, GPEET is down-regulated in late procyclic forms, 
suggesting a role in the establishment of the initial infection, and the amino acid 
repeats at the C terminus may provide protection against digestive enzymes in the 
tsetse midgut (Acosta-Serrano et al. (2000)).  Moreover, despite EP procyclin null 
mutants showing no phenotype in culture, a reduction in the establishment of  heavy 
infections was observed (Ruepp et al. (1997)). 
1.3.3.2 Metabolic changes 
In contrast to the glucose rich mammalian blood stream, the tsetse fly represents a 
glucose depleted environment for the trypanosome cell (Vickerman et al. (1985)) 
(Vickerman et al. (1988)).  Thus, the procyclic cell develops an elaborated 
mitochondrion with an overall volume increase from 5% to 25% of cellular volume, 
exhibiting a branched network of discoid cristae (Vickerman et al. (1988)).  
Moreover, the procyclic form is enriched for cytochrome oxidase subunits associated 
with the electron transport chain (Tasker et al. (2001)) (Mayho et al. (2006)), and 
switches metabolism from glycolysis to utilising the amino acid proline as a carbon 
source in vivo (Evans and Brown (1972)) (Lamour et al. (2005)) (Bringaud et al. 
(2006)).  However, although the glycosomes change shape from spherical to rod-
shaped (Vickerman (1988)), in vitro they are still functional and the procyclic form 
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cell preferentially utilises glycolysis for its energy requirements when glucose is 
available (Kuile and Opperdoes (1992)) (Lamour et al. (2005)). 
1.3.3.3 Morphological changes 
Differentiation to the procyclic form is accompanied by a number of morphological 
changes.  The trypanosome increases in length from approximately 15µm to 25µm, 
with a specific elongation of the post-kinetoplastic portion of the cell body 
(Vickerman (1985)) (Matthews et al. (1995)), resulting in the repositioning of the 
kinetoplast away from the posterior of the cell.  Additionally, the flagellum extends 
beyond the anterior of the cell, contributing to the increased length of the procyclic 
form.  The resulting procyclic form is long and slim, and re-enters the cell cycle to 
proliferate in the tsetse midgut. 
1.3.4 Mesocyclic form 
Procyclic form trypanosomes differentiate to the mesocyclic form in the tsetse fly 
anterior midgut (Van den Abbeele et al. (1999)) (see Figure 1.3-1).  In vivo 
morphological observations demonstrate an increase in length from approximately 
25µm to 34µm in the anterior midgut (Van den Abbeele et al. (1999)).  Interestingly, 
mesocyclic trypanosomes in the anterior midgut appear to be cell cycle arrested in 
G1, leading us to draw parallels with the stumpy form that is receptive to a 
differentiation trigger. 
The mesocyclic trypanosome is less well characterised than the blood forms and the 
procyclic forms because it has not yet been possible to culture them.  Additionally, 
the triggers that induce differentiation from the procyclic to the mesocyclic form 
have not yet been identified, either in vivo or in vitro, thus analysis of this life cycle 
stage has been restricted to morphology, karyotype and site of tsetse infection 
location. 
1.3.5 Epimastigote form 
Differentiation to the epimastigote form is accompanied by migration through the 
peritrophic membrane and then the proventriculus, along the foregut to the salivary 
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gland (see Figure 1.3-1).  During this migration, mesocyclic form trypanosomes 
differentiate to the long post-mesocyclic trypomastigote, enter G2 arrest and 
differentiate to the short epimastigote form (see Figure 1.3-1) (Vickerman (1988)) 
(Van den Abbeele et al. (1999)) (Gibson and Bailey (2003)). 
Most distinctively, the trypomastigote post-mesocyclic cell repositions the 
kinetoplast from midway between the nucleus and the posterior of the cell, to 
anterior of the nucleus. Sharma et al. (Sharma et al. (2008)) report that this 
repositioning is due to a decrease in the distance between the nucleus and the 
posterior of the cell, and that position of the kinetoplast relative to the posterior 
remains constant. 
The differentiation to the epimastigote form is accompanied by an asymmetric cell 
division that results in one long and one short epimastigote form (Lewis and 
Langridge (1947)) (Van den Abbeele et al. (1999)) (Sharma et al. (2008)).  It is 
thought that the long form is terminal, and that the short form attaches to the salivary 
glands and continues the lifecycle (Sharma et al. (2008)). 
The short epimastigote form is attached to the salivary gland by junctional 
complexes between elaborations on the flagellum and the epithelial microvilli 
membrane (Vickerman (1985)).  Although DNA exchange has yet to be visualised, 
studies using fluorescent proteins suggest that sexual reproduction occurs at high 
efficiency in epimastigotes prior to attachment to the salivary gland (Gibson et al. 
(2008)). 
The epimastigote form expresses the cell surface protein family BARP (brucei 
alanine rich proteins).  Although originally identified as a blood form surface 
molecule (Nolan et al. (2000)),  BARP was recently shown to be specific for the 
epimastigote form (Urwyler et al. (2007)), and will provide a valuable diagnostic 
tool in dissecting out the molecular regulatory mechanisms of this lifecycle stage.  
Procyclin mRNAs are also expressed in epimastigotes, but protein was not detected 
either by immunofluorescence (Urwyler et al. (2005)) or MALDI-TOF (Acosta-
Serrano et al. (2001)), and none as yet have a clearly assigned function. 
1 - Introduction 17 
1.3.6 Metacyclic form 
Short epimastigotes differentiate to the metacyclic form while still attached to the 
insect salivary gland (Vickerman (1985)),  and enter G1 cell cycle arrest in readiness 
for completing the lifecycle (see Figure 1.3-1).  Metacyclic form trypanosomes are 
pre-adapted to evade the mammalian immune system through the expression of a 
variable surface antigen.  There are a number of interesting differences between 
metacyclic VSG expression and blood form VSG expression.  Metacyclic cells 
express a more limited VSG repertoire  (less than 27 in one stock of T.b. 
rhodesiense, compared to approximately 1000 in blood forms (Turner et al. (1988))), 
do not undergo antigenic variation, and do not re-arrange their telomeric DNA in 
order to activate VSG expression (Lenardo et al. (1986)) (Graham et al. (1990)) 
(Matthews et al. (1990)).  Thus, the same 15 – 20 metacyclic VSGs appear to be 
expressed when T. brucei is cyclically passaged through tsetse.  Additionally, 
metacyclic VSG expression is mono-cistronic with no expression site associated 
genes (ESAGs) between the promoter and the VSG (Alarcon et al. (1994)) and 
subject to control exclusively at the level of transcription initiation (Graham and 
Barry (1995)) by a locus specific mechanism (Ginger et al. (2002)).  Metacyclic 
VSG expression is heterogeneous within the population (Le Ray et al. (1978)) (Barry 
et al. (1979)) (Hajduk and Vickerman (1981)) (although only 1 metacyclic VSG 
isotype is expressed at the cell surface membrane of each cell), and the metacyclic 
VSG expression sites are found in the telomeres of large chromosomes, in contrast to 
the majority of blood form VSG expression sites that are found mostly in 
chromosomes less than 1000kb (Cornelissen et al. (1985)) (Lenardo et al. (1984)).  
Upon infecting the mammalian blood, the metacyclic VSG is expressed for 
approximately 6 days prior to switching to a blood form expression site (Esser et al. 
(1982)). 
During the differentiation process generating metacyclic forms, the glycosomes 
revert from rod shaped to the characteristic spherical shape observed in blood forms, 
and the mitochondrion reduces from a branched to a simple structure (Vickerman 
(1988)), suggesting a metabolic pre-adaptation to the mammalian blood stream.  In 
addition, the flagellar outgrowths that promote attachment to the salivary gland 
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epithelial cells are reduced and the cell is subsequently released into the tsetse 
salivary gland lumen such that upon tsetse feeding the metacyclic is injected into the 
blood stream (Tetley and Vickerman (1985)). 
Perhaps most strikingly, during this transition the kinetoplast repositions to a 
trypomastigote arrangement, whereby the kinetoplast is located between the nucleus 
and the posterior of the cell (Vickerman et al. (1988)).  The function of the 
repositioning of the kinetoplast throughout the trypanosome lifecycle is unknown; 
one might speculate that repositioning would effect the function of the flagellum 
throughout the lifecycle, or possibly be associated with different modes of 
metabolism.   The trypanosome goes to great lengths to regulate the relative position 
of the kinetoplast suggesting it has important implications. 
It has been noted in numerous studies that trypanosomes do not complete their 
lifecycle through tsetse with high efficiency (Letch (1984)) (MacLeod and Turner 
(1999)) (Peacock et al (2007)); however, once salivary glands are colonised, the 
tsetse remains infective until it dies, and thus have the potential to infect a high 
number of hosts throughout its 3 month lifespan. 
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Figure 1.3-1  The trypanosome lifecycle  (A)  The tsetse intestinal system is shown 
(adapted from Vickerman (1988)). (B) The different lifecycle stages are shown (adapted 
from Robertson (1913)). 
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1.4 Chemicals reported to induce slender to stumpy form 
differentiation 
In an naturally occurring, pleomorphic trypanosomes infection, slender forms are 
thought to differentiate to the stumpy form in response to cell density (Black et al. 
(1985)) (Seed and Sechelski (1989)) (Hamm et al. (1990)) (Reuner et al. (1997)); 
further analysis showed that this was due to an unidentified extra-cellular factor 
released by the trypanosomes, termed stumpy induction factor (SIF) (Vassella et al. 
(1997)).  The molecular pathways that regulate and control the differentiation of 
slender forms to stumpy forms remain largely unidentified (Vassella et al. (2001)) 
(Pfister et al. (2006)), although some progress has been made in characterising the 
types of pathway that might be involved, chiefly through the use of membrane 
permeable chemicals and inhibitors.  Progress in this field has been hampered by the 
lack of useful and unambiguous markers for the stumpy form, and hence the 
development of a quantitative bioassay.  A number of markers do exist, but are 
associated with mitochondrial activation, which has been shown to be implicated in 
oxidative stress response and cell death in eukaryotic cells (Giffin et al. (1986)) 
(Giffin and McCann (1989)) (Lin and Beal (2006)) (Sapienza et al. (2008)). 
1.4.1 The role of cAMP signalling 
Intracellular levels of cAMP have been implicated in G1 arrest in eukaryotic cells for 
a number of years (Froehlich and Rachmeler (1972)), and cells of malignant origin 
incapable of cell cycle control have very low, or no, membrane adenyl cyclase 
activity (Granner et al. (1968)) (Makman (1970)).  The first investigation of cAMP 
levels in Trypanosoma spp. showed that the stumpy form in Trypanosoma lewisi 
contains cAMP levels approximately double that of dividing, slender forms from an 
early parasitaemia (Strickler and Patton (1975)).  This was extended to include the 
intracellular concentrations of cAMP at different stages of parasitaemia in 
Trypanosoma brucei (Mancini and Patton (1981)) (Vassella et al. (1997)) and in 
response to conditioned media containing SIF (Vassella et al. (1997)).  Further, 
several chemical treatment affected stumpy formation, whereby a cAMP 
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phosphodiesterase (PDE) inhibitor, theophylline, blocked stumpy formation (Reed et 
al. (1985)), and a different PDE inhibitor, etazolate, induced stumpy formation 
(Vassella et al. (1997)).  However, etazolate has other possible targets in the cell, 
such as chloride channels. 
The most compelling evidence that cAMP signaling plays an important role in 
differentiation to the stumpy form was the observation that a membrane cAMP 
permeable derivative was able to induce transformation of slender cells to stumpy 
form cells (Vassella et al. (1997)).  The authors treated pleomorphic cells with 8-(4-
chlorophenylthio)-cAMP (or pCPTcAMP), a membrane-permeable derivative of 
cAMP that is relatively resistant to degradation by phosphodiesterases, and 
demonstrated differentiation to the stumpy form in response.  Non membrane-
permeable cAMP derivatives and 8-(4-chlorophenylthio)-cGMP (or pCPTcGMP) 
had no effect, suggesting intracellular cAMP signaling.  Interestingly, despite 
monomorphic cells being unable to respond to SIF in conditioned media, either 
though stumpy formation or increases in intracellular cAMP concentrations, 
monomorphic cells can differentiate to stumpy forms in response to pCPTcAMP, 
suggesting that they are not defective in all parts of the stumpy formation pathway 
(Breidbach et al. (2002)). 
Further investigation of the role of cAMP signaling in suggested that it was not the 
cAMP analogue itself that stimulated differentiation to the stumpy form, but rather 
the 5’-AMP/adenosine analog products of cAMP hydrolysis (Laxman et al. (2006)).  
The authors showed that non-hydrolysable, membrane-permeable, derivatives of 
cAMP did not induce stumpy formation, whereas membrane-permeable hydrolysis 
products of AMP/adenosine (such as 8-pCPT-2’-O-Me-ado) did, suggesting that 
AMP stimulates stumpy formation by an unknown route.  The SIF induced signaling 
pathway of stumpy formation has not yet been characterised, and few genes involved 
have, as yet, been identified (Vassella et al. (2001)) (Pfister et al. (2006)). 
1.4.2 Thiazolidinediones 
Thiazolidinediones such as troglitazone, rosiglitazone or ciglitazone are used as anti-
diabetic drugs due to their effects upon fatty acid and glucose metabolism (Henry 
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(1996)) (Wolffenbuttel and Graal (1996)) and have been implicated in cell growth 
inhibition and apoptosis in rat mesangial cells (Tsuchiya et al. (2003)), and adipocyte 
differentiation of preadipocyte and mesenchymal stem cell lines (Lehmann et al. 
(1995)).  This work has recently been extended to determine whether there was an 
effect upon T. brucei blood form growth and differentiation (Denninger et al. 
(2007)). 
The authors report that troglitizone induces stumpy formation in a dose dependent 
manner, and assay this using transformation to procyclic form efficiency, growth 
inhibition, cell cycle position, and mitochondrial activation.  However, although their 
extensive experiments suggest a possible mitochondrial activation that is in 
accordance with stumpy formation, some of the mitochondrial subunits do not show 
the extent of upregulation that one would expect.  For example, DHLADH protein 
expression was only increased 1.6 fold with respect to monomorphic slender form 
cells, and levels were not compared with that found in ‘true’ stumpy forms.  Perhaps 
more worryingly, troglitizone treated cells did not show an accumulation in G1 as 
judged by flow cytometry and karyotype analysis; in contrast, the troglitizone treated 
population of cells could not be distinguished from non-treated controls by cell cycle 
position.  Moreover, although the authors report an enhanced differentiation to the 
procyclic form in the troglitizone treated cells as judged by immunofluorescence 
analysis of VSG loss, differentiation was not quantified, and data regarding the 
number of cells expressing procyclin was not shown.  Furthermore, after 8 hours 
exposure of troglitizone treated cells to cis-aconitate, there did not appear to be high 
levels of differentiation, demonstrating that differentiation was not synchronous as 
would be predicted with true stumpy forms.  Troglitizone treated cells did show an 
initial enhanced cell growth in procyclic form media, but subsequently die at 10 days 
post citrate/ cis-aconitate induction, whereas control cells continue to grow, albeit 
slowly.  Additionally, morphological comparisons using a pleomorphic strain to 
determine whether troglitizone induces morphological differentiation to the stumpy 
form were not compared with a non-treated control.  Hence the observed 
morphological changes could represent normal stumpy form differentiation in 
response to SIF (Vassella et al. (1997)). 
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In summary, it is not clear whether troglitizone induces slender to stumpy form 
differentiation, and further analysis needs to be done.  Nonetheless, the anti-
proliferative properties of troglitizone may provide a useful route to trypanosomiasis 
control, as drugs of this class are already in use to treat diabetes. 
1.4.3 DL-α-difluoromethylornithine (DFMO) 
DFMO acts as a specific and irreversible inhibitor of ornithin decarboxylase (ODC), 
which catalyses the conversion of ornithine to putrescine, and thus causes an 
intracellular polyamine deficiency.  It was originally reported to have cancer cell 
anti-proliferative activity and is currently in development as an anti-trypanosomiasis 
drug against the late stage of the T. b. gambiense infection (Bacchi et al. (1980)) 
(Bacchi et al. (1994)) (Van Nieuwenhove et al. (1985)) (Doua et al. (1987)) (see 
Section 1.2.1.4).   
DFMO was reported to cause differentiation to the short stumpy form in the late 
1980s (Giffin et al. (1986)). (McCann et al. (1986)) (Giffin et al. (1989)).  DFMO 
treated cells demonstrated mitochondrial activation, stained positive for NAD 
diaphorase activity and exhibited a stumpy morphology; however, they were unable 
to transform to the procyclic form when incubated in SDM79 media and did not 
show uniform accumulation in their cell cycle.  The ability of DFMO treated cells to 
differentiate synchronously in response to citrate/ cis-aconitate was not tested.  
However, the high rate of cell death combined with the appearance of multinucleate 
cells suggests that the stumpy formation and mitochondrial activation reported may 
be accounted for by cellular stress induced by putrescine depletion.  Additionally, 
stumpy forms have subsequently been shown to have similar levels of ODC activity 
as slender forms, suggesting that putrescine depletion does not occur in this form 
(Bass and Wang (1991)).  Further analysis on the effect of DFMO and the role of 
polyamines in slender to stumpy differentiation may be required, especially in light 
of the therapeutic value of DFMO in treating African Trypanosomiasis. 
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1.5 Conditions reported to induce stumpy to procyclic form 
differentiation 
Several blood form to procyclic form differentiation triggers have been identified, 
these exhibiting differing efficiencies of induction. 
1.5.1 Incubation at 27°C 
The first recorded stimulus that was able to trigger blood form to procyclic form 
differentiation in vitro was a temperature shift from 37°C to 27°C (Evans and Brown 
(1971)) (Srivastava and Bowman (1971)) (Srivastava  and Bowman (1972)) (Brown 
et al. (1973) (Ghiotto et al. (1979)) (Bienen et al. (1980)).  Several researchers 
reported growth of trypanosomes that were sensitive to cyanide when parasites 
harvested from blood were incubated at 27°C, demonstrating a change to the insect 
form of metabolism.  This differentiation was shown to occur over the course of 72 
to 96 hours, with subsequent stable growth.  Further analysis documented the 
kinetics of differentiation, with approximately 20% and 90% differentiation after 24 
and 48 hours respectively, depending on the effects of different media substrates 
(Bienen et al. (1980)). 
1.5.2 Incubation at 27°C and the addition of tri-carboxylates 
Brun and Schönenberger (Brun and Schönenberger (1981)) showed that highly 
efficient and synchronous differentiation to the procyclic form could be induced by 
the addition of the tricarboxylates Krebs cycle intermediates citrate and cis-aconitate.  
A concentration of 2 – 10 mM cis-aconitate was the most efficient at stimulating 
differentiation, followed by citrate in the same range; differentiation was not detected 
using 0.1 mM of either of these tri-carboxylates, was saturated at concentrations of 8 
mM, and inhibited at concentrations above 16 mM, possibly due to cytoxic effects.  
Interestingly, and inexplicably, although no other tri-carboxylate was able to induce 
efficient differentiation, a mixture of all the tri-carboxylates in the absence of citrate/ 
cis-aconitate was able to induce differentiation.  Nothing further has been reported on 
this anomaly, suggesting that it may have been an experimental artifact. 
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This work was extended (Czichos et al. (1986)) to show that, although trypanosomes 
would differentiate at 37°C, a temperature reduction to 27°C in addition to citrate/ 
cis-aconitate was necessary for the establishment of a dividing procyclic form 
population.  Furthermore, the authors showed that exposure to cis-aconitate for  >8 
hours was necessary for a level of differentiation >2% after 72 hours, suggesting that 
these cells require a long exposure to citrate/ cis-aconitate to become fully committed 
to the procyclic form.  It is worth noting, however, that this latter study utilized the 
monomorphic strain MITat 1.4 that does not give rise to stumpy form cells, and that 
stumpy form cells express procyclin and undergo the other events of differentiation 
within 4 hours of exposure to citrate/ cis-aconitate (Ziegelbauer et al. (1990)) 
(Matthews and Gull (1994)) and will differentiate at 27°C in the absence of citrate/ 
cis-aconitate.  A discussion of the relative efficiencies of differentiation between 
monomorphic and pleomorphic cell types is detailed in Section 1.6. 
The ability to efficiently and synchronously recreate the differentiation of blood 
forms to procyclic forms in vitro has been invaluable in the dissection and analysis of 
the events associated with this transition.  However, the high concentrations required 
meant citrate/ cis-aconitate was excluded from being the physiological trigger.  In 
2004, however, Engstler et al. showed that when stumpy form trypanosomes are 
subjected to a cold shock of >15°C (i.e. from 37°C to 20°C), differentiation to the 
procyclic form was able to proceed at concentrations of cis-aconitate as low as 10 
µM, albeit with slower kinetics.  The concentration of citrate in the tsetse midgut is 
not known; although citrate concentrations in whole tsetse extracts has been reported 
to be 15.9 µM (Hunt et al. (1994)), this study did not determine the midgut 
concentration specifically.  However, citrate concentrations in human blood plasma 
has been reported to vary between 80 µM to 230 µM (Jacobs and Lee (1964)) 
(Taylor et al. (1998)).  Thus, trypanosomes taken up as part of a blood meal are 
exposed to concentrations of citrate that have been reported induce differentiation at 
20°C, suggesting that citrate, and possibly cis-aconitate, may well be an in vivo 
trigger for differentiation. 
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1.5.3 Mild acid treatment 
Rolin et al. (1998) investigated the role of other stimuli in promoting differentiation.  
The effects of mild acid treatment were investigated because firstly, mild acid 
treatment had been shown to play an important role in the differentiation of 
flagellated forms to amastigotes in Leishmania and T. cruzi (Kanbara et al. (1990)) 
(Zilberstein et al. (1991)) (Bates et al. (1992)) (Tomlinson et al. (1995)), and 
secondly, because mild acid stimulated a number of events that were associated with 
blood form differentiation, namely VSG release and activation of adenylate cyclase 
(Rolin et al. (1993)) (Rolin et al (1996)).  Rolin et al. (1998) report that when 
pleomorphic trypanosomes, comprising a mixed population of slender, intermediate 
and stumpy form parasites, were pre-incubated at pH 5.5 prior to incubation at 27°C, 
differentiation to the procyclic form was induced, albeit at a lower efficiency than 
when cells are incubated in cis-aconitate.  Interestingly, the authors reported that, 
although slender forms were quickly lysed under these conditions, intermediate 
forms were stimulated to differentiate to the stumpy form.  This demonstrates that (a) 
stumpy formation is enhanced by low pH (b) stumpy like cells are more resistant to 
pH changes, possibly as an adaptation to tsetse colonisation.  The latter was 
confirmed by Nolan et al. (2000).  The mechanism of stumpy form resistance to pH 
change is not known, but one might speculate that it is associated with an improved 
ability to maintain membrane potential. 
The physiological relevance of these findings is still not clear as the tsetse midgut pH 
exhibits an alkaline pH (Van den Abbeele et al. (1999)); however, the precise 
compartment in which trypanosomes initiate differentiation may not be the tsetse 
midgut, and parasites may be subjected to pH changes during uptake by the tsetse. A 
number of cellular factors are affected by pH change, including the operation of 
transporters, but the mechanism of action of mild acid-induced differentiation is not 
known. 
1.5.4 Proteolytic stress 
Differentiation of blood form trypanosomes in response to proteolytic stress was first 
described by Yabu and Takayanagi  in 1988.  The authors subjected cultured, 
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monomorphic Trypanosoma brucei gambiense to trypsin treatment and observed 
levels of differentiation comparable with that obtained through citrate/ cis-aconitate 
treatment; however, the percentage of cell death was high and a small founder 
population survived and differentiated (see Matthews and Gull (1997)), thus 
differentiation efficiencies cannot be usefully compared to citrate/ cis-aconitate 
induced differentiation.  Their work was extended using pleomorphic trypanosomes 
to include a mixture of microbial proteinases that induced differentiation at a higher 
efficiency than citrate/ cis-aconitate (Hunt et al. (1994)) (Sbicego et al. (1999)), and 
was lytic to long slender trypanosomes (Sbicego et al. (1999)). 
Studies using a tsetse midgut homogenate demonstrated that activities triggering 
differentiation were destroyed upon heating, and inhibited using trypsin inhibitors, 
suggesting that a protease component played an important role in vivo (Imbuga et al. 
(1992)).  Thus, proteinase treatment of trypanosomes may mimic the tsetse midgut, 
where a number of tsetse digestive enzymes are thought to operate.  The mechanism 
of operation is not known, however, and is thought to operate differently from the 
citrate/ cis-aconitate pathway. 
1.5.5 Replacement of glucose with glycerol in the media 
Milne et al. (Milne et al. (1998)) report the inefficient differentiation of blood form 
parasites at 37°C in response to replacing the glucose carbon source with glycerol.  
Differentiation was determined using a number of assays (including morphology, 
procyclin expression, CAP5.5 expression), and the resulting procyclic form 
trypanosomes appeared to divide with faster kinetics at 37°C than at 27°C.  The 
authors speculated that glucose deprivation may be an in vivo trigger, as glucose is 
thought to be depleted in the blood meal within 15 minutes of tsetse feeding 
(Vickerman (1985)) (Mike Turner, unpublished observations). 
This observation has a number of interesting implications, not least that temperature 
can be uncoupled from procyclic form proliferation.  This is in apparent contrast to 
previous observations using citrate/ cis-aconitate as a differentiation trigger (Czichos 
et al. (1986)) (Mutomba and Wang (1995)), whereby a temperature reduction to 
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27°C was required in order for trypanosomes to re-enter the cell cycle.  The 
significance of this disparity is not clear and has not been investigated further, but it 
does highlight that differentiation can be uncoupled from procyclic form 
proliferation.  This is supported by the observation that glucose, although having no 
effect upon differentiation per se, was found to inhibit the growth of transforming 
cells (Bienen et al. (1980)) and established procyclic cultures (Ebikeme et al. 
(2008)).  Thus, the differentiation observed by Milne et al. (1998) may be an 
example of founder effect combined with enhanced survival of procyclic form 
parasites in the absence of glucose. 
1.6 The relationship between cell cycle position, life cycle position, 
and competence to differentiate 
Robertson was the first person to suggest that slender cells do not transmit to the 
tsetse, and that intermediate and stumpy form cells form the establish the midgut 
infection (Robertson (1913)). Since then, this theory has been the centre of some 
controversy.  
The principal evidence supporting the stumpy, cell cycle arrested form, as being the 
transmission competent form comes from experiments demonstrating synchronous 
differentiation of stumpy form cells (Ziegelbauer et al. (1990)) (Matthews and Gull 
(1994)).  The authors showed that in a pleomorphic population, after 6 hours of cis-
aconitate treatment only cells identified as being stumpy form were expressing 
procyclin (Matthews and Gull (1994)).  Furthermore, an analysis of the 
differentiating population showed that of 175 dividing cells (as judged by 
karyotype), none were expressing procyclin.  The authors identified 2 possible 
explanations for this, (a) stumpy forms only were able to initiate differentiation, or 
(b) the ability to respond to cis-aconitate depended upon cell cycle position.  To 
investigate this further, the authors differentiated 2 monomorphic cell lines that had 
lost the capacity to transform into the stumpy form, and a very early pleomorphic 
population of cells comprising predominantly slender forms.  The authors showed 
that these cells differentiated very poorly in the first 6 hours (<10%, compared with 
>95% in a stumpy population), thus verifying that stumpy cells differentiated at a 
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much higher frequency than slender cells in the first 6 hours.  Importantly, the 
authors also showed that there was a delay in BrDU uptake in differentiating 
monomorphic cells, indicating that cells in this population enter cell cycle arrest.  
Thus, although the link between pleomorphic differentiation and cell cycle position 
is convincing, this paper does not conclusively link the ability to initiate 
differentiation to cell cycle position in monomorphic cells.  The reduced 
differentiation efficiency of monomorphic slender cells could be attributed to either 
i) that only a small proportion of cells that are in G1 is receptive to the differentiation 
trigger (thus termed stumpy*) or ii) slender cells are receptive to the trigger 
throughout the cell cycle, but respond with slower kinetics than stumpy form cells.  
Attempts to address this issue by determining the cell cycle position of differentiated 
monomorphic cells very early through differentiation were unsuccessful (Keith 
Matthews, personal communication). 
Opponents of this hypothesis support the view that trypanosome differentiation is 
distinct from differentiation in other eukaryotic cells, and reflects a simple change in 
gene expression levels, rather than a true differentiation (Mutomba and Wang 
(1996)) (Mutomba and Wang (1998)) (Li and Wang (2003)).  Thus, it is argued that a 
specific cell cycle position or G1/0 arrest is not necessary for efficient differentiation 
to the procyclic form.  To investigate this, a monomorphic cell line was generated 
that was able to inducibly ablate proteosomal subunits, and consequently enter cell 
cycle arrest in G1 and G2 (Li and Wang (2003)) .  The authors reported that this did 
not inhibit the differentiation of cells to the procyclic form, thus disproving a link 
between cell cycle progression and differentiation.  However, the cell cycle arrest 
reported in this paper was not convincing and was shown to have a high death rate, 
possibly resulting in secondary effects.  Moreover, a quantitative analysis of 
differentiation was not performed until 60 hours post-differentiation, such that 
interpretation of the data may have been complicated by procyclic form outgrowth.  
Additionally, their null hypothesis relies on procyclin expression being dependent 
upon cell cycle progression, rather than cell cycle position, which has been shown 
not to be the case (Matthews and Gull (1994)).  Perhaps more convincingly, the 
authors subjected a pleomorphic population of cells to chemical inhibitors of DNA α 
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polymerase (using aphidicolin (APH)) and DNA synthesis (using hydroxyurea 
(HU)), giving rise to cells arrested in G2 that appeared to differentiate (Mutomba and 
Wang (1996)).  However, these cells did not differentiate as well as control cells and 
the high rate of cell death may have complicated the subsequent analysis. 
The evidence indicates that stumpy forms are able to differentiate with much higher 
efficiency than slender forms, and that true slender forms may not be able to 
differentiate at all.  However, when explaining the low levels of differentiation in 
monomorphic cells at early timepoints, it is very difficult to distinguish between low 
frequency of differentiation initiation (possibly due to a requirement for cell cycle 
arrest in G1), and the reduced speed of differentiation once it is initiated; thus, this 
issue is not fully resolved. 
1.7 Transporters 
Transporters represent a very large subset of genes in the parasitic protozoa;  
between  2 – 2.5% of genes in the ‘tritryp’ genome database are annotated as having 
a transporter-like function (Berriman et al. (2005)) (Ivens et al. (2005)) (El Sayed et 
al. (2005)).  In addition to their intrinsic biological importance in nutrient scavenging 
and environmental sensing, transporters play a central role in drug intervention in 
trypanosomes through either (i) enabling uptake or (ii) enabling efflux of toxic drugs  
For example, the T. brucei transporter TbAT1, that is responsible for uptake of 
adenosine and adenine from the host blood, plays a crucial role in sensitivity to 
melarsoprol, as resistant trypanosomes have been shown to lack this transporter 
(Carter and Fairlamb (1993)) (Carter et al. (1995)).  Other transporters, such as 
HAPT1 and LAPT1, appear to mediate the uptake of pentamidine and 
melaminophenyl arsenical drugs (Matovu et al. (2003)).  Additionally, transporters 
themselves can be good candidates as drug targets; Leishmania glucose transporter 
null mutants are not viable in the blood because glucose is an essential precursor in 
synthesizing glucoconjugate and complex carbohydrates (Landfear (2008)).  Hence, 
an inhibitor of this transporter may have blood form trypanocidal activity.  
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Thus, understanding the role of transporters in pathogenic organisms, and the 
mechanism of substrate transfer, is of principal importance in the rational design of 
anti-parasitic drugs.  Currently, bioinformatics is a poor tool for predicting 
transporter substrate specificity and function; however, with more experimental data 
and better algorithms, this can be expected to change in the next few years. 
1.7.1 Adenosine binding cassette (ABC) transporters 
ABC transporters are ubiquitous molecules found in prokaryotic and eukaryotic cells, 
both at the cell surface and in organelles.  They catalyse the translocation of a diverse 
range of substrates across the cell surface membrane, often against the concentration 
gradient, using the energy release when ATP is dephosphorylated to ADP (Higgins 
(1992)). 
Bioinformatics based prediction of ABC transporters has become a valuable and 
reliable tool due to the well defined domains and conserved motifs in this group of 
proteins.  They contain two nucleotide binding domains (NBDs) that are 
characterised by the conserved ABC signature, the Walker A and the Walker B 
motifs (Walker et al. (1982)) (Higgins et al. (1985)) (Higgins et al. (1986)).  In the 
cystic fibrosis transmembrane conductance regulator (CFTR) channel, one NBD is 
associated with ‘opening’, and the other is associated with ‘closing’ the channel 
(Carson and Welsh (1995)) (Cotten and Welsh (1998)) (Gadsby and Nairn (1999)) 
(Vergani et al. (2003)). 
Mutations in ABC genes have been associated with a number of diseases; for 
examples, mutations in the NBD of the CFTR gene have been linked with cystic 
fibrosis.  Other ABC genes have been linked with drug resistance; for example, Pgp 
encoded by MDR1 gene in human tumors has been shown to export multiple anti-
cancer drugs (Ambudkar et al. (1999)) (Gottesman et al. (2002)) (Tombline et 
al.(2004)).  To date, 18 ABC transporters have been found in Trypanosoma brucei, 
36 in Leishmania, and several have been associated with drug resistance  
(Hendrickson et al. (1993)) (Chow et al. (1993) (Ouellette et al. (1998)) (Katakura et 
al. (1999)) (Shahi et al. (2002)). 
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1.7.2 Equilibrative nucleoside transporters (ENT) 
Trypanosomes cannot synthesis purines de novo (Hammond and Gutteridge (1984)) 
(Fairlamb (1989)) and consequently have efficient means for scavenging nucleosides 
from the extracellular environment. Thus far, 8 cell surface membrane purine 
transporter have been identified in Trypanosoma brucei (Sanchez et al. (2004)) (De 
Koning et al. (2005)), and all are members of the ENT family. ENT proteins are 
monomeric, are predicted to have 11 transmembrane helices and utilize a pre-
existing chemiosmotic gradient to translocate substrates across the lipid bilayer.  
Despite being named after the properties of the first mammalian member of this 
group to be characterised, some protozoan members concentrate their substrate 
utilizing a proton gradient (Landfear (2001)), whereas others transport non-
nucleoside substrates such as nucleobases (Henriques et al. (2003)).  
Protozoan ENTs have been distinguished based upon their substrate specificity 
(Carter and Fairlamb (1993)): P1 transporters are specific for inosine and adenosine, 
whereas P2 transporters are able to transport adenine, and the trypanocidal 
melaminophenyl arsenicals and diamidines.  For this reason, most research into 
kinetoplastid ENTs has concentrated on the P2 type transporters, such as TbAT1, 
HAPT1 and LAPT. 
1.7.3 Major Facilitator Superfamily (MFS) 
The MFS represent the largest family of transporters (Henderson and Maiden (1990)) 
can be found in all types of cell, and allow the uptake of nutrients, excretion of 
metabolic end-products and environmental sensing (Mitchel (1957)) (Grifith et al. 
(1992)) (Marger and Saier (1993)) (Essenberg et al. (1997)) (Pao et al. (1998)).  
They are secondary transporters able to catalyse the translocation of a wide range of 
low molecular mass substrates across a membrane by utilising a net chemiosmotic 
gradient (Paulsen et al. (1998)).  In this way, many members of the MFS utilise a 
cationic gradient to transport a substrate against its concentration gradient, for 
example; the E. coli lactose permease (LacY) is a member of the MFS that 
translocates galactoside into the bacterial cell against its concentration gradient by 
utilising the proton concentration difference between the intra- and extra-cellular 
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environments (Matsushita et al. (1983)).  Elegantly, this proton gradient is generated 
by the action of active proton pumps, and in common with other MFS transporters, 
translocation can be reversed if the respective gradients are reversed. 
Members of the MFS are predicted to have either 6, 12 or 14 transmembrane 
spanning helices (TMS) (Goswitz and Brooker (1995)); it is thought the 6 TMS MFS 
is a product of an evolutionary duplication of an ancestral 3 TMS transporter, and 
that the 12 TMS MFS resulted from the 6 TMS being duplicated, with an extra 2 
TMS becoming duplicated in the 14 TMS (Griffith et al. (1992)) (Henderson and 
Maiden (1990)) (Paulsen and Skurray (1993)).  MFS have a conserved motif between 
TMS 2 and 3, and another between TMS 8 and 9 (Henderson and Maiden (1990)).  
There is no evidence that wild type MFS act as multimers (Sahin-Tóth et al. (1994)); 
however, mutant MFS whereby several TMS have been deleted are able to be 
complemented by other mutants where the respective TMS are present, showing up 
to 60% wild type activity (Bibi and Kaback (1991)).  By far the most well studied of 
the MFS are those containing 12 TMS; members of the 6 and 14 TMS are fewer and 
less well characterised. 
The hydrophobic nature of transporters, and their transitory configurations, makes 
them inherently difficult to crystallize, meaning that few structures have been 
resolved.  The generation of a mutant thermostable LacY that favours one 
conformation facilitated the crystallization of this transporter in 2003 (Abramson et 
al. (2003)); the TMS are arranged as two groups of 6 helix bundles, whereby each of 
the TMS passes through the membrane such that a hydrophilic circular pore is 
formed.  In the open conformation, side chains within the TMS are available for 
substrate binding deep within the pore, and subsequent translocation upon 
conformational change.  This basic model has been applied to the rest of the MFS, 
although it is clear that there will be variation between transporters, especially those 
that contain different numbers of TMS, and much work is continuing to determine 
the precise mechanism of transport and which residues are involved at each stage. 
Other members of the MFS include the multidrug resistance (Mdr) transporters that 
are characterised by their ability to export a wide range of drugs from pathogenic 
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microorganisms or cancer cells.  These appear to form numerous, weak hydrophobic 
bonds between the substrate and the side chains within the pore, possibly explaining 
their wide substrate specificity (Neyfakh (2002)).  Other transporters, with more 
specific substrates, have fewer, stronger and more specific hydrogen bonds with a 
narrower range of substrates. 
A number of MFS transporters have been characterised in T. brucei and other 
kinetoplastids.  In particular, the Glucose transporter (GLUT) family in Leishmania 
(Langford et al. (1994)) (Snapp and Landfear (1997)) (Burchmore and Landfear 
(1998)) (Rodriguez-Contreras and Landfear (2006)) (Rodriguez-Contreras et al. 
(2007)) is of particular importance as the energy requirements of the blood form 
parasite are met exclusively through glycolysis. 
1.7.4 Channels 
1.7.4.1 Aquaporins 
Aquaporins are tetrameric, membrane bound protein channels that selectively allow 
the transfer of small molecules, such as water or glycerol, across the lipid bilayer.  
They serve crucial functions in cells, such as osmoregulation, size control, and in 
multicellular organisms help to maintain homeostasis of the organism.  Aquaporins 
form tetrameric channels, whereby each monomer consists of 6 α transmembrane 
helices.  Within the tetramer, each monomer forms a distinct pore that penetrates the 
lipid bilayer, allowing access for substrate molecules.  The α helices are orientated in 
such a way that hydrophobic helices face the surrounding bilayer, and hydrophilic 
helices face inward to form the hydrophilic pore.  Each monomer contains 2 distinct 
Asn-Pro-Ala (NPA) signature motifs that appear to be important for specificity in 
some aquaporins (Fujiyoshi et al. (2002)). 
The principal mechanism of aquaporin selectivity is size exclusion.  For example, in  
AQ1, a mammalian water-specific aquaporin, each monomer narrows to 2.8 Å above 
and below the lipid bilayer such that entry of molecules larger than H2O into the pore 
is excluded (Sui et al. (2001)).  Additionally, the NDC of AQ1 contains a pair of 
dipoles; in order to cross the channel each water molecule must interact with the 
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dipole, thus isolating it from surrounding water molecules and preventing access of 
H+ ions.  Other aquaporins are required to maintain homeostasis, cell size or osmotic 
potential.  In plant cells, aquaporins allow access of CO2 for photosynthesis (Uehlein 
et al. (2003)), and in the kidney duct-epithelial cells, aquaporins are released onto the 
cell surface from intracellular storage vesicles in response to vasopressin binding and 
the association with another membrane bound protein (Kamsteeg et al. (2007)) 
(Kamsteeg et al. (2008)), thus increasing the water permeability of the cell surface 
membrane. 
Kinetoplastids have several characterised aquaporins that are thought to enable the 
parasite to survive the differences in osmotic potential between different hosts 
through the lifecycle, to regulate variations in the cellular volume in different 
lifecycle stages, and to transport small molecules.  In T. brucei, 3 aquaporins have 
been characterised that are differentially regulated throughout the lifecycle, and are 
able to transport water for osmoregulation, and glycerol, a waste product of 
glycolysis (Uzcategui et al. (2004)). 
1.7.4.2 Ion channels 
Ion channels allow the highly selective passage of ions such as Na+, Ca+, K+ and Cl- 
across the lipid bilayer in response to an ionic gradient (Dutzler (2004)).  These 
molecules are required to maintain a constant intracellular pH for efficient enzyme 
function, nervous system signalling, and also to form the ionic gradients that are 
required to facilitate transport of other solutes (Kavanaugh (1998)).  They contain a 
variable number of transmembrane helices (up to 24 helices per channel) (Saier 
(2000)), and the mature, functional protein is often a multimer (Nelson et al. (1999)) 
(Liapi and Wood (2005)).  Ion channels have particular relevance to single celled 
parasites such as Trypanosoma brucei due to the fluctuation of extracellular pH 
throughout the parasite lifecycle. 
In contrast to other types of transporter which are found in several transitory states 
throughout substrate translocation, ion channels function as ‘open’ or ‘closed’ gates 
(Jiang et al. (2002)).  When in the open conformation, solute passage can occur with 
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very high flux (up to 108 ions transported per second), and can help to build a 
concentration gradient by utilising the existing concentration gradient of a co-
transported molecule (Kavanaugh (1998)).  Ion channels can be classified by the 
mechanism of gate switching, including the voltage gated and ligand gated ion 
channels (Saier (2000)), whereby either a change in the electrical potential difference 
or ligand binding respectively causes a conformational change in the channel, 
resulting in an open or closed gate. 
A number of ion channels have been annotated in the T. brucei genome (Berriman et 
al. (2005)), and several have been subsequently detected by proteomic analysis 
(Bridges et al. (2008)); however few have been characterised in detail due to the 
inherent difficulties associated with detecting hydrophobic proteins. 
1.8 DiD1 generation and identification of the Proteins Associated with 
Differentiation (PAD) gene family 
In order to help elucidate the mechanisms underlying differentiation, a cell line was 
selected for that was unable to initiate differentiation to the procyclic form in 
response to cis-aconitate (Tasker et al. (2000)) (see Figure 1.8-1).  The selection 
regime for this relied on two biological characteristics: firstly, the variant surface 
glycoprotein (VSG) protects the blood form parasite against lysis by the mammalian 
alternative complement lysis pathway (Ferrante and Allison (1983)) and, secondly, 
that blood form parasites lose their VSG coat as one of the first steps of 
differentiation (Gruszynski et al. (2003)) (see Section 1.3.3.1 for details).  Thus, the 
monomorphic slender T. b. rhodesiense East African Trypanosomiasis Research 
Organization (EATRO) 2340 GUP2965 cell line was incubated with 6 mM cis-
aconitate in SDM79 at 27°C and monitored for VSG loss.  When 99% of cells were 
identified as VSG-negative by immunofluorescence analysis, the cells were pelleted 
and inoculated into a mouse in order for the remaining 1% of parasites to form an 
infection, thus providing a very powerful selection pressure for cells that do not lose 
their VSG surface coat in response to cis-aconitate.  After 4 cycles of differentiation 
and selection, the population of cells was clearly less able to differentiate, and the 
Defective in Differentiation cell line 1 (DID1) was cloned for analysis. 
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Analysis of the DiD1 cell line defect revealed that the majority of cells were 
impaired in their ability to differentiate in response to cis-aconitate: in addition to not 
losing their VSG surface coat, these cells did not gain procyclin, undergo kinetoplast 
repositioning, mitochondrial elaboration, or any of the hallmarks of differentiation.  
The authors concluded that since VSG loss is an early indicator of differentiation, the 
DiD1 cell lines fails to initiate differentiation in response to cis-aconitate (Tasker et 
al. (2000)). 
Importantly, a small sub-population of DiD1 cells were able to differentiate, 
comparable to differentiation in the absence of cis-aconitate (approximately 0.2% of 
cells can gain a procyclin coat after 72 hours incubation at 27°C regardless of the 
presence or absence of cis-aconitate).  This suggested that it was not differentiation 
per se that was impaired, but rather the cis-aconitate response pathway.  Other 
differentiation triggers were not reported (Tasker et al. (2000)), but subsequent 
analysis demonstrated that both DiD1 and parental cells underwent massive cell 
death in response to protease and mild acid treatment, as would be expected with a 
monomorphic slender population (Maria Tasker, unpublished observations).  
However, both the DiD1 cells and the parental cells were able to establish midgut 
infections in tsetse (Maria Tasker, unpublished observations).  This demonstrates 
that, in vivo, differentiation can operate independently of citrate/ cis-aconitate 
pathways, and that DiD1 cells were able to respond to other triggers. 
Interestingly, the authors were able to rescue the differentiation defect by generating 
DiD1 ∆GPI-PLC mutants.  In order to determine whether the DiD1 cells that were 
able to differentiate were doing so by a non cis-aconitate mediated pathway, the 
authors removed GPI-PLC from the DiD1 cell line through sequential rounds of gene 
knockout, and tested this cell line to determine whether the small numbers of cells 
able to differentiate was now lost.  The rationale for this was that it had been 
proposed that inefficient differentiation is facilitated by a GPI-PLC mediated 
pathway (Rolin et al. (1998)).  Surprisingly, when ∆GPI-PLC DiD1 cells were grown 
to a very high parasitaemia in immunosuppressed mice, cells reverted to a 
morphologically pleomorphic population and were able to differentiate efficiently in 
response to cis-aconitate.  This effect was not shown when cells were grown in 
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culture, and the reversion to a pleomorphic morphology was probably not a specific 
characteristic of DiD1 cells.  The authors speculated that the rescue of the 
differentiation phenotype was due to the attenuated in vivo growth caused by GPI-
PLC deletion (Webb et al. (1997)) allowing the accumulation of a cryptic, stumpy-
specific, characteristic that allows reception of the cis-aconitate signal. 
In order to further understand the DiD1 defect, and thus to gain insight into the 
mechanisms underlying cis-aconitate induced differentiation, Davies and Levin 
(University of Manchester) performed a macroarray hybridisation analysis to identify 
transcripts that were differentially regulated between the DiD1 and the parental cell 
line.  A macroarray was generated from a sheared genomic DNA library (a kind gift 
from Prof. E. Ullu, Yale University, USA) and probed with radiolabelled cDNA 
from the DiD1 and the parental cell line.  This identified 1 clone as differentially 
hybridizing to DiD1 cDNA, and not parental cDNA.  This clone was subsequently 
shown to contain sequence from two adjacent genes on chromosome 7.  These genes 
were part of an 8 gene cluster, and named Proteins Associated with Differentiation 
(PAD) 1 – 8. 














Figure 1.8-1  Selection of the DiD1 cell line.  Monomorphic slender cells were induced 
to differentiate by incubation with 6 mM cis-aconitate at 27°C, and monitored for VSG 
loss.  Subsequent to 99% VSG loss, cells were pelleted and injected into a mouse.  The 
resulting parasitaemia was isolated and cells were purified by anion exchange prior to 
undergoing another round of selection.  After 4 rounds of selection, the population of cells 
was clearly less responsive to differentiation conditions, and the Defective in 
Differentiation cell line 1 (DiD1) was cloned. 
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1.9 Aims and objectives 
Work undertaken as part of this thesis has aimed to 
• Determine the basis of the DiD1 defect 
• Functionally characterise members of the PAD array, with particular 










Materials and Methods 
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2 Materials and Methods 
2.1 Trypanosomes 
2.1.1 Strains and cell lines 
Unless otherwise stated, the trypanosome cell lines used in this study are derived 
from the Trypanosoma brucei brucei Lister 427 strain (henceforth they are 
abbreviated ‘427’).   These are laboratory adapted, monomorphic and non-human 
infective.  The origin of this cell line is detailed in Professor George Cross’s web 
page (http://tryps.rockefeller.edu/). 
The 427 derived ‘S16’ is a blood stream form cell line used for RNAi and has been 
engineered to constitutively express T7 polymerase and the tetracycline repressor 
protein from the non-transcribed spacer of the ribosomal DNA locus (Wirtz et al. 
(1999)).  This allows the target mRNA transcript to be ablated upon induction with 
tetracycline. T7 polymerase expression is relatively deleterious to the cell, so this cell 
line was maintained in 2.5 µg ml
-1
 G418 to ensure retention of the T7 polymerase 
gene. 
The 427-449 cell line is the Lister 427 transfected with the pHD449 construct (Wirtz 
et al. (1999)) used for inducible, ectopic expression in both blood forms and 
procyclic forms.  It contains the tetracycline repressor gene integrated into the 
tubulin locus and transcription is driven by read-through transcription.  This cell line 
is phleomycin resistant, stable, and does not need to be maintained in selective 
media. 
The monomorphic DiD1 cell line was derived from T.b.rhodesiense GUP 2965.3 
through successive rounds of selection against cells that are able to initiate 
differentiation (Tasker et al. (2000)). 
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AnTat 1.1 (van Meirvenne et al. (1975)) and the derived ‘90:13’ cell line containing 
T7 polymerase and the tetracycline repressor protein (Engstler et al. (2004)) (a kind 
gift of Markus Engstler and Michael Boshart) are both Trypanosoma brucei brucei, 
pleomorphic, and are thought to be competent to complete the lifecycle through 
tsetse flies. 
2.1.2 Culturing 
Laboratory adapted blood form trypanosomes were cultured in HMI9 media in 5% 
CO2 (Hirumi and Hirumi (1989)) using vented flasks (Greiner).  Blood forms were 
maintained in logarithmic growth between 1 × 10
5




.  Cell counts 
were performed on a Beckman Coulter Z2 Coulter Particle Counter and Size 
Analyzer calibrated to 2.5 – 7.0 µm. 
Pleomorphic blood forms were cultured in completed HMI9 media (Hirumi and 
Hirumi, (1989)) supplemented with 0.55% or 1.1% methylcellulose (for AnTat 1.1 or 





maintenance of logarithmic growth (McCulloch et al. (2004)).  Cell counts were 
performed using a haemocytometer (see above). 
Procyclic form trypanosomes were cultured in SDM79 (Cross and Manning (1973)) 
(Brun and Schonenberger (1979)) in sealed flasks.  They were maintained in 
logarithmic growth between 1 × 10
6




. Where procyclic forms 
were obtained from differentiated blood forms, SDM79 was supplemented with 
10mM glycerol to maintain the cells in early procyclic form and to help form an 
established culture. 
Cryopreserved stocks were made by centrifuging 10 ml of culture in logarithmic 
growth phase at 600g for 10 minutes.  The pellet containing the cells was 
resuspended in 0.5 ml of supernatant, to which 0.5 ml of HMI9 supplemented with 
14% glycerol was added, followed by gentle vortexing.  This was placed into a 
cryovial at -80° C in a polystyrene insulator to allow slow freezing.  After 2 days, the 
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cryovial was placed into a normal freezer box and stored at -80° C.  Long term 
storage was in liquid nitrogen. 
2.1.3 Purification of trypanosome cells from blood 
Trypanosome cells were purified from mouse blood by passing them over a DEAE 
cellulose anion exchange column (Lanham and Godfrey (1970)).  Briefly, DEAE 
cellulose was mixed with PSG pH 7.8 and allowed to settle in a glass column.  1 – 2 
ml of blood was obtained by heart puncture and pippetted on to the top of the 
cellulose column.  PSG was pippetted on to the column such that the trypanosome 
cells flowed through the column leaving the mouse blood cells within the matrix.  
The flowthrough was observed until it was no longer cloudy and subsequently 
centrifuged at 800 g for 10 minutes prior to use.  Note that all mouse handling was 
performed by Deborah Hall or Keith Matthews, who are licensed to do this work. 
2.1.4 Differentiation 
2.1.4.1 Cis-aconitate induced differentiation 
Unless otherwise stated, trypanosomes were differentiated from the blood form to the 
procyclic form by incubation in HMI9 or SDM79 media supplemented with 6 mM 
cis-aconitate, at 27°C in non-vented flasks.   
Differentiation was assayed at various time-points post induction.  Cells were either 
assayed using flow cytometry analysis or immunofluorescence to quantify the 
proportion of cells that were positive for the procyclic form marker, EP procyclin.  
Usually, 2 × 10
4
 cells were analysed using flow cytometry, and 250 cells were 
analysed using immunofluorescence. 
2.1.4.2 BZ3 induced differentiation 
A stock solution of 67 mM BZ3 (chemical name: 3-(3,5-Dibromo-4-hydroxy-
benzoyl)-2-ethyl-benzofuran-6-sulfonicacid-(4-(thiazol-2-ylsulfamyl)-phenyl)-
amide) (Calbiochem) in dimethyl sulfoxide (DMSO) was added to trypanosomes in 
HMI9 or SDM79 at a final concentration of 150 µM (Szöor et al. (2006)).  Cells 
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were incubated at 27°C and procyclin expression was monitored as described 
previously. 
2.1.4.3 Pronase induced differentiation 
Cells were washed in PSG pH 7.4 and resuspended in PSG supplemented with 4 U 
ml
-1
 Pronase (Sigma) for 10 minutes at 25°C.  Cells were washed twice with PSG, 
resuspended in SDM79, and incubated at 27°C (Hunt et al. (1994)) (Sbicego et al. 
(1999)). 
2.1.5 Transfection 
Two methods based on electroporation were used when transfecting trypanosomes. 
2.1.5.1 BTX 
For each transfection, 10 ml of cells in mid-log growth were centrifuged at 600 g for 
10 minutes.  The cells were washed in half volume of ZFPMG (blood form parasites) 





.  DNA was prepared by restriction enzyme digestion of 15 µg of 
ultrapure plasmid overnight and purifying this through a nucleospin column 
(Macherey-Nagel). Electroporation was performed in 4 mm gap Electroporation 
cuvettes (Molecular BioProducts) using a BTX Electro Square Porator ECM830 set 
to 3 pulses of 1700V, 100 µs duration, at 200 ms intervals.  Cells were recovered 
overnight in 10 ml HMI9 and plated out the next day in selective media at 




.  Transfectants required passaging 7 – 10 days post 
selection; if less than 30% of wells survived these were likely to be clonal. 
2.1.5.2 Amaxa nucleofection 
The Amaxa nucleofection has been reported to give 1000x higher yield of stable 
transfectants (Burkard et al. (2007)), and has been used with much success in this 
study. 
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2.1.5.2.1 Transfection of monomorphic cells 
4 × 10
7
 cells per transfection were centrifuged at 600g for 10 minutes and 
resuspended in 100 µl of Amaxa T cell buffer.  DNA was prepared by overnight 
restriction enzyme digestion of 15 µg of ultrapure plasmid, purification through a 
Nucleospin column (Macherey-Nagel) followed by ethanol precipitation and 
resuspension in 5 µl of TE buffer.  Electroporation was performed on the DNA 
mixed with the cells in the cuvettes supplied using the Amaxa nucleofector machine 
and programme X001.  Cells were recovered overnight in 25 ml HMI9 and cultured 
thereafter in selective media.  After 7 – 10 days the mock transfected cells were 
dead; if clonal cell lines were required it was often necessary to clone through 
limiting dilution in 24 well plates. 
2.1.5.2.2 Transfection of pleomorphic cells 
Transfection of pleomorphic cells is much more technically challenging than with 
monomorphic cells.  The protocol was performed as described (McCulloch et al. 
(2004)).  Cells from an early stage infection in mice (3 – 4 days, depending on the 
infection) with few, or no, intermediate or stumpy forms were purified from the 
mouse blood by centrifugation at 7000 rpm in a tabletop centrifuge, and using a 
yellow tip with the end cut off to take the white buffy coat.  The red blood cell/ 
trypanosome mixture was transfected as described for monomorphic cells using the 
AMAXA nucleofection protocol (see 2.1.5.2.1).  Cells were allowed to equilibrate in 
HMI9 media for 2 hours prior to being centrifuged and transferred at a concentration 




into HMI9 media supplement with 1.1% methyl 
cellulose.  Half of the cells were plated into the top row of a 24 well plate (1 ml per 
well) and serial diluted 1:10 in methyl cellulose containing media, such that the final 
dilution of cells was 1:1000. The rest of the cells were allowed to remain in a vented 
flask.  All cells were recovered overnight at 37°C in 5% CO2 to allow expression of 
the  drug resistance protein, and an equal volume of 2 × selective media (i.e. at 
double the normal concentration of drug) was added to the flask, and each well, such 
that the final concentration of selective drug was that normally used for selection of 
blood form parasites.  Parasites in the flask were maintained at a concentration of < 5 





 throughout selection. Non-transfected control parasites were 
monitored for cell death; 5 – 7 days post selection, transfectant wells, or parasites 
from the flask, were centrifuged and inoculated into a cyclophosphamide treated 
mouse.  Blood from the resulting parasitaemia was harvested by heart puncture and 
freezer stocks were made as described (see Section 2.1.2) using a 1:1 ratio of blood: 
freezer mix. 
2.1.5.2.3 Transient transfection of pleomorphic cells 
Cells were taken from an early stage parasitaemia and purified by DEAE cellulose 
anion exchange (see Section 2.1.3).  The cells were then centrifuged and transfected 
using 100 µg of uncut, ultra-pure plasmid DNA using the Amaxa nucleofection 
protocol (see Section 2.1.5.2), and allowed to recover in HMI9 media that had not 
been supplemented with methyl cellulose.  Experiments were performed either 24, or 
48, hours post transfection.  
Note that the stage of parasitaemia was critical for experiments performed in this 
study.  To induce RNAi prior to expression of stumpy specific proteins, a 3 – 4 day 
parasitaemia with < 2% intermediate or stumpy forms was required.  Cells isolated 
too early in the infection did not differentiate to the stumpy form, and consequently 
died such that analysis could not be performed. 
2.1.5.2.4 Drug concentrations 
The blood form selective drug concentrations used in this study were: Hygromycin 2 
µg ml
-1
, phleomycin 2.5 µg ml
-1
, G418 1 µg ml
-1
, puromycin 0.5 µg ml
-1
 (Sigma). 
2.1.6 Inducing cold shock 
Stumpy form trypanosomes were purified from mice over a diethylaminoethyl 
cellulose (DE52) (Whatman) column, centrifuged, resuspended in HMI9, and 
incubated at 37°C, 5% CO2 in vented flasks for 2 hours to equilibrate and recover.  
All solutions were pre-warmed to prevent inadvertent cold shock.  Cells to be cold 
shocked were placed in non-vented culture flasks at 20°C for 18 – 24 hours.  
2 – Materials and Methods 48 
2.2 Bacteria 
2.2.1 Strains 
Escherichia coli XL1- blue cells of genotype: SupE44, hsdR17, recA1, endA1, 






)].  This strain gives 
good yields of high quality DNA and is suitable for beta-galactosidase based 
screening. 
2.2.2 Transformation 
100 µl of prepared cells were incubated with transforming DNA such that the 
volume of DNA did not exceed 5% of the final volume (i.e. 5 µl).  After 30 minutes 
incubation on ice, the cells were subjected to heat shock of 42°C for 30 seconds, and 
were immediately placed on ice for 2 minutes.  The cells were recovered in 300 µl 
LB or SOC for 1 hour at 37°C shaking at 220 RPM.  The cells were then plated onto 
LB agar supplemented with 100 µg ml
-1
 ampicillin and incubated overnight at 37°C.  
Transformation efficiencies were approximately 10
7




2.3 Molecular Biology techniques 
2.3.1 Polymerase Chain Reaction 
The following represents a standard PCR reaction: 20% 5× buffer, 0.2 mM dNTPs, 
1.5 mM MgCl2, 1 µM forward primer, 1 µM reverse primer, 0.0375 units µl
-1
.  A 
standard cyclical reaction for a non-proof reading polymerase such as GoTaq or Taq 
(Promega) was: 95°C denaturation for 30 seconds, 55°C annealing for 30 seconds, 
72°C elongation for 1 minute kb
-1
 for 30 cycles.  An initial denaturation of 95°C for 
5 minutes and a final elongation of 72°C for 2 minutes kb
-1
 were also performed in 
addition to the standard 30 cycles.  If a blend of a proof reading polymerase and non-
proof reading was used, such as ‘Expand Polymerase’ (Roche), then the elongation 
times were doubled.  Reaction buffers were purchased from Promega (proprietary 
composition) and oligonucleotide primers were purchased from Sigma Genosys. 
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2.3.2 Preparation and purification of DNA 
2.3.2.1 DNA Preparation 
Trypanosome genomic DNA was prepared by centrifuging a large number of live 
cells (> 5 × 10
7
) at 600g for 10 minutes and lysing them in 300 µl TELT (see 
Appendix A) by gently pipetting up and down.  DNA was purified from protein 
contaminants by adding 300 µl phenol: chloroform and gently mixing by inverting 
the tube, followed by centrifugation at 13K g for 10 minutes in a microfuge, and 
removal of the aqueous phase using a large bore pipette tip.  This step was repeated 
to remove the last traces of protein.  Salts from TELT were removed by addition of 
900 µl ethanol and incubation at room temperature for 5 minutes; precipitated DNA 
was centrifuged at maximum speed in a microfuge and washed with 70% ethanol 
prior to resuspension in 100 µl of TE buffer. 
Small-scale preparations of plasmid DNA were prepared using solutions I, II and III 
(Birnboim and Doly (1979)): 1 ml of overnight bacterial culture was centrifuged at 
7K g for 5 minutes in a microcentrifuge.  The supernatant was aspirated and the 
pellet resuspended in 100 µl solution I.  200 µl solution II was added to the cellular 
suspension and incubated at room temperature for 5 minutes to allow lysis.  150 µl of 
solution III was added to rapidly neutralise the reaction; the cells were then placed on 
ice for 10 minutes to allow precipitation of the proteins and chromosomal DNA.  The 
cells were centrifuged at maximum speed for 10 minutes in a microfuge and the 
supernatant was re-centrifuged to remove the last of the cellular debris. Then, 900 µl 
of ethanol was added to the supernatant and incubated at -80°C for 1 hour to ensure 
plasmid precipitation.  The DNA was recovered by centrifuging at 14K g for 10 
minutes at 4°C, the supernatant aspirated and the DNA pellet washed with 500 µl of 
70% ethanol.  After air-drying for 5 minutes at room temperature, the pellet was 
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The QIAGEN Plasmid Midi kit was used for the larger preparations of pure plasmid 
DNA that were necessary for transfection.  The DNA was prepared according to 
manufacturers instructions (QIAGEN Plasmid Purification Handbook, Third edition). 
2.3.2.2 DNA purification 
Salts and proteins can interfere with enzymatic reactions and transfections so it often 
necessary to purify DNA from contaminants.  DNA was purified from agarose or 
from solution using a NucleoSpin Extract II kit (Machery-Nagel) as per the 
manufacturers instructions. 
2.3.3 DNA restriction enzyme digestion 
The following represents a typical restriction enzyme digest of DNA: 10% 10× 
buffer (NEB 1, 2, 3 or 4), 10% 10× BSA, 5% restriction enzyme(s), DNA.  Reactions 
were incubated for < 2 hours at 37°C (with the exception of BclI with has an 
optimum digestion temperature of 50°C).  Enzymes were purchased from either 
Roche, Qiagen or New England Biolabs. 
2.3.4 DNA ligation 
The following represents a typical ligation: 10% 10× ligase buffer (300mM Tris-HCl 
(pH 7.8), 100mM MgCl2, 100mM DTT and 10mM ATP), 0.15 U µl
-1
 T4 DNA 
ligase, 5 ng µl
-1
 vector DNA, and the maximum amount of insert DNA in the 
remaining volume, to comprise a total of 10 µl.  A ‘no-insert’ negative control was 
always performed, and reaction were incubated over-night at 4°C to allow ligation to 
occur. 
2.3.5 DNA sequencing 
Sequencing was performed by the Edinburgh School of Biological Sciences 
Sequencing Service (SBSS).  Sequencing data was analysed using 4Peaks free 
software downloaded from http://mekentosj.com/4peaks/, in combination with an 
internet based alignment programme Multalin (http://bioinfo.genopole-
toulouse.prd.fr/multalin/). 
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2.4 Northern analysis 
All apparatus were cleaned by washing with detergent, followed by rinsing with ultra 
pure H2O and 70% ethanol before air-drying. 
2.4.1 Riboprobe preparation 
A PCR reaction was performed using an insert cloned into pGEM T easy so that the 
amplicon contained T7 and SP6 polymerase binding sites.  This amplicon was used 
as template in a digitoxin (DIG) RNA labelling reaction using the Roche RNA 
labelling kit following the manufacturer’s instructions, so that a single stranded, DIG 
labelled, RNA probe was made that was anti-sense to the target mRNA transcript.  
Riboprobes were stored at -80°C. 
2.4.2 Resolving trypanosome RNA on a denaturing agarose gel 
An RNA denaturing gel was prepared by melting 1.2 g of agarose in 87 ml ultra pure 
H2O followed by addition of 10 ml of 10× MOPS and 3 ml 37 % formaldehyde.  The 
gel was allowed to set in a fume hood so that it had 16 wells for loading of RNA 
samples. 
RNA was prepared from trypanosome cells using an RNeasy mini kit (QIAGEN 
catalogue #74106) according to the manufacturers instructions for animal cell RNA 
purification. 
Approximately 4 µg of RNA in a maximum volume of 6 µl was mixed with 9µl 
formamide, 3µl formaldehyde (37%), 2µl 10xMOPS and 2 µl RNA loading buffer, 
denatured at 65°C for 5 minutes and loaded onto the gel immediately.  The RNA was 
resolved at 150 V for 90 minutes in a 1× MOPS, stained with ethidium bromide and 
destained with water twice for 20 minutes.  The RNA was visualised using a UV 
transilluminator and the ribosomal subunits photographed for use as an RNA loading 
control.  In addition, the distance that the ribosomal subunits had migrated was 
measured using a ruler in order to calculate the size of any transcript that was 
detected. 
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2.4.3 Blotting trypanosome RNA 
The RNA was blotted using a capillary blot system, where the bottom 2 cm of a 
plastic biohazard tray was filled with 20× SSC, and a gel tray was placed upside 
down on top of a small lunch box within the biohazard tray.  A wick, made from 2× 
MME filter paper (Whatman), was wetted in 10x SSC and laid across the gel tray 
such that it made contact with the 20× SSC reservoir.  The RNA gel was placed 
upside down on top of the wick, followed by a piece of positively charged membrane 
pre-wetted in 2× SSC cut to the size and shape of the RNA gel. 4 pieces of 2× MME 
paper were placed on top of the nylon membrane and the entire apparatus was 
wrapped in parafilm to prevent evaporation of the 20× SSC reservoir.  A hole was 
cut in the parafilm to expose the gel stack, and 6 cm of absorbent tissue was placed 
on top of the gel stack with a 500 gram weight placed on top.  The next day the nylon 
was removed to dry, and the RNA was then cross-linked to the membrane using a 
Uvitec cross linker at 0.12 joules for 120 seconds. 
2.4.4 Probe hybridization and detection 
1 µl of the riboprobe was denatured by boiling for 5 minutes in hybridisation buffer 
and then used to probe the nylon membrane overnight at 68°C in 8 ml of 
hybridisation buffer.  Using freshly cleaned boxes for each step, the membrane was 
washed twice for 30 minutes at hybridisation temperature in 2xSSC/0.1% SDS, and 
once for 30 minutes in 0.5xSSC/0.1% SDS.  The membrane was then blocked for 1 
hour at room temperature in Maleic acid with 1% block prior to incubating with 1 µl 
anti-DIG antibody in 50 ml of Maleic acid containing 1% block, for 30 minutes.  The 
membrane was washed 3 x 10 minutes in Maleic Acid Buffer with 0.3% Tween-20 
before soaking for 2 minutes in detection buffer (100mMTris-HCl, 100mM NaCl pH 
9.5). 
The membrane was incubated with 1 ml 1× CDP star (New England Biolabs) in bag 
W for 2 minutes before removing the CDP star and incubating the membrane in 
sealed hybridisation bag W for 15 minutes.  The membrane was exposed to X ray 
film inside a cassette for 5 minutes to determine the required exposure time before 
development. 
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2.5 Southern Analysis 
2.5.1 DNA probe synthesis 
A DIG DNA labelling kit (Roche) was used to synthesise a DNA probe according to 
the manufacturer’s instructions.  The template for this reaction was a PCR product 
with homology to the target sequence. 
2.5.2 Resolving trypanosome genomic DNA on an agarose gel 
5 µg of trypanosome genomic DNA was digested overnight with a single restriction 
enzyme and resolved on a 1% agarose gel in 1× TAE buffer at 150 V for 90 minutes.  
The gel was stained with ethidium bromide, destained with water, and visualised 
using a UV transilluminator. 
2.5.3 Genomic DNA blotting 
The gel was de-purinated with 0.25 M HCl
- 
for 30 minutes, denatured with 
Denaturing Solution (1.5 M NaCl, 0.5 M NaOH) for 30 minutes, and neutralised with 
Neutralising Solution (1.5 M NaCl, 1 M Tris, pH 7.4) for 30 minutes.  The DNA was 
then blotted using a capillary blot apparatus and cross linked to the nylon membrane 
as for a Northern analysis (described above). 
2.5.4 Probe hybridization and detection 
The membrane was blocked in 10 ml of hybridisation buffer (5% dextran sulphate, 
5×SSC, 10% liquid block solution (Pharmacia), 0.1% SDS) for 1 hour at 65°C in a 
rotating hybridisation tube.  The hybridisation buffer was replaced with fresh, pre-
warmed buffer, and 250 ng of DNA probe denatured by boiling at 100°C for 5 
minutes was added to the membrane hybridisation buffer and incubated overnight. 
The membrane was washed twice with 50 – 100 ml of pre-warmed 1×SSC, 0.1%SDS 
for 30 minutes at 65°C, and then twice with 50 – 100 ml of pre-warmed 0.1×SSC, 
0.1% SDS at 65°C.  The membrane was then blocked in 50 ml blocking buffer at 
room temperature for 1 hour, and probed with 2 µl α-DIG antibody diluted in 50 ml 
buffer A.  Unbound conjugate was removed by washing 3 times for 15 minutes with 
0.3% Tween in buffer A (100 mM Tris, 300 mM NaCl, pH9.5).  Signal was detected 
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by incubating the membrane with 1 ml 1× CDP star (New England Biolabs) for 2 
minutes, removing excess CDP star in sealed hybridisation bag W and exposing X 
ray film to the membrane in a photographic cassette. 
2.6 Western analysis 
2.6.1 Preparation of protein sample 
A known quantity of live trypanosomes in culture was pelleted at 600 g for 10 
minutes, washed in PBS and resuspended in protein sample buffer at a concentration 
of 3 × 10
6
 trypanosomes in 5 µl.  Cells were lysed and genomic DNA was sheared by 
either passing the cells through a 0.5 mM gauge needle (BD Microlance) or, where 
the sample volume was very little, by placing in a room temperature water bath 
sonicator (Bandelin Sonrex RK100 H) for 20 seconds.  Cell lysate was re-suspended 
in Laemmli protein sample buffer (62.5 mM Tris-HCl pH6.8, 2% SDS, 10% 
glycerol, 0.002% Bromophenol blue, 5% β-mercaptoethanol) at 3 × 10
6
 cells per 10 
µl.  Protein sample was kept on ice wherever possible, and were not boiled unless 
otherwise stated in order to prevent hydrophobic proteins from precipitating. 
2.6.2 Preparation of SDS gel 
The following comprises the components of a 12 % acrylamide SDS gel: 12 % 
acrylamide-bisacrylimide mix, 375 mM Tris pH8.8, 0.005 % ammonium persulphate 
(APS) (w/v), 0.005 % tetramethylethylenediamine (TEMED), where the APS and the 
TEMED were added immediately prior to pouring the gel.  The gel was poured in a 
Bio-Rad PROTEAN II casting apparatus, and allowed to set for approximately 15 
minutes to give a 0.75 mm thick gel.  A stacking gel (375 mM Tris pH6.8, 6.8% 
acrylamide, 0.1% SDS, 0.056% ammonium persulphate, 0.0056% TEMED) was 
poured on top of the resolving gel and allowed to set with a 10 or 15 well comb 
inserted such that samples of 10 - 20 µl could be loaded. 
2.6.3 Resolving proteins on an SDS polyacrylamide gel 
Samples were loaded such that protein from 3 × 10
6
 cells was resolved in each lane.  
The gel was run at 100 V for approximately 2 hours on ice in 1 × running buffer (25 
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mM Tris-HCl pH8.3, 192 mM glycine, 0.1% SDS).  If the protein was to be 
visualised on the gel then the gel was soaked in Coomassie blue stain (50% 
methanol, 10% acetic acid, 0.1% Coomassie Brilliant blue) for 10 minutes, and 
destained several times with Destain solution (40% methanol, 10% acetic acid) until 
it was possible to distinguish the different protein bands. 
2.6.4 Blotting proteins 
2.6.4.1 Semi-dry transfer 
Proteins were blotted using either a semidry blotter (BIO-RAD Trans-blot SD semi-
dry transfer cell) and power-pack (Bio-Rad Power-PAC 200) onto nitrocellulose 
membrane (Whatman Schleicher and Schuell, PROTRAN, pore size 0.45 µm) 
according to manufacturer’s instructions.  Briefly, the acrylamide gel, nitrocellulose 
cut to the correct size and extra thick filter paper were equilibrated in cold transfer 
buffer (2.5 mM Tris, 15 mM Glycine, 0.02% SDS, 20% methanol) for 5 minutes and 
placed sequentially onto the semidry blotter in the following order: 3 mm extra thick 
filter paper (Whatman), nitrocellulose, acrylamide gel, extra thick filter paper.  The 
blot was carefully rolled between as each layer was added to ensure no air bubbles 
interfered with the transfer, and then transferred at 15 V for 60 minutes.  The proteins 
were visualised by staining with Ponceau stain (0.4% Ponceau S, 3% trichloroacetic 
acid (TCA)) for 10 minutes, and de-staining several times with ultra pure water. 
2.6.4.2 Wet transfer 
Protein were blotted using a wet blotting system (Bio-Rad) according to 
manufacturers instruction’s.  Briefly, the gel, PVDF membrane (Immobilon-P, 
Millipore), and 3MM filter paper (Whatman) were equilibrated in wet transfer buffer 
(25 mM Tris-HCl, 192 mM glycine, 20% methanol) for at least 30 minutes.  Each 
layer was placed onto the wet blotting apparatus in the following order, with careful 
rolling in between each layer to ensure there were no bubbles: 2 layers of 3MM filter 
paper, the acrylamide gel, the PVDF membrane, and the 2 layers of filter paper.  The 
‘sandwich’ was placed into the transfer apparatus, which was filled with chilled wet 
transfer buffer, and left to transfer at 30V overnight at 4°C. 
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2.6.4.3 Blocking and staining blot 
See Appendix A for antibody concentrations. 
Blots were blocked overnight at 4 °C with 5 % non-fat powdered milk (Marvel 
Original dried skimmed milk) in 1× PBS or LI-COR Odyssey block diluted 1:1 in 1× 
PBS, and then stained with the primary antibody in either 5 % milk: PBS or LI-COR 
Odyssey block diluted 1:1 in 1× PBS(0.05% Tween) by gently rocking for 1 hour at 
room temperature or overnight at 4°C.  The blot was then washed 5 × 3 minutes by 
rocking gently with excess 0.05 % TWEEN in 1× PBS, stained with the appropriate 
secondary antibody in 5% milk: PBS or LI-COR Odyssey block diluted 1:1 in 1× 
PBS(0.05% TWEEN) for 1 hour at room temperature.  The washes were then 
repeated. 
2.6.4.4 Visualising the chemiluminescent signal 
The blot was incubated with either Enhanced chemiluminescence (ECL) substrate 
(GE Healthcare, Amersham) for 1 minute or high sensitivity ECL (Millipore 
Immobilon Western Chemiluminescent HRP Substrate) for 5 minutes depending on 
the sensitivity that was required.  Resulting bands were visualised by exposing X ray 
film to the blot in a photographic cassette. 
2.6.5 Quantitative Western blots 
The use of the LI-COR Odyssey system allowed quantitation of the signal obtained 
from Western blots.  This system makes use of a secondary antibody conjugated to a 
fluorochrome, which is subsequently detected using an infrared laser.  Co-staining 
with a tubulin loading control using secondary antibodies conjugated to different 
fluorochromes with non-overlapping emission spectra allowed relative protein 
abundance to be quantified. 
The principle difference in utilising this system is the use of secondary antibodies.  
Red anti-rabbit (product #: 926-32221) and green anti-mouse (product #:926-32210) 
were purchased from LI-COR and used in place of HRP-conjugated secondary 
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antibodies.  Blots were scanned using the LI-COR Odyssey Imager, and the signal 
was analysed in Microsoft Excel relative to the tubulin signal. 
2.6.6 Western blot of PAD proteins 
Hydrophobic proteins are notoriously difficult to detect due to their tendency to 
precipitate, and therefore not enter the acrylamide get.  The following represents the 
fully optimised protocol for PAD protein detection.  The principle difference from 
the standard Western blot protocol was that the protein sample was maintained at a 
low temperature at all times. 
A known concentration of cells was centrifuged, resuspended in 1 ml of PBS, and re-
centrifuged.  The supernatant was aspirated, and resuspended at 3 x 10
6
 cells per 10 
µl of protein sample buffer containing β-mercaptoethanol by ‘grating’ the eppendorf 
along an eppendorf rack.  Genomic DNA was sheared by sonication in a sonicator 
water bath, and the sample was then placed upon ice.  10 µl of protein sample was 
resolved on a 10% polyacrylamide gel at 100V for approximately 4 hours using 
chilled buffers in a 4°C fridge.  Gels were blotted onto PVDF Immobilon-P 
(Millipore) using a wet blotting system (Bio-RAD) with chilled buffers in the fridge 
as per the manufacturer’s instructions.  Membranes were subsequently treated as for 
a standard quantitative, or chemiluminescent, Western blot (see Section 2.6.4.3). 
2.7 Immunofluorescence 
Immunofluorescence was used for two different purposes in this study.  The first was 
to stain for a life cycle development marker such as EP Procyclin in order to quantify 
a population’s progression through differentiation.  The second was to localise a 
protein within the cell.  As the objective was different in each case, the cells required 
different fixation conditions. 
Stained slides were visualised using either a ‘Zeiss Axioskop 2 plus’ microscope, or 
a Leica SP6 confocal microscope.  Images were analysed in either Volocity 
(Improvision) (for the confocal data), Adobe Photoshop or ImageJ. 
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2.7.1 Methanol fixation 
Methanol fixation preserves the cellular morphology of the fixed cell, but disrupts 




 cells from culture were centrifuged at 600 g for 10 minutes, 
resuspended in approximately 30 µl of supernatant, and spread across a glass slide 
(Menzel-Glaser Microcope slides 76 × 26 mm).  After approximately 30 minutes of 
air-drying the cells were fixed by immersing in cold methanol for at least 10 minutes, 
and stored at -20 °C. 
All stains and blocks were performed in a humidity chamber to prevent evaporation.  
Cells were re-hydrated in excess PBS and blocked with 100µl 20 % foetal bovine 
serum (Invitrogen) in PBS for 30 minutes, stained with 100µl primary antibody 
diluted in 2 % BSA PBS for 45 minutes and washed 3 × 5 minutes in excess PBS, re-
stained with 100µl secondary antibody diluted in 2 % BSA PBS for 45 minutes and 
the washes repeated.  Finally, the cellular DNA was stained with 10 µg ml
-1
 4',6-
diamidino-2-phenylindole (DAPI) and the slides washed once with excess PBS and 
mounted in 10 % PDA in MOWIOL using a coverslip (Scientific Laboratory 
Supplies).  Cells were kept at 4°C to allow the MOWIOL to set and the PDA diffuse 
into the cell. 
2.7.2 Paraformaldehyde fixation 
The protocol was adapted from published protocols (Field et al. (2004)).  Briefly, 2 × 
10
6
 cells were pelleted at 600 g for 10 minutes, washed in vPBS, and resuspended in 
100 µl vPBS.  100 µl of 6 % paraformaldehyde was added to the cells for fixation.  
After exactly 10 minutes, 5 ml of vPBS was added to the cells, which were pelleted 
gently, and allowed to settle on a poly-lysine coated slide (VWR International) for 20 
minutes before being washed in excess 1× PBS.  Cells were permeabilised for 10 
minutes using 0.05% TritonX, blocked in 20 % foetal calf serum in vPBS for 45 
minutes, and stained with the primary antibody in 20 % foetal bovine serum in vPBS 
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for >1 hour.  Subsequent to washing in excess PBS, the cells were then stained with 
the secondary antibody in 20 % FBS: vPBS for 1 hour, washed in excess PBS 3 × 5 
minutes after which the cellular DNA was stained with a 1 µg ml
-1
 working stock of 
DAPI.  The cells were washed again 3 × 5 minutes in excess PBS and mounted using 
10 % PDA in MOWIOL. Cells were kept at 4°C to allow the MOWIOL to set and 
the PDA permeate into the cell. 
2.8 Flow cytometry 
Flow cytometry was used primarily as a way of assaying the progression of 
differentiation to the procyclic form of a population of cells. 
2.8.1 Fixing cells 
Between 2 – 5 × 10
6
 live cells from culture were fixed by centrifuging at 600 g for 5 
minutes, washing with PBS and re-suspending in 2 % formaldehyde/ 0.05 % 
glutaraldehyde fix for a minimum of 1 hour at 4 °C (Roditi et al. (1989)).  Cells were 
kept up to 72 hours in fix prior to staining; note that best fixation occurred when cells 
were allowed to fix for at least 24 hours, as judged by the forward and side scatter. 
2.8.2 Blocking and staining 
Washes were performed by centrifuging cells at 600 g for 6 minutes and re-
suspending in PBS and re-centrifuging as before.  Stains were performed by 
incubating the cellular suspension in 200 µl of antibody diluted in 2 % BSA in PBS.  
Cells were washed twice to remove the last traces of fixative prior to staining with 
the primary antibody for 1 hour at 4°C, washed twice and stained with the secondary 
antibody for 1 hour at 4°C.  Cells were washed once again before analysis. 
2.8.3 Use of the FACS machine 
Cells were analysed using FACSCalibur FACS machine (BD). In all cases, an 
unstained negative control was used to determine the level of auto-fluorescence.  In 
addition, a ‘secondary only’ control was included to determine the level of non-
specific binding of the fluorochrome-conjugated antibody.  Wherever possible a 
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positive and negative control sample was also used to help calibrate the settings on 
the FACS machine so that positive and negative cells could be distinguished. 
2.8.4 Analysis of data 
Data was analysed using FlowJo (Tree Star). 
2.9 Citrate transport assay 
2.9.1 Synthesis of PAD1 RNA 
PAD1 was cloned into the EcoRI and HindIII digested Xenopus expression vector 
pGHJ (Liman et al. (1992)) (Bröer et al. (1997)) such that a Kozak sequence was 
cloned into the 5’ end of PAD1, and an HA epitope tag would be synthesised on the 
C-terminus of the translated protein.  A small scale preparation of plasmid DNA was 
linearised, and synthetic PAD1 RNA was made using RNA polymerase in the 
presence of 1 mM rATP, 1 mM rCTP, 1 mM rUTP, 0.2 mM rGTP and 1 mM of the 
cap analogue m7G(5')ppp(5')G according to manufacturer’s instructions (Promega, 
Madison, WI).  RNA was purified after DNase treatment through a nucleotide 
purification column (QIAGEN), eluted in 2 × 50 µl of elution buffer, and ethanol 
precipitated for resuspension at approximately 1.5 mg ml
-1
. 
2.9.2 Preparation of Xenopus oocytes for micro-injection 
Xenopus laevis frogs were operated on by Rosa Marchetti.  Briefly, the frog was 
made unconscious by submersion in a 0.1% 3-aminobenzoic acid ethyl ester solution 
(Sigma, St. Louis, Mo, USA) and placed on ice for surgery.  Oocytes were removed 
after surgery on the abdomen of the frog with a scalpel to remove a large number of 
oocytes (as many as 100).  Oocytes were incubated with trypsin for an hour at 4 °C 
to remove extraneous tissue and to allow for easier injection. 
2.9.3 Microinjection of Xenopus laevis oocyctes 
Glass capillaries (WPI, Sarasota, FL, USA) with a long shank were pulled using a 
normal puller to make a micro-injection needle.  A WPI microinjector (WPI, 
Sarasota, USA) was used to inject purified PAD1 cRNA into oocytes held in place 
on a 35 mm petri dish with a polypropylene mesh glued to the bottom to fix the 
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oocytes.  Oocytes were incubated at 16°C in ND96 buffer (96 mM NaCl, 2 mM KCl, 
1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.4) for 5 – 7 days to allow 
recovery of the oocytes, and the translation and localisation of PAD1 to the cell 
surface membrane. 
2.9.4 Citrate transport assay 
10 oocytes were used per condition.  10 oocytes were transferred into a 5 ml tube and 
flushed twice with 4 ml ND96 at either pH7, 8, or 9. The supernatant was then 
removed completely.  Thereafter, 100 µl of transport buffer containing citrate and 
radiolabelled 
14
C citrate was added to each oocyte and incubated for either 30 or 60 
minutes.  3 ml of ice cold transport buffer was added to stop transport, and the 
oocytes were washed 3 × with 4 ml ice cold transport buffer.  1 ml of ice cold 
transport buffer was added and the oocytes were removed into a scintillation vial and 
vortexed in 200 µl of 10 % SDS buffer to lyse the cell.  Next, 1.5 ml of scintillation 
fluid was added and each vial was put into a liquid scintillation counter to detect the 
quantity of radiolabeled citrate taken up by the cell. 
2.9.5 Analysis of data 
Analysis was performed using excel to calculate the average radioactivity (counts per 
minute) by the oocytes. 
2.10 Plasmid constructs used in this study 
Trypanosome transgenic technology utilizes plasmid constructs that allow inducible 
ectopic expression, ablation and deletion of trypanosome genes.  This study was 
heavily reliant on the constructs described. 
2.10.1 pHD451 
Described in Biebinger et al. (1997), this is an ectopic expression plasmid primarily 
designed for expression in procyclic form trypanosomes that integrates into the 
ribosomal spacer, and utilizes a procyclin promoter to express the trans-gene.  Due to 
incompatible cloning sites, it was necessary to insert a XhoI restriction enzyme site 
between the HindIII and BamHI sites using annealed primers #24 and #25 (see 
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Appendix A, and Section 5.2.1.1).  Low expression in bloodstream forms made this 
construct non-optimal for over-expression of PAD1 in monomorphic bloodstream 
forms. 
In addition, a version of this construct that contains a TY epitope tag sequence 
downstream of the insertion site was used to allow synthesis of an epitope tagged 
protein and subsequent detection using BB2 antibody in transfected parasites. 
2.10.2 pHD617 and pHD617 (PuroR) 
Described in Biebinger et al. (1997), pHD617 is optimized for expression in 
bloodstream form trypanosomes.  pHD617 confers hygromycin resistance and was 
therefore not compatible for conditional rescue of the hygromycin resistant knockout 
parasites.  For this reason, a puromycin resistance version of pHD617 was made.  
Briefly, pHD617 was modified to contain an NdeI at the 5’ end of the resistance gene 
by digesting with XhoI and NdeI and inserting an amplicon containing the EP 
procyclin promoter from pHD451 using primers #92 and #93.  An amplicon 
containing the puromycin resistance cassette from pHD1034 was cloned into NdeI 
and AvrII sites of the modified pHD617 using primers #94 and #95 to give pHD617 
(PuroR). See Appendix A for map and the list of primers. 
2.10.3 pHD449 
pHD449 (Biebinger et al. (1997)) contains the tetracycline repressor protein and, 
upon transfection, integrates into the tubulin gene array.  Transcription is constitutive 
and reliant on read-through transcription through the tubulin gene locus. 
2.10.4 pALC14 
pALC14 (Bochud-Allemann and Schneider (2002)) was a kind gift from Andre 
Schneider (University of Bern, Switzerland).  pALC14 contains a puromycin 
resistance cassette and allows inducible expression of a stem loop RNA transcribed 
from the ribosomal spacer region to give ablation of a target mRNA transcript (see 
Appendix A for a schematic of this construct).  An amplicon was first ligated into the 
XhoI-BamHI cloning site, and then the HindIII-NdeI-XbaI multiple cloning site, 
such that the 2 amplicon sequences were separated by a 460 nucleotide ‘stuffer’ 
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sequence and in the reverse complement orientation (see Section 6.2.1 for details).  
When generating pALC14 constructs to target PAD1 and the entire PAD array, 
BamHI was not used as this site is already present within the amplicon.  For this 
reason, BclI was used in its place because fragments generated using this enzyme can 
be cloned into BamHI restriction sites.  Two pALC14 based constructs were used in 
this study: ‘array:pALC14’ using primers #106 and #109 that was designed to ablate 
all of the genes in the PAD array, and ‘PAD1: pALC14’ made using primers #108 
and #109 that was designed to only ablate PAD1 mRNA. 
2.10.5 Gene deletion constructs 
Gene deletion was performed using drug resistance cassettes flanked by regions of 
homology to sequences adjacent to the region to be deleted.  The constructs were 
generated from existing constructs containing Neomycin and Hygromycin resistance 
cassettes (Hendriks and Matthews (2005)) in order to generate cell lines that have 
PAD1, and the entire 28 kb array, deleted. The neomycin resistance construct 
contains a tetracycline repressor gene to allow inducible expression of a rescue gene. 
2.10.5.1 PAD1 deletion constructs 
The first round PAD1 deletion construct was made by amplifying regions in the 5’ 
(primers #67 and #68) and 3’ UTR (primers #63 and #64) of PAD1 from genomic 
DNA and inserting them into the cloning sites flanking the neomycin resistance gene 
and tetracycline repressor gene so that the final construct has (5’   3’)  PAD1 5’ 
UTR – tetracycline repressor gene –neomycin resistance gene - PAD1 3’UTR.  The 
second round PAD1 deletion construct was made in the same way using homologous 
regions (primers #46 and #45, #65 and #66) nested within the first round knockout, 
so that the final construct has (5’  3’) PAD1 5’ UTR – hygromycin – PAD1 3’ 
UTR.  Both constructs were digested with KpnI and SacI and purified using a 
nucleospin column prior to transfection.  The list of primers can be found in 
Appendix A, and an explanatory diagram can be found in Section 6.4.1. 
2 – Materials and Methods 64 
2.10.5.2 PAD array deletion constructs 
In this case, the region to be removed was much larger so it was judged that much 
bigger regions of homology would be necessary, and consequently it was not 
possible to perform a ‘nested’ knock out.  A 2.5 kb region of homology was cloned 
into the 5’ insertion site of the neomycin resistance gene deletion construct (primers 
#75 and #45) and a 1.6 kb region of homology was cloned into the 3’ insertion site.  
To make the second round deletion construct, the tetracycline repressor and 
neomycin resistance cassettes were removed by digestion with XhoI and NotI, and 
replaced with an amplicon containing the hygromycin resistance cassette from the 
second round deletion construct made using primers #87 and #88. 
2.10.6 pGEM T easy 
pGEM T easy is a commercially available plasmid (Promega) and used for PCR 
product cloning without digestion, exploiting A overhangs generated by Taq and Taq 
blended polymerases.  This was used in riboprobe synthesis and DNA probe 
synthesis. 
2.10.7  pGem-He-Juel  
pGem-He-Juel, or  pGHJ (Liman et al. (1992)) (Bröoer et al. (1997)), is a Xenopus 
expression vector commonly used for Xenopus uptake assays, and contains a Kozak 










A Bioinformatics Analysis of the PAD Genes 
3 - A bioinformatics analysis of the PAD genes 66 
 
3 A Bioinformatics analysis of the PAD array 
The first stage in characterising a newly identified gene is conventionally a 
bioinformatics analysis.  Bioinformatics is the application of computing technology 
to rationalise large amounts of biological data, allowing cryptic information to be 
revealed.  A number of programmes and algorithms have been developed that  
analyse the primary sequence of DNA, RNA or a protein in order to build a 
bioinformatics profile of the gene of interest.  The nature of these programmes varies 
depending on the type of analysis, but some examples of their use are: 
• Inference of evolutionary relationships based upon DNA sequence 
divergence 
• Elucidation of protein function based upon sequence similarity to previously 
characterised proteins 
• Using the known physiochemical properties of amino acid residues to 
annotate a protein (e.g. a sequence of hydrophobic residues flanked by 
hydrophilic residues often constitutes a transmembrane domains) 
• Identification of motifs and domains of known function (e.g. zinc finger 
motifs, kinase domains, phosphatase domains) 
• Structural prediction algorithms to predict secondary and tertiary structures of 
RNA and proteins 
• Identification of short peptide sequences known to mediate localisation to 
specific cellular compartments (e.g. nuclear localisation signals). 
Some of these programmes were utilised to build a bioinformatics profile of the PAD 
genes and proteins. 
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3.1 The genomic context of the PAD genes 
The Trypanosoma brucei haploid genome is made up of over 9000 predicted genes in 
11 chromosomes arranged over approximately 26 Mb (Berriman et al. (2005)).  
These genes are arranged as directional gene clusters of up to 1 Mb that are probably 
transcribed as large polycistronic transcription units (Sather and Agabian (1985)).  
Despite early divergence of the ‘tri-tryps’ (Stevens and Gibson (1999)) (consisting of 
Trypanosoma cruzi, Leishmania major and T. brucei) there is a very high degree of 
synteny between the sequenced genomes (approximately 68% for T. brucei  and 75% 
for L. major) (El-Sayed et al. (2005)), especially within the directional gene clusters.  
Genes that are unique to a trypanosomatid genome are thought to be mostly 
associated with specific parasite life cycle roles (such as entry into the macrophage in 
the case of L. major, or antigen proteins in the case of T. brucei) or to have distinct 
metabolic or physiological roles.  Interestingly, 43% of genes that represent breaks in 
synteny are found in, or near, strand-switch regions between the directional gene 
clusters; this may represent either a positive selection pressure maintaining synteny, 
or may be associated with the mechanism of recombination between homologous 
chromosomes (El-Sayed et al. (2005)). 
The PAD genes are arranged as an 8 gene cluster over 27 kb of chromosome 7 
(referred to as the PAD array) (see Figure 3.1-1) approximately 600 Kb from the 
closest telomere.  They are situated at the end of a directional gene cluster (DGC) 
approximately 300 Kb in length and there are no syntenic PAD orthologues found in 
L. major or T. cruzi (see Figure 3.1-2).  A ClustalW alignment of the closest 
orthologs found by a TBLASTX search of the L. major and T. cruzi genomes using 
the PAD1 protein sequence shows 39% amino acid identity between the 3 translated 
genes (Figure 3.1-3).  The T. cruzi homologue (Tc00.1047053506551.10) shows 
closest similarity with 56% amino acid identity to PAD1, and the L. major 
homologue (LmjF11.0650) has slightly less identity at 52% (see Appendix A for the 
individual alignments with PAD1).  A reciprocal BLASTN and TBLASTX search, 
whereby the T. cruzi and L. major closest homologue nucleotide sequences were 
used to interrogate the T. brucei genome data, returns members of the PAD array as 
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the closest match (data not shown), thus verifying that PAD1 is the closest ortholog 
to these genes within the T. brucei genome. 
Interestingly, the first and third closest orthologs in L. major (LmjF11.0650 and 
LmjF11.0660 respectively) are members  of an array of 6 homologous genes on 
chromosome 11 (see Figure 3.1-6), all of which show closest homology to PAD 
genes in a reciprocal TBLASTX against the T. brucei genome (data not shown).  The 
second closest ortholog (LmjF13.1690) is situated at the 5’ end of an incompletely 
sequenced direction gene cluster, and does not appear to be part of a duplicated gene 
array (data not shown). 
Analysis of the T. cruzi orthologs was complicated by the incomplete sequencing of 
this genome.  The first and third best scoring TBLASTX hits 
(Tc00.1047053506551.10 and Tc00.1047053510069.20 respectively) have no 
genomic context or adjacent genes annotated in the GeneDB database.  The other 
high scoring T. cruzi TBLASTX hits were found to be on DNA fragments that 
contained 2 or more adjacent PAD orthologues.  For example, the second closest 
PAD1 orthologs (Tc00.1047053508799.270) was situated between the seventh and 
thirteenth closest orthologs (Tc00.1047053508799.260 and 
Tc00.1047053508799.280 respectively) (Figure 3.1-5 shows an alignment of these 
proteins with the PAD1 protein, and Figure 3.1-6 shows the genomic context of these 
genes), and the fourth closest ortholog (Tc00.1047053509713.30) was situated 
downstream of the twelfth and tenth closest orthologs (Tc00.1047053509713.10 and 
Tc00.1047053509713.20 respectively).  See Appendix A for a list of the T. cruzi 
orthologs.  It seems likely that the T. cruzi PAD orthologs identified form part a 
duplicated gene cluster analogous to the T. brucei PAD array.  As with L. major, the 
genes upstream of the T. cruzi PAD orthologs show no homology with the genes 
upstream of the PAD array in T. brucei; hence the T. cruzi and L. major PAD array 
equivalents are non-syntenic with the T. brucei PAD array. 
Thus, it is likely that expansion of an ancestral PAD gene occurred prior to 
divergence of the salivarian trypanosomes approximately 300 – 500 million years 
ago (Gibson and Stevens (1999)) and that the additional two genes in the T. brucei 
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genome represent a more recent gene duplication.  Alternatively, expansion of all 8 
genes in the array could have occurred before the tri-tryp divergence and L. major 
(and possibly T. cruzi) has lost 2 genes through genomic re-arrangement. 
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Figure 3.1-3  A protein alignment of PAD1 and the closest orthologs in L. major and 
T. cruzi. Orthologs were found using PAD1 as a query sequence in a TBLASTX search 
of the L. major and T. cruzi genomes.  The orthologs were aligned using clustalW using 
the default settings.  The alignment shows that the T. cruzi and L. major proteins have 
39% amino acid identity with PAD1. The asterisks, colons and dots indicate perfect, very 
high and high conservation between the 5 proteins, respectively. 
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Figure 3.1-4 The closest orthologs to the PAD genes in L. major are members of a 6 
gene cluster.  The L. major gene cluster was aligned with PAD1 using clustalW.  This 
gene cluster may represent the L. major equivalent of the PAD array, suggesting that the 
gene duplication event that gave rise to the ancestral PAD genes occurred prior to 
divergence of the tri-tryp lineage. The asterisks, colons and dots indicate perfect, very 
high and high conservation between the 5 proteins, respectively. 
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Figure 3.1-5 Close orthologs to the PAD genes in T. cruzi are members of a cluster 
containing at least 4 genes.  The second, seventh and thirteenth closest TBLASTX hits 
to PAD1 in the T. cruzi genome are a members of a partially sequenced array of 
homologous genes containing at least 4 genes.   This gene cluster may be part of the T. 
cruzi equivalent of the PAD array.  The asterisks, colons and dots indicate perfect, very 
high and high conservation between the 5 proteins, respectively.  Note that 
Tc00.1047053508799.290 is truncated due to incomplete sequencing. 
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Figure 3.1-6 The L. major and T. cruzi orthologous PAD arrays.  The genomic 
positions of (A) L. major and (B) the partially sequenced T. cruzi putative PAD array 
orthologs were visualised using ARTEMIS (Rutherford et al. (2000)).  PAD orthologs are 
indicated with an asterisk.  Note that non- orthologous genes annotated as part of this 
directional gene cluster do not demonstrate homology to genes in the genomic vicinity of 
the T. brucei PAD genes.  
A
B
* * * * * *
* * * *
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3.2 Relationships within the PAD family 
The PAD array genes probably arose through several gene duplication events of an 
original progenitor gene, and thus are highly homologous (Jackson (2007)).  A 
clustalW alignment (Higgins and Sharp (1988)) (Higgins and Sharp (1989)) (Chenna 
et al. (2003)) (Larkin et al.(2007)) of all 8 predicted proteins shows 56% overall 
amino acid identity with PAD1; moreover only 14% of the PAD1 amino acids show 
no conservation at all with the other PAD members at the corresponding positions 
(see Figure 3.2-1).  A phylogram constructed using a neighbour joining algorithm 
integrated into the clustalW website (Saitou and Nei (1987)) (Gascuel and Steel 
(2006)) based upon the protein alignment allows the PAD proteins to be grouped into 
3 sets Figure 3.2-1): 
• Group A: PAD1 and PAD2 
• Group B: PAD3, PAD5 and PAD7 
• Group C: PAD4, PAD6 and PAD8 
PAD3 appears to be most distinct from the rest of the array, and PAD5 and PAD7 
have identical amino acid and DNA sequences.  These trends are reflected in the 
DNA gene sequence in which a Multalin DNA alignment (Corpet (1988)) shows 
66% nucleotide identity between the PAD genes (see Figure 3.2-2). 
The PAD genes can also be grouped based upon their position on the chromosome: 
PAD1 and PAD2 are clustered at the 5’ end of the array, after which there is a gap of 
4.5 Kb and the other PAD genes follow at more regular intervals of approximately 
1.5 kb.  This may be indicative of the chromosomal re-arrangements that caused the 
PAD gene duplication. 
It should be noted that, due to the highly repetitive nature of this region of the 
genome, the database annotation indicates that there may genome mis-assembly and 
uncertainty in the gene copy number, thus there may be more PAD genes, or in a 
different arrangement, than is depicted by the GeneDB database.
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Figure 3.2-1  The relationship between the PAD protein sequences. (A)  The PAD 
protein sequences were aligned using clustalW.  56% of the PAD1 amino acid positions 
show identity when compared with the same position in the other PAD proteins, and 86% 
of PAD1 amino acid positions are either identical or show little variation in residue choice. 
The asterisks, colons and dots indicate perfect, very high and high conservation between 
the 5 proteins, respectively.  (B)  The relationship between the PAD protein sequences is 
depicted in a phylogram constructed using a neighbour joining algorithm.  The PAD 
proteins fall into 3 groups: A: 1 and 2, B: 3, 5 and 7, and C: 4, 6 and 8. 
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Figure 3.2-2  The relationship between the PAD gene nucleotide sequences.  (A)  
The PAD gene sequences were aligned using Multalin.  66% of the PAD1 nucleotide 
positions show perfect conservation when compared with the same position in the other 8 
PAD genes (indicated by red lettering).  (B)  A phylogram was constructed using a 
neighbour joining algorithm.  The PAD genes fall into 3 groups: (A) 1 and 2, (B) 3, 5 and 
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3.3 An analysis of the PAD array intergenic regions 
The PAD array is approximately 37.1 kb long (including all of the intergenic regions 
and open reading frames).  The average size of the PAD genes is approximately 1.8 
kb meaning that approximately 22.8 kb (61%) of the array is intergenic.  Thus, any 
analysis of the PAD array must include the intergenic regions, which are likely to 
have regulatory functions (Clayton (2002)).  
3.3.1 Predicting the positions of the PAD trans-splicing sites 
In trypanosomatids, mature mRNA transcripts are generated from a pre-cursor 
polycistronic RNA transcript (Imboden et al. (1986)) (Muhich and Boothroyd 
(1989)) (Rudenko et al. (1990)) (Clayton (2002)) through two RNA processing steps: 
a spliced leader sequence is added onto the 5’ UTR of one gene, and a poly-
adenosine tail is added to the 3’ UTR of the upstream adjacent gene in a linked 
reaction (LeBowitz et al. (1993)) (Ullu et al. (1993)) (Matthews et al. (1994)).  With 
some exceptions (notably some S phase enriched transcripts in Crithidia fasciculata 
(Mahmood et al. (1999)) and genes involved in DNA metabolism in L. major (Zick 
et al. (2005))) the 3’ UTR is responsible for the stability and translational efficiency 
of the mature transcript (Clayton et al (2002)).  Nonetheless, prediction of the trans 
splicing sites is a useful tool for determining which parts of the intergenic region 
constitute the UTRs of the transcript. 
Gopal et al. (Gopal et al. (2005)) describe development of an algorithm that detects 
trans splicing sites in L. major.  This algorithm identifies regions of the genome 
likely to contain splice sites by searching for regions enriched in TC dinucleotides.  
The splice acceptor AG dinucleotide is then identified by finding the largest inter-
AG gap between the AG dinucleotides within the splice site region, and using the 3’ 
AG dinucleotide of this gap as the splice acceptor AG.  The advantage of this system 
is that it is able to predict trans splicing signals independently of potentially cryptic 
start codons. 
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Similarly, Benz et al. (Benz et al. (2005)) describe the development of an algorithm 
that identifies trans splice sites within the Trypanosoma brucei genome sequence.  
This algorithm identifies splice leader addition sites by finding a polypyrimidine tract 
of at least eight pyrimidines immediately upstream of a predicted open reading 
frame, and then determining the closest AG dinucleotide downstream of that tract.  
The linked poly-adenosine tail addition was predicted to occur at one or more 
adenosines between 80 and 140 bases upstream of this polypyrimidine tract.  Thus, 
the algorithm defines the location of the poly-adenosine tail addition by finding the 
adenosine closest to the position 72 nucleotides upstream of the polypyrimidine tract.  
This approach relies on the identification of the correct start codon for an open 
reading frame, and may thus incorporate errors from mis-annotation of the genome 
database.  Nonetheless, this provides an effective way of estimating most trans 
splicing sites in Trypanosoma brucei. 
The genome annotation performed by Benz et al. using this approach was 
downloaded (http://web.cgb.ki.se/daniel/splicemodel.php) and used to estimate the 5’ 
and 3’ UTRs of the PAD genes for subsequent analysis. 
3.3.2 Aligning the PAD UTRs 
The predicted PAD 5’ UTRs were aligned using clustalW (Higgins and Sharp 
(1988)) (Higgins and Sharp (1989)) (Higgins et al. (1994)) (Lopez and Lloyd (1997)) 
(Larkin et al.(2007))  and visualised using Jalview (Clamp et al. (2004)).  As 
expected from an array that probably arose through tandem duplication, the PAD 5’ 
UTR sequences are very similar (see Figure 3.3-1).  They are either 112 or 133 
nucleotides long, which is longer than the median of 68 nucleotides found by cDNA 
analysis (Benz et al. (2005)) but within the range of 40 – 200 nucleotides found by 
surveying the Genbank database (Gopal et al. (2005)).  The 86 nucleotides proximal 
to the start codon are almost identical between the 5’ UTRs and only differ at two 
positions.  The 5’ UTRs fall into 2 distinct groups (see Figure 3.3-1):  
• Group A: PAD4, PAD5 and PAD7 
• Group B: PAD1, PAD2, PAD3, PAD6 and PAD8
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Figure 3.3-1  The positions and alignments of the predicted PAD UTRs.  (A) The  
PAD array predicted 5’ UTR nucleotide sequences were aligned using clustalW and 
visualised using Jalview.  The 5’ UTRs appear to fall into 2 groups: A: PAD4, 5 and 7, 
and B: PAD1, 2, 3, 6 and 8.  (B) The length of the predicted PAD 5’ and 3’ UTRs is 
shown.  The PAD 5’ UTRs are either 112 or 133 nucleotides in length whereas the PAD 
3’ UTRs are more heterogeneous and range from 754 to 4276 nucleotides in length; this 
heterogeneity appears improbable, and may in fact represent the inherent difficulties in 
predicting RNA processing signals. 
A
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The predicted PAD 3’UTRs fall into two approximate groups based on their 
sequence alignment (see Figure 3.3-2): 
• Group A: PAD1, 5 and 7;  
• Group B: PAD4 and 6  
PAD2, 3 and 8 appear to form distinct groups and vary in their proximity to group A 
and B. 
However, the extreme heterogeneity in the size of the PAD 3’ UTRs appears 
unlikely, especially when considering the PAD genes’ otherwise homologous nature.  
For example, the predicted PAD2 3’ UTR is more than 5 times the length of the 
predicted PAD1 3’ UTR; it would appear more likely that the UTR predictive 
algorithm does not predict RNA processing sites accurately in longer intergenic 
regions.  Moreover, this size heterogeneity was not detected when PAD1, 2, 5 and 7 
mRNA transcripts were analysed by Northern blot (see Section 5.1).  It is likely that 
in intergenic regions the predictions are inaccurate and underestimate the length of 
non-UTR intergenic regions. 
Nonetheless, these groups may be reflective of expression profile or translational 
efficiency; one might speculate that there may be functional redundancy between the 
proteins expressed within these groups. 
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Figure 3.3-2  A comparison of the predicted PAD 3’ UTRs.  (A) The predicted 3’ UTRs 
of the PAD genes were aligned using clustalW and visualised using Jalview.  Note that 
the PAD2 and 8 predicted 3’ UTRs were truncated to save space. (B) A phylogram was 
constructed based upon the alignment using a neighbour joining algorithm.  PAD1, 5 and 
7 and PAD4 and 6 form distinct groups.  PAD3, 8 and 2 are less closely related to other 
genes within the array. 
B
3 - A bioinformatics analysis of the PAD genes 88 
 
3.3.3 An analysis of the repetitive elements within the PAD intergenic regions 
A multiple alignment analysis of the PAD intergenic regions (see Appendix A) as 
designated by the GeneDB database identified 6 elements (designated I to VI) that 
are repeated through the intergenic regions.  These range from 59 to 955 nucleotides 
in length (see Figure 3.3-3) and are repeated at variable frequencies throughout the 
array. 
Element I is present in the intergenic region upstream of PAD1 (designated UP-1), as 
well as intergenic regions between PAD1-2, PAD2-3, PAD5-6, PAD7-8, but was not 
predicted to form part of any of the PAD 5’ or 3’ UTRs.  Thus element I is therefore 
either non-functional or has a role directing the 5’ trans-splicing reaction.  
Element II contains a predicted 5’ trans-splicing signals, whereas element IV 
contains a predicted 3’ poly-adenylation signal.  Element III appears to contain both 
5’ trans splicing signal and 3’ poly-adenylation signals.  These elements may also 
have roles in the stability or translational efficiency of the resulting mature mRNA 
transcript. 
PAD4, PAD6 and PAD8 share elements II and III and may thus be co-regulated.  
PAD2 is unique in that it contains no repeated elements in the 3’ UTR; the PAD2 
transcript was shown to be elevated in procyclic forms (see Section 5.1) thus this 
non-repeated element presumably contains a procyclic form stabilisation element. 
Mayho et al. (Mayho et al. (2006)) identified an 8 nucleotide U-rich element 
(uauuuuuu) that was over-represented in procyclic form-specific gene 3’ UTRs.  This 
element was found to be present in 31% of procyclic enriched transcripts compared 
with just 9% of blood form enriched transcripts and at an overall frequency of 9.6%.  
An analysis of the repetitive intergenic elements of the PAD array found this 
sequence twice in element IV and once in element V.  Additionally, it was found that 
this sequence was present in the non-repetitive regions of the PAD2 and PAD3 3’ 
UTR; thus, it appears that this element is present in the 3’ UTR of all of the PAD 
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genes except for PAD1. However, a Northern analysis to dissect the expression of 
the different PAD genes through the life cycle revealed that PAD5 and 7 are not 
expressed in the procyclic form of the parasite (see Section 5.1), despite containing 
this U-rich sequence.  We cannot therefore make any inference from the presence of 
this element in the PAD 3’ UTRs. 
Interestingly, element VI is present in the 3’ UTR region of PAD1, PAD5 and PAD7, 
all of which are stumpy form specific mRNA transcripts (see Section 5.1) and this 
region may therefore contain a stumpy-specific stabilisation element. Element V is 
only present in the PAD5 and PAD7 3’ UTRs and is not found in the PAD1 3’ UTR. 
This element may have an additional role unrelated to transcript stabilisation in 
stumpy form cells or may simply represent a non-regulatory sequence that was 
duplicated along with PAD5 and 7. 
Given that PAD1, 5 and 7 are stumpy specific transcripts (see Section 5.1), one 
might speculate that the elements responsible for stability in stumpy form cells might 
allow identification of other stumpy specific transcripts within the T. brucei genome.  
To this end, elements V and VI were used as a query sequence in a BLASTN search 
of the T. brucei genome.  However, other than PAD array sequence, no significant 
hits were returned from this search.  Moreover, the degree of homology shown by the 
identified hits was low, and the position on the chromosome was often on the non-
coding DNA strand.
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3.3.4 Predicting the secondary structure of the PAD 3’UTRs 
The structure of 3’UTRs is likely to be important for RNA binding protein specificity 
and therefore has an essential role in transcript stability and translational efficiency 
(Hotz et al. (1997)) (Irmer and Clayton (2001)).  Particularly, it is thought that 
mRNA regulatory proteins bind the single stranded RNA and hairpin loop region of 
folded mRNA sequence (Hehl et al. (1994)) (Furger et al. (1997)) (Hotz et al. 
(1997)) (Mayho et al. (2006)).  Experimental elucidation of RNA structure is 
expensive, technically challenging and time consuming, and currently there are no 
bioinformatics programs available that predict the three-dimensional structure 
without some experimental data and user defined parameters. 
However, there are, several programs available that predict the secondary structure of 
RNA molecules based on its primary sequence. These programs operate by 
calculating the free energy associated with a structure based on the base pairing of 
the component nucleotides.  Using a greedy algorithm, the structure is then modified 
until the minimum free energy (MFE) structure is found.   
However, secondary structure prediction can be complicated by: 
• The presence of solutes and ions that might affect RNA folding 
• A variety of different RNA structures within a population 
• More complex structures such as pseudoknots that are often badly predicted 
• Interactions with RNA binding proteins 
• Interactions with other RNA molecules 
• Variations in temperature 
For these reasons, the MFE structure may not be the biologically relevant structure 
and often a number of sub-optimal free energy structures are generated for 
comparison.  Although examining sub-optimal structures can be valuable, when 
several RNA molecules are being compared the volume of data returned is 
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impractical, and often a single consensus structure is more appropriate.  In the case 
of Sfold (Ding and Lawrence (1999)) (Ding and Lawrence (2001)) (Ding et al. 
(2004)), the sub-optimal structures are statistically sampled and a consensus, or 
centroid, structure is generated based on minimal distance from the sampled sub-
optimal structures.  Sfold was therefore used in preference to other RNA secondary 
structure prediction programmes, such as Mfold. 
Given that the elements described in Section 3.3.3 are present in several different 
contexts (e.g. in the PAD3 3’ UTR element III is downstream of a non-repetitive 
region, whereas in the PAD4 3’ UTR it is downstream of element IV), one would 
predict that they are able to fold independently of adjacent nucleotide sequences.  
Elements IV and V were submitted to Sfold in their entirety, and elements III and VI 
were modified prior to submission such that only sequence present in the 3’ UTR 
were analysed. 
Figure 3.3-4 shows that element III is predicted to have two large single stranded 
loops extending from a longer stem, and 3 smaller loops.  Element IV has a large 
terminal single stranded loop at the distal end from a more complex group of small 
stem-loops.  Element V has a large branch causing it to form a Y shaped structure.  
Additionally there are 3 principal loops and a number of smaller loops interspaced 
through the structure.  Element VI has the largest proportion of single stranded 
regions of the four elements.  Only 23 (9%) nucleotides from a total of 251 form 
bonds with other nucleotides in the structure suggesting that this element is 
extremely unstable.  This element consists primarily of 5 large and 2 small single 
stranded loops which may provide access for RNA binding proteins to form 
complexes and regulate the stability of the rest of the transcript.  
Caution should be exercised when interpreting structural predictions in the absence 
of experimental data.  Nonetheless, this kind of analysis can be useful in identifying 
regions that might be targeted in a mutation analysis of PAD gene regulation.
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Figure 3.3-4  The predicted secondary structure of elements within the PAD 3’ UTR 
as predicted by Sfold.  The elements contained within the PAD 3’ UTRs were submitted 
for secondary structure prediction analysis using Sfold.  Where an element contained a 
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3.4 Detecting conserved domains within PAD proteins 
There are numerous programmes available that can help to characterise the function 
of a protein by detection of domains that have an associated function.  Several of 
these were used to analyse the PAD proteins.  
3.4.1 Pfam analysis 
The Pfam database (Sonnhammer et al. (1998)) (Finn et al. (2006)) is a large 
collection of protein families and conserved domains that can be interrogated with a 
query sequence to help characterise a protein.  Pfam consists of 9318 protein families 
(http://pfam.sanger.ac.uk/) that are divided into the high quality, manually curated 
PfamA and the automatically generated PfamB (Sonnhammer et al. (1997)) (Finn et 
al. (2006)). 
Each family in Pfam is represented by a multiple sequence alignments that gives rise 
to a hidden Markov model.  A hidden Markov model is a statistical model that 
describes the ‘hidden’ parameters of a stochastic process.  In this example, the 
hidden Markov model describes the mathematical relationship between proteins 
within the same family, and the probability of a query protein being a member of the 
same family is calculated. 
Both the manually edited PfamA and the automatically generated PfamB 
components were searched using the PAD proteins as a query sequence.  Thus, all of 
the PAD proteins contain a clear Major Facilitator Superfamily (MFS) 1 domain 
(Pfam accession number IPR011701) and as such are members of this clan (see 
Table 3.5-1).  Members of the MFS typically have 6, 12, 14 or 24 transmembrane 
helices and transport a substrate by facilitating an existing chemiosmotic gradient 
(Rubin et al. (1990)) (Paulsen et al. (1998)).  Transport is not active as in the ATP 
binding cassette (ABC) transporters and can occur bidirectionally through uniport, 
symport or antiport (see Figure 3.4-1 and Section 1.7.3).  No other domains were 
detected within the primary sequence using Pfam. 
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3.4.2 CDD analysis 
PAD1 was also analysed using the Conserved Domain Database (CDD).  CDD is a 
collection of ancient domains and full length proteins that have been aligned and a 
profile has been constructed using a reverse position-specific BLAST algorithm.  A 
query sequence is then compared with the position score matrices prepared from the 
underlying domain alignments.  When PAD proteins were used as a query sequence 
it was found that they have a nodulin-like domain (Pfam06813) (see Table 3.5-1), a 
conserved region within plant nodulin-like proteins that is often found in MFS 
proteins.  Nodulin-like transporters are largely uncharacterised, but several are 
known to transport nitrate (Vincill et al. (2005)) and other small solutes. 
3.4.3 Prosite analysis 
Prosite (Hulo et al. (2006)) is a collection of protein domains, families, and 
functional sites that have been collected into groups based upon their sequence 
similarity and likely function.  By analysing the constant and variable regions within 
these groups a ‘signature’ for each group has been built that allows members to be 
distinguished from unrelated proteins.  A query sequence is then analysed and 
compared with the database of signatures to determine which, if any, of the groups it 
belongs to.  Using the PAD proteins as query sequences no matches were found (see 
Table 3.5-1).  The most likely reason for this is that functional analyses of transporter 
molecules have largely failed to identify the specific characteristics required for 
substrate specificity mechanism of action. 




Figure 3.4-1  A schematic showing the mechanisms of transport for major 
facilitator superfamily transporters. (A) Uniport where a single substrate is transported 
across the membrane, (B) Symport where two substrates are transported in the same 
direction across the membrane and (C) Antiport, where two substrates are transported in 
opposite directions across the membrane.  The blue and brown shapes depict the 
transported molecules, the arrows show the direction of transport and the orange tubes 
the MFS transporters. 
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3.5 Predicting the localisation of the PAD proteins 
Determining the cellular localisation of a protein is a vital step to elucidating its 
function, and there are a number of programmes available that can to identify cellular 
targeting sequences. 
SignalP3.0 (Neilsen (1997)) (Bendtsen (2004)) (Emanuelsson (2007)) uses a 
combination of neural networks and hidden Markov models to predict the presence 
and location of a signal peptide within the query sequence.  Signal peptides are 
amino terminal peptides approximately 15 – 30 residues long that are responsible for 
insertion of the protein into the membrane during translation, and target the protein 
for translocation across the plasma membrane in prokaryotes, and across the 
endoplasmic reticulum in eukaryotes.  Typically, a signal peptide contains a 
positively charged region at the amino terminus (n-region) followed by a 
hydrophobic region (h-region) of a least 6 residues and ending in a carboxyl terminal 
region containing polar, uncharged residues (c-region).  A signal peptide is generally 
cleaved and, unless it contains a retention sequence, the protein is secreted by default 
in secretory vesicles.  When the PAD proteins were used as a query sequence in the 
SignalP programme, no signal peptides were detected, but a signal anchor, or 
uncleaved signal peptide, was predicted with a strong probability (see Table 3.5-1).  
Signal anchors have an almost identical structure to signal peptides, but differ in that 
they do not contain a cleavage site and therefore remain part of the mature protein.  
Proteins containing signal peptides where the amino terminus is cytoplasmic are 
termed type II membrane proteins, as is the case with the PAD proteins. 
WolfPSort (Horton et al. (2006)) (Horton et al. (2007)) analyses a sequence to detect 
subcellular localisation amino acid sequences that may elucidate a protein’s final 
position within the cell and is most able to detect signals that localise proteins to the 
cytosol, nucleus or the mitochondrion.  WolfPSort is designed to analyse animal, 
plant or fungal proteins rather than protozoan proteins, so all of these options were 
tried sequentially.  No localisation motifs were detected in the PAD proteins;  in 
particular, it is notable that targeting motifs for the membrane bound organelles such 
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as the mitochondrion were not found.  A possible vacuolar targeting motif (TPLK) 
was detected indicating potential endosomal trafficking. 
TargetP (Emanuelsson (2000)) (Nielsen (1997)) analyses a protein to detect either 
mitochondrial targeting motifs or signal peptides.  None were found in the PAD 
proteins, suggesting that the protein is not targeted to the mitochondrion and is not 
cleaved and secreted. 
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Table 3.5-1  A summary of the PAD protein bioinformatics data 
Programme Detection Results Reliability
Pfam
Conserved domains using the Pfam 
database
MFS-1 E = 1.7E
-6
CDD Conserved domains (a.a. 44 - 217) Nodulin-like domainE = 4E
-6
Prosite Conserved domains None found
Prosite Conserved domains None found
WolfPSort ER retention motif in the C-terminusNone found
ER Membrane Retention Signals None found
SKL: peroxisomal targeting signal in the 
C-terminus
None found
2nd peroxisomal targeting signal None found
Possible vacuolar targeting motif
TPLK found at pos. 
449
RNA-binding motif None found
Actinin-type actin-binding motifs None found
N-myristoylation pattern: None found
Farnesylation/Geranylgeranylation motifN ne found
Transport motif from cell surface to GolgiNone found
Tyrosines in the tail None found
Dileucine motif in the tail None found
big-PI GPI anchor cleavage sites None found
PSORT Signal peptide None found
Mitochondrial localising peptide None found
SignalP3.0 Signal peptide None found
Anchor peptide Yes P = 0.836
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3.6 Predicting the secondary structure of the PAD proteins 
The web based topology prediction programme TMHMM (Tusnády and Simon 
(1998)) (Tusnády and Simon (2001)) was used to interrogate the amino acid 
sequence of the PAD proteins.  TMHMM uses a hidden Markov model to analyse the 
differences in amino acid composition within the query sequence (rather than 
utilising the absolute frequency of individual amino acids), such that the positions of 
the transmembrane spanning (TMS) regions, intracellular loops and extra-cellular 
loops are predicted.  The data from HMMTOP was visualised as a secondary 
structure using the downloadable programme TMRPres2D (Spyropoulos et al. 
(2004)).  In total, 14 TMS were predicted for the  PAD proteins (see Figure 3.6-1A 
and Appendix A), consistent with them being part of the major facilitator 
superfamily and the Pfam data.  In addition, the positions of two large intra-cellular 
loops are indicated for PAD1, and both the amino terminus and the carboxyl 
terminus are predicted to be intracellular. 
Charged amino acids are thought to be important in substrate binding, particularly if 
present in membrane helices (Guan and Nakae (2001)) (Shelden et al. (2003)) 
(Manoharan et al. (2006)) (Valdés et al. (2006)).  Rahman et al. (Rahman et al. 
(1999)) showed that charged amino acid residues in helices 7 and 10 are essential for 
substrate binding in the rat monocarboxylate transporter MCT1 (see Section 3.8 for 
further discussion of PAD protein similarities with carboxylate transporters).  
Interestingly, only PAD 2, 4 and 6 have charged residues in helix 7, while PAD1, 5, 
7 and 8 appear to have a reciprocal charged residue in helix 9, and PAD 3 in helix 13 
(see Figure 3.6-1); it would be informative to determine whether the PAD proteins 
divide into these three groups in either substrate specificity, affinity or translocation. 
In contrast, all of the PAD members contain a charged residue in helix 4, 5 and 13, 
suggesting that these residues are essential for substrate binding or translocation; any 
mutagenesis strategy to determine which parts of the polypeptide are important for 
function would focus on these residues. 
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There are examples that show there is the potential for overlap of function between 
transporter and receptor molecules.  Özcan et al. (Özcan et al. (1998)) show that two 
proteins of the major facilitator superfamily in Saccharomyces cerevisiae are able to 
sense the presence of glucose and transmit the signal without substrate translocation.  
These proteins have long (218 and 314 residues) carboxyl terminal cytoplasmic 
domains containing a 25 amino acid residue motif that is necessary for signal 
transduction.  In contrast, the PAD genes have cytoplasmic carboxyl domains of less 
than 50 residues and do not contain the glucose sensing motif, suggesting they 
function as conventional transporters. 
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Figure 3.6-1  The secondary structure prediction of the PAD proteins. (A) The 
positions of the transmembrane spanning regions as predicted by HMMTOP are shown 
for each of the PAD proteins. Helices containing charged amino acid residues are circled 
in red.  (B) The secondary structure of PAD1 was visualised as a representative of the 
PAD cluster using TMRPres2D based upon the HMMTOP output.  Charged amino acid 
residues are circled in red.  The secondary structure for the other PAD proteins can be 
found in appendix A. 
A.
B.
Total entropy of the model:  16.9982
Entropy of the best path:  17.0051
PAD 1 PAD 2 PAD 3 PAD 4 PAD 5/7 PAD 6 PAD 8
Helix 1 27-46 27-46 27-46 27-46 27-46 27-46 27-46
Helix 2 67-85 67-86 65-84 67-85 65-84 67-85 65-84
Helix 3 92-111 93-112 93-112 92-111 93-112 92-111 93-112
Helix 4 130-149 129-148 129-148 130-149 129-148 130-149 129-148
Helix 5 162-179 155-174 155-174 162-181 155-174 162-181 155-174
Helix 6 188-205 183-205 185-204 186-205 185-204 186-205 187-205
Helix 7 245-268 245-268 245-268 240-259 245-268 240-259 240-259
Helix 8 277-300 277-295 277-295 280-299 277-295 280-299 280-299
Helix 9 355-374 355-374 355-374 355-374 355-374 355-374 355-374
Helix 10 395-414 395-414 395-414 395-414 395-414 395-414 395-414
Helix 11 427-450 427-450 427-447 427-448 427-450 427-448 427-450
Helix 12 459-476 459-477 460-477 457-476 459-477 457-476 459-477
Helix 13 489-507 490-509 490-509 489-507 490-509 489-507 490-509
Helix 14 528-547 528-547 528-547 528-547 528-547 528-547 528-547
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3.7 Predicting the three-dimensional structure of the PAD proteins 
Predicting the three dimensional structure from the amino acid sequence of a protein 
is inherently difficult and prone to error.  Programmes that do this rely on finding 
homology to experimentally verified structures and use this as a template with which 
to predict the structure of a query sequence.  This is particularly challenging with 
regard to transmembrane proteins as the membrane forms an integral part of the 
structure and can make predictions problematic.  Several programmes (e.g. 3D 
jigsaw (Bates and Sternberg (1999)) (Bates et al. (2001)) (Contreras-Moreira et al. 
(2002))) were used to predict the structure of PAD proteins but were unsuccessful 
due to the lack of an existing experimentally verified structure to use as a template. 
3.8 Using PSI-BLAST to help elucidate the PAD proteins’ function 
Finally, to identify homologues that may have an identified substrate or may 
otherwise help elucidate PAD function a Position Specific Iterated Basic Local 
Alignment Search Tool (PSI-BLAST) search was performed.  PSI-BLAST performs 
a BLASTP search that identifies homologues in a database of sequences.  Using 
these ‘hits’ a profile is built a profile using a hidden Markov model such that 
frequently occurring amino acids at specific positions are given more importance; the 
BLAST search is then re-iterated using this profile.  PSI-BLAST is more sensitive 
than conventional BLAST and may detect homologues that would otherwise go 
unidentified. Furthermore, the proteins identified through BLAST based algorithms 
can be grouped based upon alignment with other members of the MFS and 
construction of a neighbour-joining tree.  This strategy has been successfully used to 
predict the substrate and mechanism of transporters (Martin et al. (2005)) (Saliba et 
al. (2006)). 
Seventeen BLAST iterations were performed using PAD1 as a query sequence until 
the results came to convergence and no more hits were returned.  In the top 250 hits, 
19 proteins had putative or characterised transport substrates identified (see Table 
3.8-1).  Of these, 15 were oxalate/formate antiporters, 2 were non-specific 
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monocarboxylate transporters,  1 was a nitrate and chloride transporter and 1 was a 
DNA polymerase III alpha subunit.  Oxalate, (COO)2
2, and formate, HCOO-,  are di-
carboxylates and monocarboxylates respectively.  Nitrate, NO3
-, is a small inorganic 
anion with a formal charge of -1.  Note that the return of the alpha subunit of DNA 
polymerase III is probably a miss-annotation of the database; a Pfam analysis shows 
it to be a member of the MFS and it has no polymerase domains.  Moreover,  a 
TBLASTX search using this gene as a query sequence returned only transporters 
(data not shown).  
The return of predominantly carboxylate transporters may be significant because 
both citrate and cis-aconitate are tricarboxylates, and a role for the PAD proteins in 
citrate or cis-aconitate transport correlates with a role in citrate /cis-aconitate mediate 
differentiation.  The return of 15 oxalate/formate antiporters may also indicate that 
PAD1 also functions as an antiporter. 
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Accession Number Description E value
gi|57545995|gb|AAW5188
4.1|      
nitrate and chloride transporter [Glycine max] 8E-130
gi|152982869|ref|YP_0013
55198.1|
oxalate/formate antiporter, MFS superfamily 
[Janthinobacterium sp.            Marseille].
1.00E-95
gi|116695641|ref|YP_8412
17.1|   




9.1|    
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12.1|   
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MFS monocarboxylic acid transporter, putative 
[Aspergillus clavatus NRRL 1]
1.00E-61
gi|91781396|ref|YP_55660
2.1|    
Putative oxalate/formate antiporter, majorfacilitator 
superfamily (MFS) [Burkholderia xenovorans LB400]
2.00E-55
Table 3.8-1  A summary of the characterised hits from a PSI-BLAST using PAD1 as 
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4 Characterisation of the DiD1 cell line 
As described in Section 1.8, the DiD1 differentiation phenotype was selected for by 
selecting for cells that failed to lose their protective VSG coat in response to cis-
aconitate (Tasker et al. (2000)).  Deletion of GPI-PLC caused a reduced virulence, 
and an unexpected reversion to pleomorphism, consequently restoring DiD1 cells’ 
ability to respond to cis-aconitate.  The underlying defect in the DiD1 cells is not 
known, but it was proposed that they lack a stumpy form characteristic enabling 
them to differentiate to the procyclic form.  Thus, an analysis of the defect in the 
DiD1 cell line may give insight into the mechanisms that allow the initiation of 
differentiation. 
4.1 A Northern analysis to compare PAD genes in the DiD1 and 
parental cell lines 
As described in Section 1.8, a macroarray hybridisation analysis identified a plasmid 
containing fragments of PAD1 and 2 as differentially hybridising to DiD1 cDNA 
with respect to the parental cDNA.  Subsequent Northern analysis using a riboprobe 
based upon this plasmid verified the original result (Davies and Levin, University of 
Manchester, unpublished data).  As discussed in Section 3.1, the PAD array 
constitutes 8 highly homologous genes at the 3’ end of a directional gene cluster.  
Thus, it was of interest to determine if PAD1, PAD2 or both genes were enriched in 
the DiD1 cell line, and if other members of the array were also differentially 
expressed. 
Riboprobes that were synthesised previously (courtesy of Pam Davies, University of 
Manchester) were used in a Northern blot to determine if there was differential 
expression between the parental and the DiD1 cell line.  These probes were designed 
to detect: 
• PAD1 
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• PAD2 
• PAD3 
• PAD5 and 7 (the nucleotide sequence for these genes is identical, thus it is 
not possible to distinguish between them) 
Additionally, a riboprobe was designed to detect all 8 genes simultaneously by using 
the entire open reading frame of PAD2. 
Figure 4.1-1 shows that, of the mRNA transcripts tested, only PAD1 and PAD2 were 
found to be enriched in the DiD1 cell line; PAD3 mRNA was not detected (data not 
shown), suggesting that this transcript is either not expressed or that the riboprobe 
preparation failed (no further analysis was performed on PAD3); PAD4, 6 and 8 
expression was not assayed.  The riboprobe to detect the entire array of PAD also 
detected an upregulation of PAD genes in DiD1, but this was mild in comparison 
with PAD1 and PAD2 upregulation, suggesting that few of the PAD genes had 
enriched expression in the DiD1 cell line. 
Thus, it appears that PAD1 and PAD2 are probably the only members of the PAD 
array that are aberrantly expressed in the DiD1 cell line.  This may not be surprising 
given that these genes are adjacent within the array.  The 3’ UTRs of PAD1 and 
PAD2 are distinct (see Section 3.3.2), suggesting that the upregulation of these 
transcripts may not be due to a single mRNA binding protein that confers stability 
upon both transcripts.  Moreover, despite the 3’ UTRs of PAD5 and 7 sharing a 272 
bp element with PAD1 (see Section 3.3.3), PAD5 and 7 were not enriched in the 
DiD1 cell line, implying that enrichment of PAD1 in DiD1 cells was not conferred 
by this region of the 3’ UTR. 










Figure 4.1-1  Expression of PAD genes in parental and DiD1 cells.  A Northern blot 
analysis to determine expression level differences between the parental (P) and DiD1 cell 
line of (A) PAD1, (B) PAD2, (C) PAD5/7 and (D) the entire array, shows that only PAD1 
and PAD2 express elevated levels of mRNA transcript in DiD1 cells. 
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4.2 A Southern analysis to detect PAD array genome rearrangements 
PAD1 and PAD2 may have been subject to a genomic re-arrangement that has 
caused them to be duplicated and consequently more highly expressed, or they may 
have moved to a region of the genome that is more highly transcribed.  To test these 
possibilities, a Southern blot was performed to detect any large scale genomic re-
arrangements affecting the PAD array genes in the DiD1 line. 
The original DiD1 cell line was culture adapted subsequent to its selection in order to 
generate GPI-PLC deletion mutants.  However, this cell line was lost in a freezer 
malfunction and subsequent attempts to culture-adapt the DiD1 cell line were 
unsuccessful.  For this reason, DiD1 and the parental cells were purified from 
infected mouse blood using a DEAE cellulose anion exchange column, and genomic 
DNA was prepared from the cell lysate (see Materials and Methods for details).  
Parental and DiD1 genomic DNA were subsequently digested with either EcoRI or 
BamHI for Southern blotting. 
A DNA probe was synthesised by treating an amplicon containing the entire open 
reading frame of PAD2 with Klenow polymerase in the presence of labelled 
nucleotides (see Materials and Methods for details).  The homology of the PAD 
genes is such that this probe would anneal to all of the PAD genes (see Section 3.2 
for PAD gene alignments). 
Figure 4.2-1 shows that, when this probe was used in a Southern blot, there did not 
appear to be any differences in probe hybridisation between the DiD1 cell line and 
the parental strain; however, the bands that were observed do not correlate precisely 
with the sizes predicted based on the genome reference data.  The database predicts 
that 9 fragments should be released through BamHI digestion; of these, it should be 
possible to distinguish at least 6 on a 0.7% agarose gel, but only 5 bands were 
detected.  Additionally, when the genomic DNA is digested using EcoRI, 3 bands are 
predicted from the database but 4 are detected.  It is likely that differences between 
the genome reference strain and the parental cell line have accumulated since the 
Chapter 4 – Characterisation of the DiD1 Cell Line 111 
strains diverged, resulting in modifications of restriction enzyme sites, or additions 
and deletions of genomic DNA sequence.  This is not uncommon in arrays of tandem 
repeats; in their analysis of 3 different T. brucei  strains (427, 247 and the 927 
genome reference strain), Callejas et al. (Callejas et al. (2006)) report that either 
duplications or deletions had occurred in all of the tandem gene arrays in 
chromosome 1.  Of the bands that were detected, the sizes of the predicted bands 
appeared to correlate approximately with those that were observed, suggesting that 
differences are minor.  Nonetheless, it is clear that there are differences between the 
genome reference strain and the EATRO 2340 GUP2965 cell line in this region of 
the chromosome. 
There were, however, no differences detected between the DiD1 cell line and the 
parental cell line.  We can therefore conclude that it is unlikely that large scale 
genomic rearrangements have occurred in this region of the genome during the 
selection of DiD1 cells.  It should be noted, however, that if the entire array has been 
duplicated along with the restriction sites used in this analysis, this may not be 
detected by Southern blot. 
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Figure 4.2-1 A Southern blot to determine whether any genomic rearrangements 
have occurred during the selection of the DiD1 cell line. (A) A Southern blot analysis 
performed on  parental (P) and DiD1 genomic DNA shows that a large scale genomic 
rearrangement has not occurred during DiD1 selection.  (B) A summary of the Southern 
data, compared with what would be predicted genome reference data.  There does 
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4.3 A sequencing analysis to compare the PAD1 3’ intergenic region in 
the DiD1 and parental cell lines 
Trypanosomatids control mRNA transcript levels predominantly through the use of 
mRNA binding proteins that bind to the 3’ UTR of expressed genes.  These predicted 
proteins can confer stability or instability (Schürch et al. (1997)) (Furger et al. 
(1997)) (Hotz et al. (1997)) (Mayho et al. (2006)), as well as either enhancing or 
repressing translation of the target transcript.  As discussed (see Section 4.1), PAD1 
and PAD2 mRNA transcripts were found to be enriched in the DiD1 cell line, and a 
Southern analysis concluded that this was not due to an obvious genomic 
rearrangement (see Figure 4.2-1).  Therefore, an alternative possibility was that 
enrichment of PAD1 and 2 expression in DiD1 cells  may be due to the presence of 
mutation(s) in the 3’ UTR of these genes during selection of the DiD1 cell line, thus 
preventing regulation of the mature transcript.  A sequence analysis was therefore 
performed on the PAD1 3’ UTR.  The PAD1 3’ UTR was chosen rather than PAD2 
3’ UTR because the data from the Northern analysis indicated that this gene has a 
role in differentiation (being both upregulated in DiD1 cells (see Section 4.1) and 
stumpy form cells (see Section 5.1)), and, as it has the smallest 3’ UTR, it was 
relatively straightforward analyse. 
Primers were designed that were predicted to amplify the entire intergenic sequence 
between PAD1 and PAD2 (see Appendix A for primer list).  Genomic DNA from the 
parental cell line and from the DiD1 cell line was used as a template, and the 
resulting amplicons were cloned into pGEM-T easy for DNA sequencing (see 
Materials and Methods for details).  To prevent the possible mis-interpretation of a 
polymerase-incorporated error, two separate reactions were performed for each 
template, and 5 positive clones derived from each PCR reaction were sequenced to 
make a total of 10 clones for each template.  A consensus sequence of each clone 
was then aligned with the genome reference data. 
Figure 4.3-1 shows that no mutations in the PAD1 – 2 intergenic region were 
detected in the DiD1 cell line.  From ten DiD1 clones, one clone had a T  A 
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change at position 140, and one clone had a G  T change at position 178 (data not 
shown); these were considered to be polymerase-incorporated errors and were not 
detected in any of the other clones.  Additionally, from ten parental clones, one clone 
had a T  C difference at position 789, and one clone had a T  G difference at 
position 821; similarly, these were considered to be polymerase incorporated errors 
as they were not present in any of the other clones (data not shown).  Interestingly, 
this analysis did determine that there are 2 ‘alleles’ of this intergenic region 
(discriminated by G/A at position 929) in both the parental strain and the DiD1 cell 
line.  The genome reference strain appears to represent a third ‘allele’. 
Thus it would appear that the enrichment of PAD1 is not due the presence of 
mutation(s) within the PAD1 3’ UTR.  A similar analysis of the PAD2 3’ UTR was 
not thought to be necessary as one would expect the enrichment of these genes in the 
DiD1 cell line to have a common cause.  The underlying cause of PAD1 and PAD2 
mRNA transcript enrichment in the DiD1 cell line is therefore not known.  One 
possibility is that altered specificity or action of a PAD gene RNA binding protein 
has occurred through the selection process that prevents proper de-stabilisation of 
these transcripts in the monomorphic slender form.  If this is the case, then one could 
speculate that, despite the distinct expression profile of these genes, both are acted 
upon by a common RNA binding protein, possibly as part of a multi-protein 
complex.  It would be informative to determine which RNA binding proteins regulate 
the different PAD genes, and to determine whether there is any altered RNA target 
specificity in the DiD1 cell line. 
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Figure 4.3-1 A sequencing analysis of the PAD1 3' intergenic region. The PAD1 3’ 
intergenic region was amplified from the DiD1 and 65.3 parental strain and cloned for 
sequencing.  10 clones from 2 different PCR reactions were sequenced to ensure that 
both copies of the PAD1 3’ UTR were analysed, The resulting ‘alleles’ were aligned with 
the PAD1 3’ intergenic region from the genome reference data. 
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4.4 A sequencing analysis to determine the presence of mutations of 
PAD genes in the DiD1 cell line 
The enriched expression of PAD1 mRNA in stumpy form cells (see Section 5.1) 
suggests that this gene may have a role in initiating differentiation to the procyclic 
form.  Additionally, PAD2 protein is elevated in expression in response to conditions 
that induce hypersensitivity to cis-aconitate (see Section 5.16), supporting its 
putative role in promoting cis-aconitate mediated differentiation. It is thus counter-
intuitive that PAD1 and PAD2 have elevated expression in a cell line that is 
defective in its ability to respond to cis-aconitate.  One possibility is that the selection 
regime favoured cells with defective PAD proteins that cause a dominant negative 
effect.  If this were the case, one would expect that PAD genes in DiD1 have 
accumulated mutation(s) through the selection cycles.  To test this hypothesis, a 
sequence analysis was performed to detect any differences in PAD1 and PAD2 
between the DiD1 and the parental cell lines. 
The polymerase chain reaction (PCR) was used to amplify PAD1 and 2 from DiD1 
and parental genomic DNA (see appendix A for primer list, and Materials and 
Methods for more details).  As with the cloning of the intergenic regions (see Section 
4.3), two separate reactions were performed to eliminate the possibility of a 
polymerase incorporated confusing the analysis.  The amplicons corresponding to 
PAD1 and 2 were cloned into pGEM T easy and 5 positive clones from each PCR 
reaction (in total 10 from 65.3, and 10 from the DiD1 cell line, per gene) were 
submitted for sequencing. 
Figure 4.4-1 shows that that there are 2 PAD1 alleles in the 65.3 parental strain, 
distinguished by 11 amino acid polymorphisms.  Additionally, the genome reference 
strain appears to represent a third allele.  Both alleles were found in the DiD1 cell 
line, and no mutations appear to have occurred during the DiD1 selection. 
Figure 4.4-2 shows that, as with PAD1, there are 2 PAD2 alleles in the parental cell 
line.  These can be distinguished by 2 amino acid polymorphisms; again, a distinct 
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allele is present in the genome reference strain.  As with PAD1, both alleles were 
detected in the DiD1 cell line, and neither appeared to have accumulated any 
mutations. 
In summary, no mutations were detected in the DiD1 PAD1 or PAD2 alleles that 
might cause a dominant negative effect.  Given that no mutations were detected by 
this analysis in the 3’ UTR of PAD1, and Southern blot did not reveal any genomic 
re-arrangements in the PAD array locus, upregulation of PAD1 and 2 in the DiD1 
cell line is probably a consequence of an unknown defect that caused the DiD1 cells 
to differentiate poorly in response to cis-aconitate. 
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Figure 4.4-1 An alignment of the parental, DiD1 and genome reference strain PAD1 
encoded proteins.  PAD1 was amplified from DiD1 and parental 65.3 genomic DNA and 
cloned into pGEM T easy for sequencing.  Consensus protein sequences were generated 
and aligned with the PAD1 genome reference sequences. 
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Figure 4.4-2  An alignment of the parental, DiD1 and genome reference strain PAD2  
encoded proteins.  PAD2 was amplified from DiD1 and parental 65.3 genomic DNA and 
cloned into pGEM T easy for sequencing.  Consensus protein sequences were generated 
and aligned with the PAD2 genome reference sequences 
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4.5 Ectopic expression of PAD1 to recapitulate the DiD1 differentiation 
defect 
The mechanism of PAD1 and PAD2 upregulation in DiD1 cells was not determined 
by any of the analyses presented in this study.  Additionally, the sequence analysis of 
PAD1 and PAD2 had not uncovered any evidence of a mutated PAD gene that might 
cause a dominant negative effect.  It was therefore of interest to determine whether 
upregulation of PAD genes per se was sufficient to inhibit differentiation of cells.  A 
possible, speculative, mechanism for this might be that low levels of PAD protein are 
able to transmit the cis-aconitate signal to differentiate in monomorphic slender cells, 
but high mRNA expression causes mal-folding of PAD proteins such that no 
functional protein is formed, thus inhibiting differentiation. 
The following experiment set out to test this possibility. 
4.5.1 Over expression of PAD1 
PAD1 was amplified from parental 65.3 genomic DNA and cloned into the 
expression vector pHD451-Ty.  This DNA construct had been previously modified 
from pHD451 such that insertion of a gene with no stop codon into the multiple 
cloning site incorporates a carboxyl terminal Ty epitope tag upon expression (Bastin 
et al. (1996)) (Hendriks et al. (2001)).  This construct was further modified to 
facilitate cloning (see Section 5.2.1.1).  Positive clones were screened by diagnostic 
digest and verified by DNA sequencing (see Materials and Methods).  Monomorphic 
slender T. brucei Lister 427 cells containing the pHD449 TetR constitutive 
expression construct (Biebinger et al. (1997)) were then transfected with the 
pHD451:PAD1-Ty (see Materials and Methods for details) such that cells would 
express PAD1-Ty in the presence of tetracycline. 
The differentiation of cells that had been induced to express PAD1-Ty was compared 
with those that had not.  Additionally, a non-transfected cell line (with and without 
tetracycline) was included in case there was low level (‘leaky’) expression of PAD1-
Ty even in non-induced cells, or an effect of tetracycline unrelated to PAD1-Ty 
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expression.  Cells were induced for PAD1-Ty expression by supplementing the 
culture media with 2 µg ml
-1
 tetracycline for 3 days, and differentiated by incubating 
at 27°C in HMI9 supplemented with 6 mM cis-aconitate.  Differentiation capacity 
was assayed by fixing cells in methanol at 0, 24, 48 and 72 hours post cis-aconitate, 
and staining for the presence of EP procyclin on the cell surface membrane (see 
Materials and Methods for details).  The level of PAD1-Ty expression was 
determined by Western blot analysis of protein cell lysate made just prior to the 
addition of cis-aconitate using the anti-TY BB2 antibody. 
Figure 4.5-1A shows that inducing the expression of PAD1-TY does not have an 
effect upon differentiation, thus no dominant negative, or enhancement, effect was 
observed.  The Western blot (Figure 4.5-1B) shows that PAD1-Ty was being 
expressed in the presence of tetracycline, although the corresponding band is faint.  
This weak signal could be due to a number of reasons; transporter proteins have a 
complex structure, and aberrantly high expression may cause mis-folding, and 
consequent degradation.  Additionally, the tight packing of VSG on the cell surface 
may mean that high expression of a cell surface membrane bound protein was not 
possible.  Alternatively, the weak signal could be due to technical difficulties 
associated with detection of hydrophobic proteins. 
PAD1 mRNA expression levels between the DiD1 cell line and the expression cell 
line were not tested, but a comparison may determine whether the expression levels 
are equivalent, and thus whether the inability to re-capitulate the DiD1 phenotype is 
due to low expression of PAD1, or whether the enrichment of PAD1 transcript in the 
DiD1 cell line is a symptom of a different defect.  One possibility is that the Ty 
epitope tag interfered with PAD1 function, thus preventing a dominant negative 
effect from occurring; later experiments made use of ectopic expression of an 
untagged gene, and also titrated the levels of cis-aconitate to determine whether an 
effect of PAD1 expression was detected at low cis-aconitate concentrations (see 
Section 6.1). 
Nonetheless, it was clear that inducing the expression of PAD1-Ty in monomorphic 
cells did not detectably enhance, or repress, differentiation.
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Figure 4.5-1  The effect of PAD1 upon differentiation in response to cis-aconitate.  
Monomorphic slender cells ectopically expressing an epitope tagged PAD1 in response 
to tetracycline gene were assayed for their ability to differentiate.  (A)  Untransfected cells 
and cells containing an ectopic copy of PAD1 fused to a TY tag were assayed for their 
ability to differentiate in the presence and absence of tetracycline.  (B)  A Western blot 
using the BB2 monoclonal antibody demonstrates that transgenic cells express the  Ty 
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4.6 A Western to determine whether PAD proteins are upregulated in 
the DiD1 cell line 
As mRNA expression is not always reflected in protein levels, it was of interest to 
determine whether PAD1 and 2 protein are also being expressed in DiD1 cells in 
addition to their mRNA.  If, despite the high levels of mRNA transcript, PAD1 and 
PAD2 proteins were not detected, then one might speculate that the differentiation 
defect was due to inability to synthesise these proteins. 
DiD1 cell lysate was analysed for endogenous PAD array expression by Western blot 
using the α-PAD1 #1 antibody to detect PAD1, and the α-array #2 antibody to detect 
all of the PAD proteins at once.  The design and verification of these antibodies is 
discussed in depth in Section 5.2.2.1 and Section 5.5.1; briefly, peptides containing 
an amino acid sequence common to all of the PAD proteins, and peptides containing 
an amino acid sequence specific to PAD1, were used to immunise rabbits, and the 
resulting PAD specific antibodies were purified using the corresponding 
immunogenic peptides.  The LI-COR Odyssey system was used for quantitation 
relative to a tubulin loading control (see Materials and Methods for details).  Parental 
cell protein was included for comparison, and stumpy form protein was included as a 
positive control.  
Figure 4.6-1A shows that PAD1 was expressed in DiD1 cells and not in the parental 
strain, consistent with the Northern blot data (see Section 4.1).  However, 
quantitation demonstrated that Stumpy form cells expressed PAD1 approximately 20 
fold more than DiD1 cells. 
Using the α-array antibody, Figure 4.6-1B shows that 2 PAD proteins were 
expressed in DiD1 cells, whereas no PAD proteins were detected in the parental 65.3 
cell line.  The 55 kDa band was subsequently shown to correspond to PAD1, 
whereas the 57 kDa band was shown to correspond to PAD2 (see Section 5.5.3).   
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Thus, it would appear that the Western blot data is consistent with the Northern data, 
and that both PAD1 and PAD2 are expressed in DiD1 cells.  We can therefore 
conclude that the DiD1 defect is not due to the inability of DiD1 cells to express 
PAD proteins.  This result further highlights the difference between the DiD1 cells, 
and non-selected monomorphic parental cells.
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Figure 4.6-1  PAD proteins are expressed in DiD1 cells. (A) DiD1, parental 65.3 and 
stumpy form protein was analysed by Western blot with α-PAD1 to determine whether 
PAD1 is expressed in DiD1 cells.  PAD1 is not expressed in the parental cells but is 
expressed in DiD1 cells.  Expression is 20 fold higher in stumpy form cells than DiD1 
cells (B)  Western blot of DiD1 and parental 65.3 protein showed that 2 PAD proteins 
were expressed in DiD1 cells, and that none was detected in the parental cells.  Note that 
in (B), the protein was loaded on non-adjacent lanes, and that the intervening lanes are 
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4.7 A Northern analysis to determine whether there is a global 
upregulation of stumpy-enriched transcripts in the DiD1 cell line 
The original study of the DiD1 cells (Tasker et al. (2000)) showed that these cells are 
monomorphically slender and do not highly express the enzyme DHLADH, an 
enzyme known to be enriched in stumpy form cells due to their mitochondrial 
activation.  However, other stumpy form enriched proteins were not examined.  If a 
global upregulation of stumpy form enriched proteins was found in the DiD1 cell 
line, this would provide insight into the mechanism underlying the DiD1 defect.  The 
macroarray hybridization analysis to assay for upregulation of transcripts was based 
upon a sheared genomic library and thought to have approximately 80% genome 
coverage (Elisabetta Ullu, University of Yale, personal communication); thus many 
genes may have been excluded from this analysis. 
4.7.1 TbPTP1 
The protein tyrosine phosphatase TbPTP1 was shown to be enriched in stumpy form 
cells (Szöor et al. (2006)).  This protein is thought to act as a ‘break’ upon 
differentiation, and when inactivated by the tyrosine phosphatase specific inhibitor 3-
(3,5-dibromo-4-hydroxy-benzoyl)-2-ethyl-benzofuran-6-sulfonicacid-(4-(thiazol-2-
ylsulfamyl)-phenyl)-amide (referred to as BZ3) blood form cells spontaneously 
differentiate.  Therefore one can speculate that any upregulation of a group of 
proteins including TbPTP1 would inhibit the ability of these cells to initiate 
differentiation.  A Northern blot using a DIG labeled riboprobe specific to TbPTP1 
was therefore performed on slender, stumpy, procyclic and DiD1 total mRNA (see 
Materials and Methods for details).   
Figure 4.7-1A shows that there was no convincing upregulation of TbPTP1 mRNA 
transcript detected in DiD1 cells  This demonstrated that the DiD1 defect was not a 
result of an upregulated PTP1 applying a constitutive break upon differentiation.  
This does not exclude the possibility that a mutant PTP1 is constitutively active in 
DiD1 cells. 
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4.7.2 ESAG-K9 and glutamine synthase 
ESAG-K9 and glutamine synthase were found to be enriched in stumpy form cells 
(Keith Matthews, unpublished data).  Therefore, their relative expression level in the 
parental 65.3  and DiD1 cells was determined to assay whether there is a global 
upregulation of stumpy form enriched transcripts in the DiD1 cell line. 
A Northern blot using DIG labelled riboprobes on 65.3 parental and DiD1 total RNA 
was performed to determine whether ESAG-K9 and glutamine synthase transcripts 
were enriched in DiD1 cells.  Stumpy form total RNA was included for comparison.  
Figure 4.7-1B shows that no significant upregulation of either of these transcripts 
was detected. 
Thus, a Northern blot analysis to detect expression of PTP1, ESAG-K9 and 
glutamine synthase in parental cells versus DiD1 cells showed that there was no 
detectable enrichment of these transcripts in the DiD1 cells.  Moreover, Figure 4.1-1 
demonstrated that PAD5 and 7, both highly enriched in stumpy form cells (see 
Section 5.1), were not appreciably expressed in DiD1 cells.  Therefore, there does 
not appear to be a global upregulation of stumpy enriched transcripts.  The cause of 
the DiD1 defect therefore remains unidentified. 
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Figure 4.7-1  There is not a global stumpy form-transcript upregulation. A Northern 
blot was performed on DiD1, parental 65.3 and stumpy form RNA to determine whether 
there was an upregulation of (A) PTP1, and (B) ESAG-K9 and glutamine synthase.  No  
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5 A molecular characterisation of the PAD array 
The tools for molecular analyses of Trypanosoma brucei are well developed and 
sophisticated.  The genetic pliability of T. brucei has resulted in the routine use of 
RNAi mediated transcript ablation, ectopic expression of trans genes, and generation 
of deletion mutants by homologous recombination.  The completion of the T. brucei 
genome project has provided the trypanosome community with a wealth of data, as 
well as a valuable tool for bioinformatics analysis. 
However, forward genetics has, of necessity, been limited because the epimastigote 
form that is thought to undergo genetic recombination is not amenable to culture, and 
trypanosomes do not easily complete their lifecycle in tsetse.  Thus, identifying 
interesting and important genes beyond the analogues of characterised proteins is a 
major challenge in trypanosome biology.  The selection for the DiD1 phenotype, and 
the subsequent identification of the PAD array, represents an innovative use of a 
forward genetics approach to identification of genes with a putative function. 
With the identification of the PAD genes, and their implied function in 
differentiation, the molecular toolkit described above was employed to dissect their 
role in T. brucei lifecycle progression. 
5.1 A Northern analysis to determine the RNA expression profile of the 
PAD genes 
The analysis of the PAD array genomic region showed that, although the coding 
sequences of the PAD genes are highly homologous, the intergenic regions and the 
predicted 3’ UTRs that likely control mRNA transcript stability have significant 
variability.  In particular, the PAD2 predicted 3’ UTR is unique within the PAD 
array, whereas PAD1, 5 and 7 have similar repetitive elements (see Section 3.3.3).  
PAD1 and PAD2 are of particular interest as both of these genes were identified as 
being upregulated in the DiD1 cell line that is unable to differentiate efficiently (see 
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Section 1.8).  In order to dissect the mRNA expression of PAD genes throughout the 
T. brucei lifecycle, a Northern hybridisation analysis of several of the PAD genes 
was performed using RNA from monomorphic slender, stumpy and procyclic form 
cells. 
Digitoxin (DIG) labelled riboprobes had been made previously (Pam Davies, 
University of Manchester) that were designed to specifically anneal to PAD1, 2, 3 or 
5 and 7 mRNA transcripts (PAD 5 and 7 have identical nucleotide sequences in the 
open reading frame and within the 3’ UTR such that it is not possible to distinguish 
between them) (see Figure 5.1-1).  Additionally, a DIG labelled riboprobe made 
using an amplicon containing the entire PAD2 open reading frame was synthesised 
to detect transcripts derived from all of the genes within the array simultaneously 
(see Materials and Methods for details).  RNA was resolved on a denaturing agarose 
gel and stained with ethidium bromide to verify equal loading of the RNA, as 
determined by visualisation of the ribosomal subunit RNAs (see Materials and 
Methods for details).  The RNA was blotted by capillary action onto positively 
charged nylon membrane and hybridised with either riboprobe 1, 2, 3 or 5/7 in order 
to detect the corresponding PAD mRNA in the different lifecycle stages.  Hybridised 
probe was detected by staining with α-DIG followed by chemiluminescence (see 
Materials and Methods for details). 
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Figure 5.1-1  The riboprobes designed to detect PAD1, PAD2, PAD3, PAD5/7.  (A) 
The sequences of the riboprobes designed to detect specific PAD transcripts were 
aligned with their target sequences using clustalW (Larkin et al. (2007)). In addition, a 
riboprobe was synthesised using the entire open reading frame of PAD2, that shares 
enough homology with the other PAD transcripts to detect all of them at once (not 
shown).  (B)  The target sequences were derived from the 3’ end of the transcripts, 
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Figure 5.1-2A shows that the PAD genes have very different expression profiles.  
PAD1 was highly expressed in stumpy form cells but not in monomorphic slender or 
procyclic form cells.  As discussed in Section 4.1, the Northern blot also shows that 
PAD1 was highly expressed in the DiD1 cell line (although not as highly as in 
stumpy form cells), confirming the Macroarray hybridisation data. 
In contrast, Figure 5.1-2B shows that PAD2 was highly expressed in procyclic forms, 
but not in monomorphic slender or stumpy forms.  However, as with PAD1, and 
consistent with the macroarray hybridisation analysis, PAD2 was also highly 
expressed in the DiD1 cell line. 
Figure 5.1-2C shows that PAD5 and 7 were highly expressed in stumpy form cells, 
but not in monomorphic slender or procyclic cells.  PAD5 and 7 are thus distinct 
from PAD1 in that they are not expressed in the DiD1 cell line, despite being 
upregulated in stumpy form cells and containing similar 3’ UTR repetitive elements 
(see Section 3.3.3) 
PAD3 was not detected in either monomorphic slender, or stumpy form lifecycle 
stages (data not shown) (expression in the procyclic form was not tested), suggesting 
that either PAD3 is not expressed in any of the lifecycle stages assayed, or that the 
riboprobe labelling reaction failed.  PAD3 was not investigated further.  PAD4, 6 and 
8 were also not tested for their expression profile, although subsequent microarray 
analysis indicated that PAD8 was highly upregulated in stumpy form cells (S. Kabani 
and K. Matthews, unpublished data).  Further investigation focused on PAD1 and 
PAD2 since these genes were enriched in the DiD1 cell line. 
Figure 5.1-2D shows the expression of all of the PAD genes simultaneously.  It is 
clear that the highest expression occurs in stumpy form cells, with significant 
expression in procyclic form cells.  PAD array mRNA was detected in monomorphic 
slender form cells, but not to the extent of the other lifecycle stages.  There appeared 
to be one band predominantly detected; the lower bands probably represent 
degradation products and were present in the Northern blot corresponding to PAD1 
expression.  This suggests that the mature PAD mRNA transcripts are in fact of very 
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similar sizes, conflicting with the predictions from the algorithms that annotate poly-
adenylation addition signals (see Section 3.3.1). 
Of the 8 genes, PAD1 was thought to have the most interesting expression profile: it 
was the only member of the array to be implicated in initiation of differentiation 
through mRNA enrichment in both the DiD1 cell line and in the stumpy form cells.  
PAD2 was also upregulated in the DiD1 cell line, but as a predominantly procyclic 
form enriched transcript it was not initially considered to be a primary candidate for 
a gene having a role in differentiation.  PAD5 and 7 were highly expressed in stumpy 
form cells and were thus both implicated in stumpy form viability or the stumpy to 
procyclic form transition; however, they were not found to be enriched in the DiD1 
cell line and thus they were not analysed in the same depth as PAD1 and PAD2.  
Moreover, it was expected that much of the functional analysis applied to PAD1 
would also be relevant to the other PAD members, thus making the need to 
investigate every member in depth unnecessary. 
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Figure 5.1-2  A Northern blot analysis of the PAD array mRNA transcripts.  A 
Northern blot was performed to analyse the lifecycle expression of (A) PAD1, (B) PAD2, 
(C) PAD5 and 7 and (D) the entire array.  A non-quantitative summary of the PAD 
expression data is also shown (E).  PAD1, 5 and 7 are upregulated in the stumpy form, 
whereas PAD2 is upregulated in the procyclic form.  The Northern blot that shows 
expression of the entire PAD array (D) suggests that mRNA levels in the stumpy form are 
much higher than in either the procyclic form or the slender form. 
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5.2 Localisation of the PAD1 protein 
An important step in elucidating the function of a protein is to determine where the 
protein localises, and thus where it exerts its biological affect.  The bioinformatics 
evidence concluded that the PAD genes are all transmembrane proteins, but this does 
not allow determination of anything more specific in terms of sub-cellular location.  
Possible membranous locations include: 
• The cell surface membrane 
• The endoplasmic reticulum 
• The mitochondrial membrane 
• The nuclear membrane 
• The Golgi apparatus 
• The lysosomal membrane 
• The glycosomal membrane 
Each of these potential locations has a characteristic immunofluorescence staining 
profile that can be distinguished using immunofluorescence microscopy and confocal 
microscopy.  Therefore, several strategies were pursued to determine the localisation 
of the PAD1 protein by immunofluorescence. 
5.2.1 Localisation of an ectopically expressed, epitope tagged copy of PAD1 
Prior to the availability of an α-PAD1 antibody, localisation of PAD1 was 
investigated using a cell line expressing an epitope tagged, ectopically expressed 
copy of PAD1.  The location of this ectopically expressed protein can be determined 
by immunofluorescence utilising the monoclonal BB2 antibody that targets the Ty1 
virus-like particle derived epitope tag (Ty tag) (Bastin et al. (1996)) incorporated into 
PAD1 (PAD1-Ty).  The advantage of this strategy was that the anti-epitope tag 
antibody was already available and has been shown to generate good data with little 
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or no cross-reactivity to other cellular protein (Bastin et al. (2001)).  However, this 
strategy suffers from several potential dangers:  
• ectopic expression of a protein may overwhelm the intra-cellular transport 
machinery thus causing its mis-localisation of the resulting protein (for 
example, an endogenous protein may localise to the endoplasmic reticulum 
but over-expression of the ectopic copy may cause mis-localisation to the cell 
surface membrane) 
• the high expression of the ectopic copy may cause aberrant folding, causing 
the protein to be either mis-localised or degraded  
• the presence of the Ty epitope tag may interfere with protein folding, 
targeting signals or with protein-protein interactions, thus causing mis-
localisation or degradation 
Despite these caveats, this strategy has been used to successfully localise a number 
of proteins (Hellemond et al. (2000)) (Tasker et al. (2001)) (Hammarton et al. 
(2003)) and was therefore pursued in the first instance. 
5.2.1.1 Generating the DNA constructs pHD451(XhoI) and pHD451(XhoI):PAD1-TY 
The DNA plasmid construct pHD451 was designed for inducible expression of gene 
products in T. brucei (Biebinger et al. (1999)).  Briefly, the gene of interest was 
cloned  between the HindIII and BamHI restriction enzyme digestion sites 
downstream of an EP procyclin promoter and an EP procyclin 5’ UTR.  The EP 
promoter was previously modified to contain an internal tetracycline-inducible 
repressor (TetR) binding site (i.e. a tetracycline operator sequence) such that, in the 
presence of the TetR protein, gene transcription is inhibited.  Upon addition of 
tetracycline, TetR forms a complex with tetracycline and no longer binds to the 
tetracycline operator, thus allowing the initiation of transcription (see Appendix A 
for a diagram of these DNA constructs).  This construct had been previously 
modified such that cloning a gene into the HindIII and BamHI restriction enzyme 
sites would incorporate a Ty epitope tag into the 3’ end of the open reading frame of 
the gene, thus the final protein contains a C-terminal Ty epitope tag. 
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However, cloning PAD1 into this DNA construct without modification was difficult 
due to the presence of an internal BamHI restriction site within the PAD1 gene.  A 
conventional solution to this problem would be to use a BglII restriction enzyme 
recognition site within the cloning primers in place of BamHI in order to generate 
ends compatible with cloning into the vector BamHI site.  However, the PAD1 gene 
also contains an internal BglII site, making this strategy unsuitable.  The vector 
pHD451 was therefore modified to insert a XhoI site between the HindIII and 
BamHI sites by using reverse complementary oligonucleotide primers (primers #24 
and #25) that, when annealed, would form a duplex containing an internal XhoI 
restriction enzyme site and terminal single stranded nucleotides compatible with 
cloning into HindIII and BamHI sites (see Figure 5.2-1).  This was cloned into 
pHD451 resulting in the addition of a XhoI restriction enzyme site to the existing 
HindIII and BamHI site (see Appendix A for a complete list of primer sequences). 
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Figure 5.2-1  Construction of pHD451-TY (XhoI). A pair of reverse complementary 
primers were annealed to form an internal XhoI restriction site and terminal ends 
complementary to HindIII and BamHI.  The annealed primers were ligated to HindIII and 
BamHI cut pHD451 such that the resulting DNA construct contained HindIII, XhoI and 
BamHI restriction cloning sites.  The XhoI site is shown in bold. 
5’ AGCTTGAATTC CTCGAG G 3’
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The PAD1 gene was amplified in a polymerase chain reaction from Lister 427 T. 
brucei genomic DNA using primers containing HindIII on the forward primer 
(primer #26), and XhoI on the reverse primer (primer #27); the stop codon was not 
included on the reverse primer to allow incorporation of the Ty epitope tag into the C 
terminus of the protein.  The amplicon was digested with HindIII and XhoI and 
inserted into similarly cut pHD451(XhoI) containing the Ty epitope tag sequence at 
the 3’ end of the multiple cloning site.  The resulting recombinant plasmid, 
pHD451:PAD1-Ty, was then sequenced to verify that there were no errors in the 
open reading frame of PAD1 incorporated by the DNA polymerase (data not shown). 
5.2.1.2 Transfection of trypanosome cells to express PAD1-Ty 
The monomorphic bloodstream cell line Lister 427 has previously been 
transgenically modified (Wirtz et al. (1999)) to constitutively express the TetR 
protein by integration of pHD449 into the ribosomal spacer region of the genome 
(thus creating the cell line Lister 427-449).  This cell line was transfected with NotI 
linearised pHD451(XhoI):PAD1-Ty DNA construct such that expression of PAD1-
Ty was inducible in the presence of tetracycline.  Several cell lines were successfully 
selected after transfection, one of which was investigated for PAD1 localisation. 
5.2.1.3 Immunofluorescence microscopy of cells ectopically expressing PAD1-Ty 
The cell line Lister 427-449-451:PAD1-Ty was cultured in the presence and in the 
absence of tetracycline for 2 days prior to being fixed in 3% paraformaldehyde, 
stained using the BB2 antibody, and counter stained using an α-mouse-FITC 
conjugated antibody (see Materials and Methods for details) to visualise the cellular 
location of PAD1-Ty.  In addition, a non-transfected cell line was included to control 
for potential cross-reactivity of the BB2 and α-mouse-FITC antibodies.  The 
resulting slides were examined using immunofluorescence microscopy and images 
captured using a high resolution digital camera. 
The images of the PAD1-Ty induced cells were consistent with cell surface staining 
(see Figure 5.2-2).  There was a faint peripheral concentration of signal around the 
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cell indicative of cell surface membrane staining, as well as a concentration of signal 
at the flagellar pocket, consistent with endosomal trafficking and the increased 
amount of cell surface membrane within this specialised region.  In contrast, only 
background staining was observed when wild type untransfected and non-induced 
cells were stained, thus confirming that the signal observed when PAD1-Ty is 
induced is not due to cross-reactivity of the antibody.  Interestingly, not all cells in 
the population exhibited clear staining, suggesting heterogeneity of expression in the 
population.  This has been observed in other studies (Field et al. (2004)) 
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Figure 5.2-2  Localisation of an ectopically expressed epitope tagged copy of 
PAD1.  An ectopically integrated, epitope tagged copy of PAD1 was inducibly expressed 
under the control of tetracycline and localised by staining with the mouse monoclonal 
antibody BB2 and an anti-mouse-FITC secondary antibody.  (A) Untransfected and (B) 
non-induced transfected cells showed no staining.  (C) Cells induced to express PAD1-Ty 
showed a staining pattern consistent with localisation to the cell surface membrane, 
whereby a line around the periphery of the cell, and a concentration of signal around the 
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5.2.2 Localisation of the endogenous PAD1 protein 
Although detection of an epitope tagged gene copy was useful as a first analysis, 
detection of the endogenous protein was essential to corroborate the localisation of 
PAD1 at the cell surface membrane  There are two strategies to achieve this; (i) 
integration of an epitope tagged copy of PAD1 into the PAD1 genomic locus such 
that the regulatory elements of the PAD1 gene remain the same thereby providing 
expression at physiological levels, and (ii) generating an anti-peptide antibody 
against the endogenous PAD1.  The latter route was chosen for the following 
reasons:  
• An α-PAD1 antibody would be a useful tool in dissecting the T. brucei  
lifecycle – for example allowing analysis of wild type slender and stumpy 
forms 
• The Northern analysis suggested that PAD1 was not expressed in the 
genetically pliable monomorphic cells, whereas generating a transgenic 
stumpy form that can express an epitope tagged copy of PAD1 is technically 
difficult 
• Visualising the un-modified, endogenous PAD1 protein is a more rigorous 
strategy to determine localisation 
• Presence of an epitope tag may disrupt normal localisation of the expressed 
PAD1 protein 
5.2.2.1 Generating an α-PAD1 antibody 
Anti-peptide antibodies can be raised whereby a peptide of 10 – 15 amino 
homologous to, and specific for, the protein of interest is injected into a suitable 
animal with an adjuvant over a period of several months.  The quality of the resulting 
polyclonal antibody can vary greatly and can be difficult to predict; for example, 
background staining, cross reactivity and low target binding affinity are all potential 
problems that can complicate any subsequent analysis. 
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Due to the close homology between PAD genes it was necessary to be highly 
selective when choosing which region of PAD1 to use as a template for a peptide 
immunogen.  In addition, regions that were predicted to form part of trans-membrane 
regions were excluded because these regions may not be accessible for antibody 
binding.  Two regions were chosen based on these criteria (see Figure 5.2-3).  Both 
were predicted to be intra-cellular such that it was necessary to permeabilised the cell 
prior to staining (see Figure 5.2-3A), and were from regions of the PAD protein 
distinct from other members of the family (see Figure 5.2-3C).  In addition, a 
BLASTP search using the peptide sequences as a query against the completed 
trypanosome genome database gave no ‘hits’ such that risk of antibody cross-
reactivity to other trypanosome proteins was minimised (data not shown).  The 
antibodies were ordered from Eurogentec using their “DoubleXP” programme: the 
synthetic peptides were inoculated into rabbits with an adjuvant 4 times over a period 
of 4 months and subsequently affinity purified against the corresponding peptide to 
prevent non-specific antibody contamination. 
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 Figure 5.2-3  Designing an anti-peptide antibody specific to PAD1. (A) The positions 
of the sequences used to design the immunogenic peptides are indicated by orange 
circles on the PAD1 secondary structure. (B) The sequences of the peptides are shown. 
(C) A clustalW alignment of the PAD proteins showing the two regions that the peptides 
were designed against (the peptide sequence is indicated by the red square).  The left 
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5.2.2.2 Localisation of the endogenous PAD1 using an α-PAD1 antibody 
Early attempts to validate the α-PAD1 antibodies by Western blot were unsuccessful 
due to technical issues associated with the detection of membrane associated proteins 
(see Section 5.3 for more details).  For this reason, the antibodies were initially 
validated by immunofluorescence microscopy, and were subsequently used 
successfully in Western blot with appropriate negative controls to confirm that they 
did not cross react other, slender cell, proteins (see Section 5.4.1). 
An analysis of the ectopic expression of PAD1-Ty indicated that PAD1 was probably 
localised to the cell surface membrane (see 5.2.1).  To investigate the endogenous 
protein, stumpy form trypanosomes were purified from a mouse infection and 
reacted with α-PAD1 antibodies in an immunofluorescence analysis (see Materials 
and Methods for details).  Images were analysed by confocal microscopy to obtain 
the maximum resolution of cellular structures (see Materials and Methods for 
details). 
Figure 5.2-4 shows that the staining was consistent with localisation to the cell 
surface membrane.  There was a generalised staining across the cell, but a clear line 
of intense labelling around the periphery of the cell.  There did not appear to be 
staining characteristic of the nucleus, endoplasmic reticulum, Golgi apparatus or any 
other of the intracellular organelles.  Note that, slender cells did not stain with the α-
PAD1 antibody (for further analysis of the stumpy cell specific staining, see Section 
5.4.2, Figure 5.4-1) providing a rigorous internal control for non-specific antibody 
binding of both the primary and secondary antibodies. 
Thus, both the from the ectopic, epitope tagged copy of PAD1 and the endogenous 
copy of PAD1 demonstrated cell surface membrane localisation. 
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Figure 5.2-4  The PAD1 protein is localised to the cell surface membrane. Stumpy 
form trypanosomes were fixed with 3% paraformaldehyde and permeabilised with 0.1% 
TritonX prior to settling on poly-lysine coated glass slides.  The cells were stained with 
the α-PAD1 antibody #1 and visualised using confocal microscopy.  PAD1 appears to 
localise to the cell surface membrane of the trypanosome.  DAPI staining is also shown to 
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5.3 Optimising detection of PAD1 by Western analysis using an 
ectopically expressed, epitope tagged copy of PAD1 
Transmembrane proteins can be technically challenging to detect on Western blots 
due to their hydrophobic properties and their tendency to precipitate.  Initial attempts 
to detect the Ty epitope tagged copy of PAD1 by Western blot were unsuccessful, 
despite the fact that this protein was clearly detectable by immunofluorescence (see 
Section 5.2.1.3).  Therefore, it was decided to optimise the Western detection of 
PAD1 using the Ty-specific BB2 antibody on cells expressing PAD1-TY instead of 
the α-PAD1 antibody because: 
• The BB2 antibody has excellent binding affinity and has been used 
successfully in Western analysis previously with little or no cross reactivity 
(Bastin et al. (1996)) 
• Availability of the BB2 hybridoma line meant that an unlimited supply of the 
antibody was available 
• The specificity of the newly made α-PAD1 antibodies was not well 
established 
A number of variables were considered before any band became detectable by 
Western analysis: the pH and type of transfer buffer; the voltage used in semi-dry 
blotting; the time of semi-dry transfer and the amount of protein loaded (data not 
shown).  However, when the temperature of denaturation prior to loading the protein 
on to the SDS polyacrylamide gel was varied, there was an inverse correlation 
between the temperature of denaturation and the detection of PAD1-Ty (see Figure 
5.3-1).  When the protein was not heated at all, a clear band was detected at 
approximately 55 kDa.  This was lower than the 67 kDa that was predicted for 
PAD1, which is not unusual for hydrophobic proteins.  However, it is interesting to 
note that when the denaturation temperature was raised, the PAD1-Ty protein 
appeared to resolve at a higher molecular mass (albeit much less intensely), 
suggesting that the aberrant migration at low temperature might be due to its 
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secondary structure.  Thus, it appears that at higher temperatures PAD1 precipitates 
precluding detection either due to inability of the protein to enter the gel, 
unavailability of antigenic sequence to the antibody, or both.
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Figure 5.3-1  The effect of denaturation temperature upon PAD1-Ty detection by 
Western blot.  Proteins from cells ectopically expressing PAD1 with a Ty epitope tag 
were either not heat denatured (nd) or denatured at 40°, 50°, 60°, 80° or 100° after cell 
lysis in Laemmli sample buffer.  The protein was analysed by SDS-PAGE and Western 
analysis.  PAD1-Ty was only detected clearly when the protein was not heat denatured, 
suggesting that the protein precipitates at higher temperatures precluding detection.  High 
molecular weight forms of the protein were detected upon heating, although they were far 
less intense.  The upper blot is an exposure of PAD1-Ty using the BB2 antibody, and the 
lower blot is the same membrane reacted with an antibody recognising trypanosome α-
tubulin (Woods et al. (1989)). 
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The Western blot conditions optimised for PAD1-Ty detection using the BB2 
antibody were transposed to analysis of endogenous PAD1 detected using the α-
PAD1 antibody.  Further optimisation whereby the proteins were resolved at lower 
voltages, using chilled buffers to maintain a low temperature, and transferred onto 
PVDF membrane by a wet blotting system, further enhanced sensitivity, such that 
detection was improved from an exposure time of several hours to less than 5 
seconds (see Materials and Methods for the fully optimised Western detection 
protocol). 
5.4 PAD1 is a stumpy form specific protein 
Investigations into blood form trypanosome differentiation have been hindered by 
the absence of an absolute marker discriminating slender from stumpy form cells.  
Historically, morphology was the preferred way of distinguishing the lifecycle stages 
of bloodstream trypanosomes (Bruce (1911)) (Robertson et al. (1913)), but this was 
complicated by the presence of intermediate forms that share characteristics of both 
stumpy and slender forms within a natural pleomorphic population.  Subsequently, it 
was shown that stumpy cells and not slender cells have a partially active 
mitochondrion and show mitochondrial diaphorase activity, as determined by the 
formation of formazon deposits when cells were stained with NADH2 and nitro-blue 
tetra-zolium salt (Vickerman (1965)).  This was extended (Tyler et al. (1997)) using 
an antibody specific to dihydrolipoamide dehydrogenase (DHLADH) and other 
active mitochondrial enzymes in a Western and immunofluorescence analysis of 
mitochondrial marker expression during differentiation between slender and stumpy 
forms.  However, using mitochondrial proteins to distinguish stumpy form cells is 
not ideal as eukaryotic cells are known to upregulate many mitochondrial proteins in 
response to oxidative stress or apoptotic conditions (Giffin et al. (1986)) (Giffin and 
McCann (1989)) (Lin and Beal (2006)) (Sapienza et al. (2008)).  It is therefore 
difficult to distinguish between conditions that induce cells to differentiate to the 
stumpy form and those that simply induce a stress response.  The development of a 
stumpy form surface marker unrelated to the stress response would therefore be an 
invaluable tool in the molecular analysis of the T. brucei lifecycle.  The next series of 
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experiments set out to investigate the potential for PAD1 to act as a marker for 
stumpy form cells. 
5.4.1 Western analysis 
In order to determine the protein expression profile of PAD1, protein from 
monomorphic slender, stumpy and procyclic form cells was resolved on an SDS 
polyacrylamide gel for Western analysis using the previously optimised conditions. 
The Western analysis of PAD1 detected a strong band resolving at approximately 55 
kDa (see Figure 5.4-1A), approximately 11 kDa smaller than is predicted from the 
primary amino acid sequence.  Nonetheless, there seems little doubt that this band is 
in fact PAD1 and the disparity is probably due to its hydrophobicity or secondary 
structure; cleavage of the protein is unlikely as this would probably disrupt the 
structure of the mature protein and prevent proper localisation to the cell surface 
membrane. No band was detected in either the monomorphic slender or procyclic 
form lanes (Figure 5.4-1A).  Consistent with the mRNA expression data (see Section 
5.1), the Western data therefore demonstrates that PAD1 is a stumpy form specific 
protein. 
5.4.2 Immunofluorescence 
If PAD1 is a stumpy-specific protein, then it should be possible to distinguish 
between individual slender and stumpy cells within a population by 
immunofluorescence staining with α-PAD1.  It would be expected that cells with a 
stumpy morphology would stain positive for PAD1, whereas cells with a slender 
morphology would be negative for PAD1.  Furthermore, where morphology is 
ambiguous, it would be expected that a PAD1 positive cell would be cell cycle 
arrested in G1 (termed G0) and would therefore have 1 nucleus and 1 kinetoplast 
(1K1N), and that cells that are undergoing division (2 kinetoplasts and 1 nucleus, or 
2 kinetoplasts and 2 nuclei) would be negative for PAD1.  These karyotypes can be 
simply assayed by staining cells with 4',6-diamidino-2-phenylindole (DAPI) 
followed by visualisation by fluorescence microscopy. 
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To analyse the expression of PAD1 at the single cell level, stumpy form cells were 
purified from a mouse infection (see Materials and Methods) and fixed with 
methanol prior to staining sequentially with α-PAD1 and α-rabbit-cy3 antibodies.  
Methanol is unsuitable for localisation studies because the intra-cellular 
compartments become disrupted, but was used as a fixative in this analysis for the 
preservation of cellular morphology to distinguish between slender and stumpy cells.  
Cells from a late stage parasitaemia were used so that the morphological analysis 
would be less complicated by the presence of intermediate forms within the 
population. 
Consistent with PAD1 being a stumpy form specific protein, essentially all cells with 
a stumpy morphology stained positive for PAD1 (<99%), and the few cells that were 
found with a slender morphology were overwhelmingly negative for PAD1 (93%, N 
= 154 from a total of over 5000 cells) (Figure 5.4-1B). 
Interestingly, when the PAD1 positive cells with a slender morphology are analysed, 
approximately half are 1K1N, half are 2K2N, and none are 2K1N; one might 
therefore speculate that the commitment to the stumpy form occurs in the 2K2N cell 
cycle stage, after which cells go into G1 arrest and then become morphologically 
stumpy.  However, only 11 cells (1.8%) from a total of >600 were found that were 
both PAD1 positive and morphologically slender, thus it is not possible to draw firm 
conclusions from this analysis. 
Two representative images that show PAD1 negative, dividing slender cells with 
adjacent G1 arrested PAD1 positive stumpy form cells are also shown (see Figure 
5.4-1C). 
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Figure 5.4-1  PAD1 is a stumpy form specific protein. (A) Slender, stumpy and 
procyclic form cell lysate was resolved by SDS-PAGE and probed with the anti-PAD1 #1 
antibody in a Western analysis. PAD1 is undetectable in either slender or procyclic form 
cells, but strongly expressed in  the stumpy form. (B) Pleomorphic trypanosomes were 
stained with the α-PAD1 antibody and DAPI.  Two PAD1 positive stumpy cells and two 
PAD1 negative dividing slender cells are shown as representative images. (C) Cell 
counts were performed to determine the proportion of morphologically slender and 
stumpy cells that are positive for PAD1, and this was related to cell cycle position by 
counting the number of nuclei and kinetoplast.  There is a strong correlation between 
stumpy morphology and PAD1 staining, and a negative correlation between slender 
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5.4.3 Flow cytometry analysis 
Flow cytometry allows the quantitative protein detection of a large number of 
individual cells to be determined.  Cells are fixed with a suitable fixative (such as 
formaldehyde/ glutaraldehyde, paraformaldehyde or methanol), stained with a 
primary antibody and counterstained with a fluorochrome-conjugated secondary 
antibody.  Cells containing target protein-antibody complex are detected by 
measuring the emission from excitation of the fluorochrome with a laser. 
To assess the ability of PAD1 to be used to distinguish between slender and stumpy  
form cells by flow cytometry, monomorphic slender and stumpy form cells were 
fixed and stained with α-PAD1 #1 and α-rabbit-FITC for flow cytometry analysis 
(see Materials and Methods for details).  The resulting data were analysed for 
fluorescence in the FL1 emission channel using FlowJo (Tree Star, Inc., Ashland, 
OR). 
Stumpy form cells form a distinct peak, with higher fluorescence on the histogram 
than monomorphic slender form cells (see Figure 5.4-2).  This allows us to conclude 
that stumpy form cells express PAD1 at higher levels than monomorphic slender 
form cells, supporting the hypothesis that PAD1 is a stumpy specific protein. 
Furthermore, the development of a protocol that allows stumpy form cells to be 
distinguished form slender cells and analysed by flow cytometry and fluorescence 
activated cell sorting (FACS) opens the possibility for a number of other 
experiments.  For example, the population kinetics of the slender to stumpy transition 
within a parasitaemia can be modelled using either using the endogenous PAD1 
protein, or by fusing the PAD1 3’ UTR to a reporter gene such as green fluorescent 
protein (GFP).  Additionally, with a high throughput assay for stumpy forms it 
should be possible to screen for the, as yet unidentified, stumpy induction factor 
(SIF) (see Chapter 7 for further discussion). 
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Figure 5.4-2  Slender and stumpy form populations can be distinguished by flow 
cytometry.  Monomorphic slender cells and stumpy form cells harvested from mice were  
fixed in 1% paraformaldehyde and stained with the α-PAD1 antibody in permeabilisation 
solution, and counterstained with α-rabbit-FITC.  The stumpy population (St) clearly 
fluoresces in the FITC channel with greater intensity than the monomorphic slender 
population (Sl).  Thus slender and stumpy form populations can be distinguished by flow 
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In conclusion, the Western, immunofluorescence and flow cytometry data 
demonstrate that PAD1 is the first unambiguous stumpy form molecular marker.  As 
a non-mitochondrial protein it is not subject to oxidative-stress induced upregulation 
and other non-specific affects that DHLADH and other mitochondrial enzymes may 
be affected by.  Furthermore, its localisation to the cell surface membrane means that 
it is possible to clearly determine whether a cell is PAD1 positive.  This provides an 
invaluable tool for analysing the differentiation between the slender, stumpy and 
procyclic form lifecycle stages.  Additionally, the use of PAD1 as a stumpy form 
specific protein allows the verification of chemicals that have been reported to 
induce trypanosomes to differentiate to the stumpy form.  It would be of interest to 
further dissect the timing of expression of different stumpy markers to determine at 
what point a cell commits to becoming a stumpy form (see Chapter 7 for further 
discussion). 
5.5 Investigating PAD2 expression 
The elevated expression of PAD2 mRNA in DiD1 cells meant that it was of interest 
to investigate this protein further. 
5.5.1 Designing antigenic peptides to generate α-PAD2 antibodies 
In order to determine the protein expression profile of PAD2, two antigenic peptides 
were designed that would generate polyclonal antibodies when rabbits were 
immunised.  As with the α-PAD1 antibodies, regions of the PAD2 protein were 
chosen such that the peptide was not predicted to be within the N-terminal signal 
anchor, or any of the 14 transmembrane helices.  Additionally, a protein sequence 
alignment was generated in order to identify regions that were unique to PAD2 and 
therefore not represented in any of the other PAD proteins.  Due to these highly 
stringent requirements, only 1 region at the carboxyl terminus was found that was 
suitable for antigenic peptide design. 
Two peptides were chosen based on the amino acid sequence from the carboxyl 
terminus of PAD2.  Peptide #1 consists of 15 residues at the extreme carboxyl 
terminus of PAD2, and peptide #2 consists of 10 residues near the carboxyl terminus 
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(see Figure 5.5-1A and B).  An alignment shows that these peptide do not show 
significant homology to any of the other PAD proteins (see Figure 5.5-1C).  
Additionally, a BLAST search using both of these peptides as query sequences did 
not give any matches against the Trypanosoma brucei database (data not shown). 
The peptide sequences were submitted to Eurogentec for immunisation into rabbits 
and antibody generation using their 28 day ‘Speedy Double XP Programme’.  The 
antibodies were affinity purified using the immunogenic peptides by Eurogentec. 
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Figure 5.5-1 Designing the antigenic peptides for the α-PAD2 antibodies. (A) The 
positions of the sequences used to design the peptides are indicated by orange circles on 
the PAD2 secondary structure. (B) The sequences of the peptides are shown. (C) A 
ClustalW alignment of the PAD proteins showing the region that the peptides were 
designed against (the peptide sequences are indicated by the red square).   The 
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5.5.2 A Western blot analysis to determine PAD2 expression throughout the 
trypanosome lifecycle 
Cell lysate protein from monomorphic slender, stumpy and procyclic forms was 
prepared and analysed by Western blot with the α-PAD2 antibodies using conditions 
optimised for PAD1 detection (see Materials and Methods for details). 
Figure 5.5-2 shows that a 57 kDa band was detected in both the stumpy form and the 
procyclic form lanes, with the procyclic form band showing approximately 3 fold 
elevated expression in comparison with the stumpy form.   Several strong bands at 
approximately 60 kDa were detected in Lister 427 monomorphic slender cells by the 
α-PAD2 #1 antibody, and the same bands but much weaker (although equally 
diffuse) were detected by α-PAD2 #2.  These bands were almost certainly due to the 
α-PAD2 antibodies cross reacting with VSG expressed by these monomorphic cells.  
Indeed, despite their obviously high expression, these bands were not detected by an 
α-array antibody that was reactive against all of the PAD members (see Section 
5.6.2). 
Thus, it would appear that PAD2 is expressed in stumpy forms, and approximately 3 
to 4 fold higher in procyclic forms.  Despite the apparent Lister 427 VSG cross-
reactivity, no convincing expression was detected in the monomorphic slender cell 
lysate. 














































Figure 5.5-2  The lifecycle protein expression of PAD2.  Protein from monomorphic 
slender, stumpy and procyclic form trypanosomes was analysed by Western blot for 
PAD2 expression using (A) α-PAD2 #1 and (B) α-PAD2 # 2.  (C) The signal from panel B  
was quantified using the LI-COR odyssey system and expressed relative to the tubulin 
loading control.  Procyclic forms express PAD2 at levels approximately 3 fold that of 
stumpy forms.  Monomorphic slender forms do not appear to express PAD2.  Bands 
detected in the ‘sl’ lane are probably cross-reactivity with VSG (which migrates at 60 
kDa). 
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5.6 Analysing the lifecycle expression of the entire PAD family 
As described (see Section 5.1), PAD1 is a member of an 8 gene cluster with 
differential RNA expression through the T. brucei lifecycle.  It was necessary to 
concentrate on only some of the PAD members to perform an in depth analysis, and 
PAD1 and PAD2 were chosen for the reasons discussed.  However, PAD5 and 7 
mRNA transcripts were also shown to be upregulated in stumpy form cells,  and the 
PAD2 mRNA transcript was shown to be upregulated in the DiD1 cell line as well as 
in the procyclic form.  Thus it appeared that this was an interesting array of genes 
and it was decided to investigate other members to some extent, in addition to PAD1 
and PAD2. 
5.6.1 Generating antigenic peptide antibodies recognising all PAD array 
members 
The highly homologous nature of the PAD array, while making some types of 
analysis more difficult (for example Northern analysis and RNAi mediated transcript 
ablation), had the advantage that it is comparatively simple to design an antibody that 
detects multiple members of this cluster.  To achieve this, the PAD protein sequences 
were aligned by clustalW ( see Figure 5.6-1C, and Appendix A for a full Multalin 
alignment) and one peptide sequence was selected that was common to the entire 
array, and one was chosen that was predicted bind to some members with higher 
affinity, possibly allowing specific identification of any resulting bands (see Figure 
5.6-1).  The requirement for these regions were: 
• At least 15 – 20 amino acids where there was little or no heterogeneity in the 
PAD alignment 
• They were predicted to be either extra cellular or intracellular (i.e. not 
membranous) to facilitate antibody binding 
• They should not form part of the N-terminal signal anchor – although signal 
anchors are not predicted to be cleaved, it is possible that the PAD proteins 
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have a cryptic cleavage site resulting in the antibody target sequence not 
forming part of the mature protein 
• A BLAST search identifies no other matches in the T. brucei database, thus 
minimising the risk of cross-reactivity (data not shown) 
The peptide sequences were sent to Eurogentec for synthesis and inoculation into 
rabbits followed by affinity purification against the antigenic peptide using their 
“DoubleXP” programme. 
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Figure 5.6-1  Designing the antigenic peptides for the α-array antibodies. (A) The 
positions of the sequences used to design the peptides are indicated by orange circles on 
the PAD1 secondary structure. (B) The sequences of the peptides are shown. (C) A 
ClustalW alignment of the PAD proteins showing the two regions that the peptides were 
designed against (the peptide sequence is indicated by the red square).  Anti-array #1 
(left) is predicted to bind to all of the PAD proteins equally well, whereas anti-array #2 
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5.6.2 Expression of unidentified PAD proteins through the trypanosome 
lifecycle 
Given that PAD1 mRNA and protein is stumpy form specific, and that PAD2 mRNA 
transcript is enriched in the procyclic form, it was of interest to determine the relative 
levels of PAD array protein expression in different lifecycle stages, and also to 
determine if any of the PAD proteins were expressed in monomorphic slender cells.  
This was possible because the Northern blot analysis using a riboprobe to detect all 
of the PAD gene mRNA transcripts showed that there was at least some PAD gene 
RNA expression in the monomorphic slender form (see Section 5.1, Figure 5.1-2). 
Cell lysate was made from monomorphic slender, stumpy and procyclic form cells 
and analysed by Western blot with the α-array #1 and α-array #2 using the protocol 
optimised for PAD1 detection (see Materials and Methods).  The introduction of the 
LI-COR infrared system (Weldon et al. (2008)) into the laboratory allowed a relative 
quantitation of the resulting signal in different lifecycle stages that had previously 
been unavailable.  Thus, infrared fluorochrome conjugated secondary antibodies 
were used in place of horse-radish peroxidase (HRP) conjugated antibodies.  
Additionally, the use of fluorochromes with non-overlapping emission spectra 
allowed co-staining with an α-tubulin loading control to normalize the signal from 
the α-array antibodies for relative sample loading. 
Figure 5.6-3 shows that when the α-array #1 antibody was used as a primary 
antibody in a Western blot analysis of the different lifecycle cell lysates,  no PAD 
protein was detected in monomorphic slender cells, a 55 kDa and a 57 kDa band was 
detected in the stumpy cell lysate, and a 57 kDa band was detected in the procyclic 
form cell lysate.  Similar results were obtained using the α-array #2 antibody.  A 
faint band resolving at approximately 54 kDa was also detected by α-array #2 in 
procyclic cell lysate, but this probably represents a degradation product of the 57 
kDa band, and was not detected in all procyclic form cell lysates (data not shown).  
Perhaps interestingly, the 57 kDa band detected by α-array #1 is much fainter than 
the 55 kDa band, whereas the 2 bands are of approximate equal intensity when the α-
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array #2 antibody is used.  This may represent differential affinity to different PAD 
proteins (for example, the α-array #2 antibody may bind to different member with 
differing affinities; Figure 5.6-1C) between the 2 antibodies, but probably reflects 
protein sample variation. 
Thus, it would appear that 2 different PAD proteins are expressed in the stumpy 
form, and 1 PAD protein is expressed in the procyclic form.  It is possible that 
several PAD proteins contribute to either the 55 kDa or the 57 kDa band, but it 
would seem unlikely that they would resolve so closely as to be indistinguishable on 
a 10% poly-acrylamide gel.  No PAD proteins were detected in the monomorphic 
slender cells, confirming that the bands detected by the α-PAD2 antibody were 
indeed due to VSG cross reactivity; note that this was in apparent contrast with the 
Northern blot data (see Section 5.1), that shows that there is PAD mRNA expression 
in these cells.  This may reflect a mechanism of translational control specific to 
slender cells. 
Further experiments were performed to identify which of the PAD proteins 
corresponded to each band. 
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Figure 5.6-2 The expression of PAD proteins though the T. brucei lifecycle.  Cell 
lysate from different lifecycle stages of T. brucei were analysed by Western blot (A)  α-
PAD array #1 and (B)  #2 antibodies.  Both antibodies detected a 55 kDa and 57 kDa 
band in stumpy form cell lysate and a 57 kDa band in procyclic form ell lysate.  A 54 kDa 
band is also detected in procyclic form cell lysate by α-array #2, but this probably 
represents a degradation product of the 57 kDa band. 
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5.6.3 Identification of the bands detected by the α-array antibodies 
To identify which of the PAD proteins the bands detected by the α-array antibodies 
corresponded to, cell lysate from stumpy and procyclic form was resolved by SDS-
PAGE and transferred onto PVDF membrane by wet blotting.  Each of the lanes was 
cut in half longitudinally and 1 half was analysed by Western blot using either α-
PAD1 or α-PAD2, and the other half of the lane was analysed using α-array #2.  α-
array #2 was chosen as this gave the best signal for both bands in the stumpy lane 
(Figure 5.6-2).  Post-staining, the lanes were precisely aligned and analysed using the 
LI-COR Odyssey infrared imaging system (see Materials and Methods for details). 
Figure 5.6-3 shows that the 55 kDa band in the stumpy cell lysate was confirmed as 
PAD1, and the 57 kDa band in both the stumpy form and the procyclic form was 
identified as PAD2.   
These data do not exclude the possibility that other PAD proteins resolved at the 
same size and also contribute to the signal detected by the α-array antibodies.  It is 
worth noting that, although PAD5/7 RNA expression profiles suggest stumpy 
specific expression, a third band was not detected in the stumpy form protein; 
PAD5/7 were predicted to be smaller than PAD1 and PAD2 (0.8 kDa and 1.7 kDa 
respectively), and may therefore be expected to resolve differently.  Therefore, it 
may be that PAD5 and PAD7 are not expressed at the protein level under these 
conditions. 
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Figure 5.6-3 Identification of bands detected by the α-PAD array generic antibody. 
Cell lysate protein from different lifecycle stages was resolved by SDS-PAGE and 
transferred onto PVDF membrane.  Post transfer, the protein was visualised by 
transillumination and the lanes were cut longitudinally, such that each half of the lane 
contained resolved protein.  One half of each lane was stained with α-array #2, and the 
other half was stained with either (A) α-PAD1 or (B) α-PAD2 prior to staining with an α-
rabbit secondary antibody.  The lanes were subsequently aligned and visualised using 
the LI-COR odyssey system to determine which of the bands detected by the α-array 
antibody corresponded to either PAD1 or PAD2.  The data show that the 55 kDa band in 
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5.7 Expression of PAD1 during synchronous differentiation to 
procyclic forms 
Investigating the expression of PAD1 during differentiation may reveal a mechanism 
for PAD1 regulation.  To this end, stumpy form AnTat 1.1 cells were purified from a 
late stage mouse infection, and differentiated by supplementing HMI9 media with 6 
mM cis-aconitate and incubating at 27°C.  Differentiating cells were analysed for 
PAD1 expression over a 24 hour timecourse by Western blot on cell lysate protein 
using the α-PAD1 antibody.  PAD1 protein was quantified using the LI-COR 
Odyssey system. 
Interestingly, Figure 5.7-1 shows that there appeared to be a slight (approximately 
30%) upregulation of PAD1 protein in the first 2 hours of differentiation; this may be 
due to slender and intermediate cells differentiating to the stumpy form in response 
to differentiation conditions, or may be due to substrate mediated upregulation of 
PAD1, as has been observed with numerous other transporters (Diamond et al. 
1984)) (Cheeseman and Harley (1991)) (Walker et al. (1998)) (Hu and Quick 
(2008)).  Alternatively, this may simply represent some variation between the 
prepared samples in this experiment.  However, at 24 hours there is still 
approximately 70% of the original PAD1 protein detected, suggesting that there is no 
specific mechanism for rapid clearance of PAD1 from the cell.  Instead PAD1 may 
simply be removed from the cell through dilution once the cell has re-entered the cell 
cycle and undergone cytokinesis.  No PAD1 protein was detected in established 
procyclic forms, in accordance with previous observations (see Figure 5.4-1). 
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Figure 5.7-1  Expression of PAD1 through differentiation to the procyclic form. 
Stumpy form cells were induced to differentiate by incubation with 6 mM cis-aconitate at 
27°C.  Cell lysate was prepared over a 24 hour timecourse. (A)  PAD1 expression was 
assayed by Western blot with the α-PAD1 antibody, using an α-tubulin antibody as a 
loading control.  (B) The LI-COR Odyssey infrared quantification system was used to 
determine expression of PAD1 relative to tubulin throughout differentiation. 
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5.8 Expression of PAD2 through differentiation 
It was of interest to determine how quickly PAD2 is upregulated during 
differentiation from the stumpy form to the procyclic form.  Therefore, 
differentiating stumpy form cells were analysed for PAD2 expression by Western 
blot using the α-PAD2 antibody. 
Figure 5.8-1 shows that PAD2 had relatively low expression in stumpy forms, but 
increased 2 fold after 1 hour.  Expression fluctuated between 2 to 5 hours prior to 
increasing to maximal level of approximately 17 fold the expression found in stumpy 
forms at 24 hours.  Expression in established procyclic forms was approximately 1/3 
of that expressed at 24 hours post cis-aconitate addition, but was still approximately 
6 fold more highly expressed than in stumpy forms.  A 54 kDa band was detected 
that increased slightly in intensity; this probably represents either a degradation 
product or a differently resolving form of PAD2.  Similar kinetics were detected 
using the α-PAD2 #1 antibody (data not shown).  See Section 5.9 for further 
discussion. 












































Figure 5.8-1  Expression of PAD2 through differentiation.  Stumpy form cells were 
differentiation with cis-aconitate and protein cell lysate was prepared over a 24 hours 
timecourse.  (A) Expression of PAD2 through differentiation was examined by Western 
blot analysis.  An established procyclic form sample was also included.  (B)  PAD2 
expression was quantified using the LI-COR odyssey system, and the data was 
processed in excel.  Expression is normalised to a tubulin loading control, and expressed 
relative to the stumpy form lane. 
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5.9 Expression of entire PAD family of proteins through differentiation 
PAD1 and PAD2 were shown to have distinct expression profiles both in the 
different lifecycle stages, and throughout differentiation to the procyclic form.  It was 
therefore of interest to determine the expression of all of the PAD proteins 
throughout differentiation in order to (A) confirm the expression of PAD1 and PAD2 
and (B) to determine whether any other PAD proteins were transiently expressed 
through differentiation.  Additionally, if the 55 kDa band consisted of only PAD1, 
and the 57 kDa band consisted of only PAD2, then one would predict that the 57 kDa 
band would show the same expression profile as PAD2, and the 55 kDa band would 
show the same profile as PAD1.  In contrast, if PAD proteins other than PAD1 and 
PAD2 (such as PAD5/7) contributed to either of these bands, and had a different 
expression profile, then one would predict that these bands would show a different 
profile to PAD1 and PAD2 during the differentiation time course. 
Therefore, lysate from stumpy cells undergoing differentiation (see Section 5.7) was 
analysed by Western analysis using the α-array #2 antibody and the LI-COR 
Odyssey infrared imaging system in order to visualise and quantify PAD protein 
expression through differentiation. 
Figure 5.9-1 shows the 55 kDa band precisely reflected the expression of PAD1 
through differentiation, with an initial 30% rise in expression in the first 2 hours, 
followed by a drop at 5 hours prior to a slight increase at 8 hours.  Although not 
detected at 24 hours, this was probably a result of the strong 57 kDa band masking 
detection of this protein.  This provided further evidence that the 55 kDa band was 
PAD1; although PAD5 and 7 may share the same expression profile as PAD1, it is 
unlikely that they would resolve so closely to PAD1 as to be indistinguishable. 
The 57 kDa band was consistent with the expression profile of PAD2 (compare 
Figure 5.9-1 and Figure 5.8-1) and showed an initial 2 to 3 fold increase after 1 hour.  
Similar to the expression profile determined using the α-PAD2 antibody, there was a 
slight fluctuation in signal between 2 to 5 hours, and maximal expression at 24 hours.  
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Established procyclic forms exhibit expression of the 57 kDa band at approximately 
6 fold the expression of stumpy forms, and 1/6 to 1/7 that at 24 hours. 
As has been stated, PAD2 expression was approximately 6 to 7 fold higher at 24 
hours through differentiation than is detected in established procyclic forms.  This 
has the interesting implication that this band not only represents a very early 
differentiation enriched protein, but that it is also much more highly expressed in an 
early procyclic form than a late procyclic form.  It would be interesting to determine 
whether this protein responds to glycerol in a similar way to GPEET procyclin; 
GPEET procyclin expression is maintained in the presence of glycerol in the early 
procyclic form but is subsequently switched off (Vassella et al. (2000)).   Note that 
continuously cultured procyclic forms lose repressional control over GPEET, and re-
express this protein. 
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Figure 5.9-1  The expression of PAD proteins through differentiation.  Stumpy form 
cells were supplemented with 6 mM cis-aconitate and cultured at 27°C for 24 hours.  
Protein cell lysate was prepared through this timecourse and analysed by Western blot 
using the α-array #2 antibody.  (A) A Western blot to show expression of PAD proteins 
through differentiation (B) The signal from the Western blot was quantified and graphed 
relative to α-tubulin. 
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5.10 Expression of PAD1 is associated with expression of EP procyclin 
during differentiation of pleomorphic cells 
There is an active debate in the trypanosome field about the capacity of slender cells 
to differentiate to procyclic forms.  Serially passaged monomorphic cell lines have 
been selected such that stumpy forms are not present within the population.  Despite 
this, monomorphic cells can differentiate to the procyclic form, albeit at a slower rate 
than a homogenous stumpy population.  This has led to the proposal that true slender 
cells are competent for differentiation (Bass and Wang (1991)) and that initiation of 
differentiation is cell cycle stage independent (Li et al. (2003)).  The alternative view 
is that stumpy cells are essential for lifecycle progression in pleomorphic cells, and 
that cell cycle arrest in G1/0 is required for differentiation (Matthews and Gull 
(1994)) (Tasker et al. (2000)) (Matthews et al. (2004)) (see Section 1.6 for further 
discussion). 
As a stumpy specific protein, PAD1 was used to investigate these conflicting 
hypotheses.  Therefore, a pleomorphic population of cells containing stumpy, 
intermediate and slender form cells was purified from a mouse infection and induced 
to differentiate by addition of 6 mM cis-aconitate and incubation at 27°C.  At 6 hours 
post cis-aconitate addition, the cells were fixed in methanol to preserve morphology 
and analysed by immunofluorescence to detect the expression of the procyclic 
marker EP procyclin, and the stumpy marker PAD1.  The expectation was that if 
stumpy and intermediate cells are not required for differentiation then there would 
little or no correlation between the expression of PAD1 and EP procyclin.  If, 
however, stumpy or intermediate form cells are an essential step in T. brucei 
lifecycle progression, then we should observe precise co-expression of PAD1 and EP 
procyclin on the cell surface. 
Figure 5.10-1 shows that PAD1 expression correlated very closely with EP procyclin 
at 6 hours post cis-aconitate induction.  More than 95% of the cells counted were 
either both EP positive and PAD1 positive, or EP negative and PAD1 negative.  In 
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contrast, very few (less than 5%) were positive for one surface protein and not the 
other.  Note that in the EP-ve/PAD1-ve population more than 80% of the cells 
exhibited 1 nucleus and 1 kinetoplast, (1K1N).  Hence stumpy formation, rather than 
cell-cycle position alone, was required for EP procyclin expression.  
Given that PAD1 has been established as a stumpy specific protein (see Figure 
5.4-1), the strong correlation between expression of EP procyclin and PAD1 during 
differentiation strongly supports the hypothesis that the stumpy form is required for 
lifecycle progression in a natural population of T. brucei. 
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Figure 5.10-1  The correlation between PAD1 expression and EP expression during 
differentiation.  The correlation of PAD1 and EP procyclin expression was determined in 
differentiating pleomorphic cells by immunofluorescence.  (A) A representative field of 
view in which EP procyclin expression was precisely associated with PAD1 expression.  
The arrow indicates a cell that was not labelled with either marker.  (B) Cells were scored 
as positive or negative for PAD1 and EP, and the position of the cell cycle was 
determined by counting the number of nuclei and kinetoplasts. 
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5.11 PAD expression in monomorphic slender cells 
PAD proteins were not detected in monomorphic slender cells (see Figure 5.4-1).  
Thus, if the hypothesis that the PAD proteins are essential for reception of cis-
aconitate is correct, the question arises: how are monomorphic cells able to 
differentiate in response to cis-aconitate?  There are several examples of substrate 
induced upregulation of transporter molecules (Duan et al. (1999)) (Samuvel et al. 
(2005)) (Bernstein and Quick (1999)) (Munir et al. (2000)) and it may be that PAD1 
is upregulated in the presence of cis-aconitate in monomorphic cells.  This would 
have the interesting implication that cis-aconitate is not only able to induce 
differentiation to the procyclic form, but is also able to promote the slender to 
stumpy lifecycle progression.  To test this possibility two strategies were attempted. 
5.11.1 The affect of differentiation conditions on PAD1 protein expression in 
monomorphs 
A healthy, exponentially growing monomorphic culture was subjected to four 
different treatments for 6 hours to identify which, if any, of the conditions for 
differentiation were able to upregulate PAD1 expression: 
• 0 mM cis-aconitate; 37°C 
• 6 mM cis-aconitate; 37°C 
• 0 mM cis-aconitate; 27°C 
• 6 mM cis-aconitate; 27°C 
After 6 hours, cell lysates were prepared and Western blots were performed to detect 
any upregulation of PAD1, or any of the other PAD proteins. 
Figure 5.11-1 shows that upregulation of PAD1 or the other PAD proteins was not 
detected in cells exposed to any of the above conditions.  It may be that the high 
concentrations of cis-aconitate needed to stimulate differentiation of monomorphs 
forces signalling through other routes (such as a non-specific transporter).  
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Alternatively, it may be that PAD proteins were expressed at levels that are 
undetectable in this analysis.  Nonetheless, no evidence of substrate-induced 
upregulation was detected. 















Figure 5.11-1  PAD expression under differentiation conditions.  Lister 427 
monomorphic slender cells were incubated with and without 6 mM cis-aconitate at 37°C 
and 27°C for 6 hours.  Protein cell lysate was analysed by Western blot with (A) α-PAD1 
and (B) α-array antibodies to determine whether PAD proteins are upregulated under 
differentiation conditions.  No evidence of PAD protein upregulation was detected. 
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5.12 Investigating the kinetics of cold shock 
Cold shock, as described by Engstler et al. (Engstler et al. (2004)), is induced by 
subjecting blood form trypanosomes to a drop in temperature from 37°C to 20°C.  
Under these conditions, stumpy forms express EP procyclin on their cell surface 
membrane and become hypersensitive to cis-aconitate.  Slender cells also express EP 
procyclin in response to cold shock, but are unable to localise it to the cell surface 
and do not become hypersensitive to cis-aconitate.  In order to investigate the affect 
of cold shock upon PAD1 protein expression it was necessary to first investigate the 
kinetics of cold shock.  Specifically, the duration of temperature regulation needed to 
induce EP expression and its reversibility were assessed. 
Thus, stumpy form cells were purified from a mouse infection and allowed to 
recover for 1 hour in HMI9 media at 37°C (see Materials and Methods for details).  
The culture was then divided such that half the cells were incubated at 20°C, and the 
other half were incubated at 37°C to control for potential inadvertent cold shock 
during cell purification.  Thereafter, the cells were fixed in methanol at time intervals 
over 24 hours and the extent of cold shock assayed by immunofluorescence for EP 
procyclin expression.  After 6 hours, a small proportion of cold shocked cells were 
re-incubated at 37°C to determine whether cold shock was reversible. 
Figure 5.12-1 demonstrates that there appeared to be no detectable EP procyclin 
expression in response to cold shock within the first 2 hours, that by 3 hours a small 
proportion of cells were expressing  EP procyclin, this rising to 27% by 5 hours.  
There was a small drop after 6 hours, whereupon procyclin appeared to remain stable 
at approximately 20% until 24 hours.  Cells that were cold shocked for 6 hours, and 
then re-incubated at 37°C overnight, were able to reverse the cell surface expression 
of EP procyclin, such that only 3% of cells continued to express EP procyclin, 
compared to 20% of cells after 6 hours of cold shock. 
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Although expression of EP procyclin and hypersensitivity to cis-aconitate may not be 
coincident, we can conclude that cells are able to respond to cold shock within 4 
hours, and that the cold shock affect is mostly reversible with respect to EP 
expression.  This is useful technical information as it allowed design of experiments 
to investigate cold shock, and that, as long as due care is taken, we did not have be 
concerned with inadvertent cold shock of stumpy form cells during the purification 
process. 
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Figure 5.12-1  The kinetics of cold shock. AnTat 1.1 stumpy form cells were subjected 
to cold shock over a 24 hour timecourse.  After 6 hours at 20°C, a small proportion of 
cells were re-incubated at 37°C overnight to determine whether the cold shock effect was 
reversible.  The extent of cold shock was assayed by staining with EP-procyclin and 
analysed by immunofluorescence microscopy.  100 cells were counted per timepoint. 
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5.13 Cold shock does not cause increased levels of PAD1 mRNA  
Given the putative role of PAD1 in cis-aconitate transport, it would not be surprising 
if PAD1 was implicated in a process that causes hypersensitivity to cis-aconitate in 
response to cold shock.  This may occur through either PAD1 mRNA transcript 
stabilisation, increased translational efficiency of the PAD1 transcript, more efficient 
translocation of the protein to the cell surface membrane or a post-translational 
modification that increases cis-aconitate uptake. 
To investigate the affect of cold shock upon expression of PAD1 mRNA, 
monomorphic slender cells, intermediate and stumpy form cells were incubated at 
20°C for 18 hours; a control population was maintained at 37°C.  RNA prepared 
from these cells was probed in a Northern blot using a DIG labelled RNA probe 
specific to PAD1 to detect any differences in PAD1 mRNA expression. 
Figure 5.13-1 shows that there did not appear to be upregulation of PAD1 in 
response to cold shock in either monomorphic slender cells, intermediate or stumpy 
form cells.  On the contrary, cold shocked intermediate and stumpy form cells 
expressed less PAD1 mRNA.  This was unlikely to be a specific response to cold 
shock, but may be due to reduced efficiency of mRNA production at lower 
temperatures.  As expected, monomorphic cells had almost undetectable levels of 
PAD1 mRNA until the blot was overexposed, and therefore probably showed no 
response to cold shock. 
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Figure 5.13-1  The affect of cold shock upon PAD1 mRNA levels in monomorphic 
slender, pleomorphic intermediate and stumpy form cells. Trypanosomes were 
incubated at 37° and 20° overnight and RNA was made for a Northern analysis of PAD1 
mRNA levels.  PAD1 RNA did not appear to up-regulated in response to cold shock, in 
contrast there may in fact be less transcript in the cold shocked intermediate and stumpy 
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5.14 There was a non-reproducible up-regulation of PAD1 protein in 
response to cold shock 
In addition to mRNA, it was of interest to assess the impact of cold shock upon the 
levels of PAD1 protein in stumpy form parasites.  Thus, stumpy form trypanosomes 
were purified from a mouse infection (described in Materials and Methods) and 
allowed to recover at 37°C for 1 hour in HMI9 media.  Half the population of cells 
was subsequently incubated at 20°C whilst the rest remained at 37°C; after 18 hours 
samples were taken for Western, immunofluorescence and FACS analysis to detect 
expression of PAD1 protein using the PAD1 antibody. 
Figure 5.14-1A shows by Western blot that there was a modest increase in PAD1 
expression in response to cold shock; no such effect was detected in the 
monomorphic slender cell lysate.  A flow cytometry analysis of PAD1 expression 
showed that a small proportion (approximately 5%) of stumpy form cells have 
increased expression of PAD1 protein (Figure 5.14-1B).  Additionally, cells were 
analysed for PAD1 protein expression by immunofluorescence there was a clear 
upregulation of PAD1 in a small proportion of cells (approximately 5%); this 
upregulation was specific to the cold shocked cells and was not observed in cells 
cultured at 37°C.  A detailed analysis of these cells showed that PAD1 high 
expressers were to be associated with an extreme stumpy morphology.  This was 
judged by such attributes as a kinetoplast that was highly proximal to the nucleus, a 
‘comma’ like shape, and no free flagellum at the anterior. 
One might speculate that the cells that express PAD1 highly in response to cold 
shock are able to transport cis-aconitate into the cell at much lower extra-cellular 
concentrations, thus conferring the hypersensitivity to cis-aconitate reported by 
Engstler et al. (2004).  Therefore, it was of interest to determine whether PAD1 high 
expression was associated with cold shock induced EP procyclin expression.  For 
example, a correlation might reveal a mechanism for upregulation.  To this end, 
duplicate slides of the original experiment were co-stained with α-EP procyclin and 
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α-PAD1, and counter stained with secondary antibodies that would distinguish 
between the mouse derived α-EP antibody, and the rabbit derived α-PAD1 antibody.  
However, no correlation was observed (data not shown). 
Although three different types of data (Western analysis, FACS analysis and 
immunofluorescence) indicated that PAD1 was upregulated somewhat in response to 
cold shock in this experiment, subsequent repeats of this experiment did not show the 
same effect.  A number of different variables were modified in an attempt to 
recapitulate the effect on PAD1 protein expression, and so establish the basis of its 
variability. 
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Figure 5.14-1  The effect of cold shock of stumpy form cells upon PAD1 
expression. Stumpy form cells harvested from a mouse parasitaemia were subjected to 
cold shock for 24 hours and analysed for PAD1 expression by (A) Western analysis, (B) 
FACS analysis and (C) Immunofluorescence analysis.  Monomorphic slender cells were 
also subjected to cold shock and included in the Western analysis with procyclic form cell 
lysate.  In each a limited upregulation of PAD expression was observed, these being 
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5.14.1 The effect upon PAD1 expression of varying the degree of parasitaemia 
and the temperature of cold shock 
The cold shock of trypanosomes was originally reported to occur at 20°C, but it was 
possible that the experiment in Section 5.14 was subject to ambient temperature 
variations resulting in a lower temperature.  Additionally, it was possible that the 
original experiment was performed using a relatively early stage parasitaemia and 
that intermediate cells are most responsive to cold shock.  For these reasons both 
temperature and the degree of parasitaemia were tested for their affect upon cold 
shock and the expression of PAD1. 
Therefore, two mice were treated with cyclophosphamide to depress their immune 
system and inoculated with AnTat 1.1 pleomorphic cells.  Thereafter, the 
parasitaemia was monitored for stumpy cell formation by examining blood from tail 
snips for morphology.  Each mouse was killed at the appropriate stage of 
parasitaemia such that one population had a mixed population of slender, stumpy and 
intermediate cells and the other had a homogenous stumpy population.  
Trypanosomes were purified using a DEAE cellulose anion exchange column and 
allowed to settle for 1 hour in HMI9 media.  Subsequently, the cells were incubated 
at 37°C, 20°C, 15°C or 10°C in flasks with non-vented lids.  After 18 hours, cell 
lysate was prepared for Western analysis, and cells were fixed with methanol for 
immunofluorescence analysis. 
Figure 5.14-2A shows that PAD1 was not upregulated in stumpy form cells in 
response to any of the cold shock conditions.  Moreover, when this experiment was 
performed on intermediate cells (see Figure 5.14-2B) the same result was observed, 
and indeed, a decrease in PAD1 protein expression was observed in response to 
lower temperatures.  Further, immunofluorescence analysis of PAD1 expression did 
not show the small proportion of cells that upregulate PAD1 protein (data not 
shown).  Thus, neither the temperature or the stage of parasitaemia induced elevated 
PAD1 expression. 
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Figure 5.14-2  The affect of varying the temperature of cold shock and the 
degree of parasitaemia upon PAD1 expression. Stumpy form (A) and 
intermediate cells (B) were cold shocked for 18 hours at 10, 15 and 20 degrees 
Celsius (additionally, stumpy form cells were also exposed to 27 degree Celsius).  
Cell lysate was prepared for Western analysis to detect any change in PAD1 
protein levels.  The membranes were re-probed with anti-tubulin antibody as a 
loading control.  PAD expression was not elevated at low temperature and, indeed, 
was somewhat decreased in panel B. 
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5.14.2 The affect of cold shock in combination with foetal calf serum (FCS) 
deprivation upon PAD1 expression 
One might speculate that, in addition to a change in temperature, a change in the 
availability of nutrients might provide an environmental cue that the trypanosome 
has changed host, thus stimulating hypersensitivity to cis-aconitate through 
upregulation of PAD1.  Additionally, there can be significant variations between 
bstches of foetal calf serum (FCS) that might explain the non-reproducibility of cold 
shock induced PAD1 upregulation.  Therefore, it was decided to combine cold shock 
with FCS deprivation in an attempt to recapitulate the original PAD1 upregulation 
observed in Section 5.14. 
Therefore, stumpy form trypanosomes were purified from a mouse infection (see 
Materials and Methods) and allowed to recover in HMI9 media containing 20% FCS 
at 37°C for 1 hour.  Trypanosomes were then pelleted and re-suspended in media 
containing either 20% FCS, or no FCS at all.  Half of the cells in each different 
condition were then incubated at 20°C in non-vented flasks, and the other half was 
incubated at 37 °C.  After approximately 18 hours, cell lysate protein was prepared 
from each of the 4 cultures and analysed for PAD1 expression by Western blot.  The 
LI-COR Odyssey system was used to quantify the signal relative to tubulin (see 
Materials and Methods). 
Figure 5.14-3 shows a 55 kDa and a 59 kDa band when protein was reacted with the 
α-PAD1 antibody in a Western blot.  The 59 kDa band is probably a differently 
resolving form of PAD1 that is sometimes detected in stumpy form lysate, but not in 
monomorphic slender cell lysate.  There did not appear to be any convincing 
upregulation of PAD1 in response to FCS deprivation at either 37°C or 20°C; 
however a mild but clear (approximately 60%) upregulation of PAD1 was detected 
in response to cold shock conditions.  This was surprising given the previous lack of 
success in recapitulating PAD1 upregulation in response to cold shock.   This could 
reflect either a variation between protein samples unrelated to cold shock, the 
limitations of the LI-COR quantitation system, or an as yet unidentified variable.
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Figure 5.14-3  The effect of cold shock and FCS deprivation upon PAD1 protein 
expression.  Stumpy form trypanosomes were harvested from mice and subjected to 
cold shock and/or foetal calf serum deprivation to assess the effect upon PAD1 protein 
expression.  (A) PAD1 protein levels were assayed by Western blot analysis on protein 
cell lysate using the α-PAD1 #1 antibody.  An α-tubulin antibody was included as a 
normalisation control.  (B)  Levels of PAD1 protein relative to tubulin were assayed using 
the LI-COR Odyssey infrared quantification system.  PAD1 was upregulated in response 
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5.14.3 The effect of cold shock in combination with pH variation upon PAD1 
expression 
It has been reported that differentiation of stumpy form trypanosomes can be induced 
to differentiate to the procyclic form through exposure to mild acid conditions (pH 
5.5) (Rolin et al. (1998)).  Additionally, Rolin et al. also noted that mild acid 
treatment can promote the intermediate to stumpy transition and cause cell death in 
slender cells.  From a physiological perspective, it is known that procyclic form 
trypanosomes grow in the tsetse in alkaline conditions (between pH 8 – 10) (Liniger 
et al. (2003)), but trypanosomes may be subject to transient pH fluctuations during 
uptake into the tsetse.  Thus, pH may be an environmental cue that helps the 
trypanosome detect a change in host and stimulate hypersensitivity to differentiating 
factors such as cis-aconitate through upregulation of PAD proteins 
To investigate this hypothesis, stumpy form cells were purified from a mouse 
parasitaemia as previously described and allowed to recover in HMI9, pH7.5 at 37°C 
for 1 hour.  Cells were subsequently resuspended in HMI9 media at pH5.5, 7.5, 8 or 
9.  Half of the cells were then incubated at 20°C, and the remaining were incubated 
at 37°C for approximately 16 hours.  Cell lysate was prepared for Western analysis, 
and cells were fixed in methanol for immunofluorescence analysis. 
Figure 5.14-4 shows that there did not appear to be an upregulation of PAD1 in 
response to pH or cold shock under these conditions.  The absence of increased 
expression in response to pH is surprising, given that mild acid conditions are 
reported to induce differentiation to the stumpy form, and would thus be predicted to 
cause upregulation of a stumpy specific protein.  However, it is possible that PAD1 
was already maximally expressed in these cells, and that mild acid treatment did not 
cause any further differentiation to the stumpy form.  The reduction in PAD1 
expression at pH5.5 may also reflect the induction of differentiation to procyclic 
forms, described by Rolin et al. (1998).  Nonetheless, the lack of cold shock induced 
PAD1 upregulation underscores the lack of reproducibility of the original cold shock 
induced upregulation of PAD1 protein
5 – Expression and Localisation of PAD Proteins 196 
Figure 5.14-4  The affect of cold shock and pH upon PAD1 protein expression in 
stumpy form trypanosomes.  Stumpy form trypanosomes were harvested from mice 
and subjected to cold shock in media of pH ranging from pH 5.5 to pH9.  (A) A Western 
blot of cell lysate made after 24 hours of cold shock using the α-PAD1 antibody.  Tubulin 
was included as a loading control.  (B)  The level of PAD1 expression relative to tubulin 
was assayed using the LI-COR Odyssey infrared quantitation system.  Under these 
conditions, PAD1 expression is not upregulated in response to pH 5.5 or in response to 
cold shock.  Cold shock appears to reduce PAD1 protein expression somewhat. 
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5.15 The effect of cold shock upon protein expression of other PAD 
members 
Cold shock did not appear to cause upregulated expression of PAD1 protein, thus it 
was of interest to determine whether other PAD members are affected by cold shock.  
Cold shock was  originally reported to induce expression of the procyclic form 
protein EP procyclin, and cause routing to the cell surface membrane of stumpy form 
cells only.  This may be of particular relevant to PAD2, which has its maximal 
expression in procyclic forms. 
5.15.1 The effect of cold shock upon the PAD family protein expression 
The pleomorphic strains AnTat 1.1 and EATRO trypanosomes were used to 
inoculate mice in order to isolate stumpy form parasites.  Stumpy form cells were 
purified from a mouse infection, resuspended in HMI9 media at approximately 5 x 
106 cells ml-1, and incubated overnight at either 37°C or 20°C.  Protein cell lysate 
was prepared for Western analysis using the α-array #2 antibody (see materials and 
methods for details). 
Figure 5.15-1 shows a mild, but clear and reproducible, upregulation of the 57 kDa 
band in response to cold shock.  The extent of upregulation was variable between 
experiments, but was generally between 3 to 6 fold, with 1 experiment showing a 45 
fold upregulation.  As shown in Section 5.6.3, the 57 kDa band corresponds to 
PAD2, and subsequent data in this Chapter confirm this (see Section 5.16).  Figure 
5.15-1B also shows that the 55 kDa band is upregulated; but this is probably 
explained by the close resolution of the 57 kDa band interfering with the calculation 
of background signal, and does not appear to be supported when the exposure 
(Figure 5.15-1A) is examined. 
Further experiment were performed in order to determine the effect of other 
variables, such as pH and foetal calf serum deprivation. 



















































Figure 5.15-1  The effect of cold shock upon PAD family protein expression.  AnTat 
1.1 and EATRO stumpy form parasites were subjected to either 37°C or 20°C overnight.  
(A) Cell lysate was prepared, and analysed for PAD family protein expression by Western 
blot.  (B)  The resulting bands were quantified relative to the tubulin loading control using 
the LI-COR odyssey system, and the data was analysed.  The 57 kDa band 
corresponding to PAD2 was 2 to 3 fold upregulated.  This upregulation in response to 
cold shock was clear, although mild, and was consistently detected. 
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5.15.2 Western analysis PAD family proteins in response to cold shock and FCS 
deprivation 
To determine the effect of foetal calf serum deprivation and cold shock upon PAD 
family protein expression, cell lysate from Section 5.14.2 was analysed using the α-
array #2 antibody to detect all of the PAD proteins. 
There were 3 bands visible in this analysis (see Figure 5.15-2).  The 60 kDa band 
may be a form of PAD1 as this has been seen in Western blots using both the α-
PAD1 antibody (see Figure 5.14-3) and did not change appreciably in response to 
FCS deprivation, cold shock or a combination of both.  The 57 kDa band, 
corresponding to PAD2, did not show a convincing response to changes in the level 
of FCS, but did show a 3 – 4 fold upregulation in response to cold shock when cells 
were incubated in media containing 20% FCS, and approximately 2.5 fold 
upregulation when cells were incubated in media without FCS.  The more limited 
cold shock-associated increase of this band in the absence of FCS was probably not 
significant and may have resulted from an impaired ability to synthesise new protein 
with limited nutrients.  The 55 kDa band corresponding to PAD1 did not show a 
response to either cold shock or FCS deprivation, consistent with previous data (see 
Section 5.14.2) 
In summary, there did not appear to be an upregulation of any of the PAD proteins in 
response to a nutrient deprived environment, but there did appear to be a 
reproducible 3 – 4 fold upregulation of the 57 kDa PAD protein in response to cold 
shock, consistent with previous data. 
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Figure 5.15-2  The affect of foetal calf serum deprivation and cold shock upon PAD 
array protein expression. Stumpy form trypanosomes were harvested from mice and 
subjected to cold shock and foetal calf serum deprivation to assess the affect upon PAD1 
protein expression.  (A) PAD protein levels were assayed by Western blot analysis on 
protein cell lysate using the α-PAD #2 antibody.  An α-tubulin antibody was included as a 
control.  (B)  Levels of PAD family protein relative to tubulin were assayed using the LI-
COR Odyssey infrared quantification system.  The LI-COR data shows that the 57 kDa 
band responded to cold shock, but FCS deprivation had no significant effect upon 
expression of any of the PAD family proteins.  The 60 kDa band is probably a form of 
PAD1 that resolves differently to the 55 kDa form of PAD1, and has been detected when 
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5.15.3 The affect of pH and cold shock upon PAD array protein expression 
Protein was analysed as for Section 5.14.3 using the α-PAD array #2 antibody.  In 
this case, there appeared to be an up-regulation of the 57 kDa band by a factor of 45 
(see Figure 5.15-3) in response to cold shock at pH7.5, and at least 3.5 fold in 
response to mild acid conditions at 37°C.  The 55 kDa band does not show any 
convincing response to either cold shock or a change in pH. 
The response of the 57 kDa band to pH5.5 does not necessarily represent pH 
regulation of this protein.  Rather, as described in Section 1.5.3, cells are reported to 
initiate differentiation to procyclic forms at pH5.5 (Rolin et al. (1998)).  Hence the 
apparent regulation at pH5.5 probably represents cell differentiation and concomitant 
elevated PAD2 expression seen in procyclic forms.  Nonetheless, it is clear that 
under all conditions, cold shock induces significant upregulation of the 57 kDa band, 
corresponding to PAD2. 
 
5 – Expression and Localisation of PAD Proteins 202 
Figure 5.15-3  The affect of pH and cold shock upon PAD array protein expression. 
Stumpy form trypanosomes were harvested from mice and subjected to cold shock or 
37°C in media of pH ranging from pH 5.5 to pH 9.  (A) A Western analysis of cell lysate 
prepared after 24 hours of incubation at 20°C or 37°C using the α-array #2 antibody.  
Tubulin was included as a loading control.  (B)  The level of PAD array protein expression 
relative to tubulin was assayed using the LI-COR Odyssey infrared quantitation system.  
Consistent with earlier data, the 55 kDa band corresponding to PAD1 is not clearly 
upregulated in response to pH or cold shock.  The 57 kDa band corresponding to PAD2 
however, appears to show a strong (45 fold) upregulation in response to cold shock 
(consistent with previous data) at pH7.5, and a 3 to 7 fold increase in response to mild 
acid at 37°C. 
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5.16 The affect of cold shock upon PAD2 expression 
Cold shock of stumpy form parasites causes a reproducible upregulation of the 57 
kDa band detected using the α-array antibodies of between 3 to 45 fold (see Section 
5.15).  This band was shown to correspond to PAD2 (see Section 5.6.3).  In order to 
verify whether PAD2 protein is indeed upregulated in response to cold shock, as 
previously described (see Section 5.14) stumpy form cells derived from three stocks 
were harvested from late stage mouse parasitaemias by DEAE cellulose anion 
exchange and subjected to either 37°C or 20°C (cold shock) overnight in HMI9 
media.  Cell lysate protein was prepared and analysed by Western blot for PAD2 
expression using the α-PAD2 antibody. 
Figure 5.16-1 shows that there was a clear and reproducible upregulation of the 
PAD2 band in response to cold shock in all 3 of the protein cell lysates analysed.  
Up-regulation was between 2 to 6 fold in the cold shocked samples, which is 
approximately what has been detected using the α-array antibodies for the 57 kDa 
band.  Only the Western data for α-PAD2 #2 is shown, but α-PAD2 #1 shared a 
similar profile. 
Thus, of the PAD family proteins, only PAD2 has been shown to display a 
reproducible upregulation in response to cold shock conditions.  It would appear 
likely that PAD2 is responsible for the upregulation of the 57 kDa band detected by 
the α-array antibodies, although it cannot be completely excluded that another PAD 
protein or proteins also contribute to this signal. 
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Figure 5.16-1  The affect of cold shock upon the expression of PAD2 protein.  (A)  
AnTat 90.13, AnTat 1.1 and EATRO stumpy form parasites were harvested from a mouse 
parasitaemia and incubated at either 37°C or 20°C overnight in HMI9 media.  Protein 
sample was prepared and analysed by SDS-PAGE and Western blot using the α-PAD2 
antibodies and the LI-COR odyssey system.  A tubulin loading control was included.  (B) 
Analysis of the signal relative to tubulin using the LI-COR Odyssey system showed that 
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5.17 The affect of cold shock upon the localisation of PAD2 in stumpy 
form cells 
Engstler et al. (2004) report stumpy form hypersensitivity in response to a 
temperature shift to 20°C.  They further speculate that this could be due to a stumpy 
form specific protein that is only routed to the cell surface under cold shock 
conditions; at 37°C a cell surface trafficking checkpoint control mechanism prevents 
cell surface membrane localisation.  The PAD2 protein upregulation detected by 
Western blot is relatively mild, and may not be sufficient to account for the dramatic 
increase in the sensitivity to cis-aconitate that has been reported.  However, if PAD2 
protein responds to cold shock in the way that the authors predict, then this would 
provide further evidence that PAD2 has a role in the reported hypersensitivity to cis-
aconitate.  To this end, experiments were designed to determine the effect, if any, of 
cold shock upon PAD2 localisation. 
5.17.1 PAD2 localisation in stumpy forms at 37°C 
Stumpy form cells were harvested from a late stage mouse parasitaemia and purified 
by DEAE cellulose anion exchange (see Materials and Methods for details), and 
recovered in HMI9 media.  After 1 hour, half the culture was incubated at 37°C, and 
the remainder was incubated at 20°C, for 18 hours.  Cells were subsequently 
analysed for PAD2 localisation by immunofluorescence microscopy using the PAD2 
specific antibodies (see Materials and Methods).  Images were captured using a 
confocal microscope, whereby the same settings were used to capture the ‘secondary 
only’ controls as were used when both primary and secondary antibodies were used. 
Figure 5.17-1B shows only very faint, background signal when only the secondary 
antibody was used for staining.  However, Figure 5.17-1A shows that when the α-
PAD2 antibody is used as a primary antibody, the majority of cells (>80%) show a 
distinctive ‘speckled’ staining pattern.  This staining pattern was not consistent with 
cell surface localisation as was shown for PAD1, and may reflect localisaion to 
internal vesicles.  Note that a small proportion of cells (2 – 10%) exhibited the 
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classic cell surface pattern (see Figure 5.17-1A), with a staining around the periphery 
of the cell, suggesting that PAD2 is localised to cell surface in some stumpy form 
cells.  This was repeated a number of times with similar results. 
The staining pattern of PAD2 in stumpy forms incubated at 37°C suggests that rather 
than being exported onto the cell surface membrane, the majority of PAD2 is 
synthesised but remains within the endosomal system of the cell.  Alternatively, it is 
possible that these speckles are cell surface bound, and that the staining pattern is due 
to cholesterol dependent microdomains, as been observed with some other membrane 
bound proteins (Prior et al. (2003)). 
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Figure 5.17-1  PAD2 localisation in stumpy forms at 37°C.  (A)  Stumpy form 
trypanosomes were stained with α-PAD2 and counter-stained with a FITC conjugated 
secondary antibody.  Note that the image in (ii) shows peripheral staining, whereas the 
remaining cells demonstrated speckled staining.  (B)  Stumpy cells stained with the 
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5.17.2 PAD2 localisation in stumpy forms at 20°C 
To determine whether the cold shock induced upregulation of PAD2 effects PAD2 
localisation, cold shocked stumpy form cells were stained with α-PAD2 and a FITC 
conjugated secondary antibody and analysed by confocal microscopy. 
Figure 5.17-2A shows that there was a strong and consistent localisation of PAD2 to 
the cell surface membrane in cold shocked stumpy form cells.  More than 90% of 
cells showed this pattern, with a small minority of cells displaying some speckles in 
addition to the cell surface pattern. Figure 5.17-2B shows that only a weak and 
diffuse signal is detected when the secondary only antibody is used with settings at 
maximum sensitivity. 
Thus, it would appear that cold shock induces a change in localisation, in addition to 
an upregulation, of PAD2 protein.  This type of system is not without precedent.  As 
discussed (see Section 1.7.4.1 and Chapter 7), aquaporin is induced to re-localise 
from intracellular storage vesicles to the apical membrane of kidney epithelial cells 
in response to a signal cascade resulting from vasopressin binding (Kamsteeg et al. 
(2007)).  This allows the expression of the transporter to the membrane with much 
faster kinetics than would be possible from upregulation of protein expression alone.  
The parallel with cold shock and hypersensitivity to cis-aconitate is clear.  One might 
speculate that the trypanosome has evolved a rapid response mechanism, such that 
PAD2 is held within intracellular vesicles until cells are cold shocked, whereupon 
they release PAD2 onto the cell surface membrane and become hypersensitive to cis-
aconitate. 
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A
B
Figure 5.17-2  PAD2 localisation in cold shocked stumpy form cells.  (A) Stumpy 
cells maintained at 20°C for 6 hours were analysed for PAD2 localisation by α-PAD2 
immunofluorescence.  PAD2 appears to localise to the cell surface membrane in cold 
shocked stumpy form cells.  (B)  Cold shocked cells were stained with only the FITC 
conjugated secondary antibody as a negative control.  Only a weak, diffuse staining was 
detected. 
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5.18 Localisation of PAD2 in procyclic form cells 
As discussed, PAD2 is predominantly expressed in procyclic form cells.  To 
determine the localisation of PAD2 in this form, paraformaldehyde fixed cultured 
procyclic cells were stained with the α-PAD2 antibody and a FITC conjugated 
secondary antibody. 
Figure 5.18-1A shows that PAD2 was localised to the cell surface membrane; 
staining was seen around the periphery of the cell, consistent with cell surface 
staining.  Three representative cells are shown, and procyclic form cells universally 
exhibit this pattern, with no evidence of speckling or intracellular-like staining. 
Figure 5.18-1B shows a negative control cell that was stained with the secondary 
antibody only; a very weak pattern was detected that did not account for the signal 
obtained when the primary antibody was included.  Thus it would appear that 
procyclic cells also express PAD2 at the cell surface membrane. 
Thus, PAD2 appears to be localised to intracellular vesicles at 37°C.  Upon cold 
shock, PAD2 appears to be re-localised to the cell surface membrane, where it stays 
as the cells differentiate to the procyclic form.  It would be interesting to determine 
the expression and localisation of PAD2, and the other PAD proteins, in mesocyclic, 
epimastigote and metacyclic forms. 
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Figure 5.18-1  PAD2 in procyclic form cells.  (A) Procyclic form cells were analysed for 
PAD2 localisation by staining fixed cells with the α-PAD2 antibody and a FITC conjugated 
secondary antibody.  The cells universally expressed PAD2 on the cell surface 
membrane.  (B)  A secondary antibody only negative control is shown.  The signal shown 
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5.19 Conclusion 
In summary, the PAD proteins are differentially expressed in different lifecycle 
stages, and in response to different environmental conditions.  Additionally, 
conditions reported to induce hypersensitivity to cis-aconitate, cause increased 
expression and re-localisation of one member of this family. 
The data presented here support the hypothesis that the PAD proteins promote 
differentiation by transporting citrate/ cis-aconitate into the cell.  A functional 
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6 An analysis of PAD family function 
The most common route to determine the function of a newly identified protein is to 
perturb the level of its expression and assay for a phenotypic effect.  In the case of 
the PAD family there were some inherent technical difficulties associated with this 
strategy.  PAD proteins were shown not to be expressed in monomorphic slender 
cells (see Sections 5.4, 5.5 and 5.6), thus the conventional approach of RNAi and 
generating null mutants in this cell type were unlikely to yield a phenotype.  
However, many groups have encountered insurmountable difficulties in performing 
reverse genetic studies in stumpy form cells; pleomorphic cells are extremely 
difficult to culture, and are thus resistant to transgenic studies.  In consequence, a 
significant amount of work was invested in genetically manipulating monomorphic 
cells to determine whether any differentiation phenotype was observed after PAD 
expression was perturbed.  This was justified since the PAD genes were originally 
identified as being upregulated in a monomorphic cell line that is unresponsive to 
cis-aconitate.  Hence, it was clear that there may be an association between PAD 
gene expression and differentiation, even in monomorphic cells. 
6.1 The effect of ectopic expression of PAD1 upon differentiation 
Ectopic expression of PAD1 was previously shown not to affect the differentiation of 
monomorphic slender cells in response to 6 mM cis-aconitate (see Section 4.5).  
However, the high extracellular concentrations of cis-aconitate used in these 
experiments meant that entry of cis-aconitate into the cell may not have been the 
limiting factor in stimulating differentiation .  Also, the earlier experiment made use 
of a cell line that was ectopically expressing a Ty epitope tagged form of PAD1.  
This may have interfered with the protein’s function or substrate interaction. 
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6.1.1 The effect of expression of an ectopic copy of PAD1 upon the sensitivity 
to cis-aconitate at 20°C and 37°C 
Ectopic expression of PAD1 did not cause an increase in the number of 
trypanosomes that are able to respond to 6 mM cis-aconitate, thus differentiation 
capacity remained the same (see Section 4.5).  However, it may be that cells 
expressing high levels of PAD1 on the cell surface membrane have increased 
efficiency of cis-aconitate transport, and are therefore able differentiate at lower 
concentrations of cis-aconitate.  Also, Engstler et al. (Engstler et al. (2004)) showed 
that, when stumpy form cells are subjected to cold shock conditions of 20°C, they 
become hypersensitive to cis-aconitate, being able to respond to a 500 fold lower 
concentration of cis-aconitate.  This effect is specific to stumpy form cells and was 
not exhibited in true slender cells, or monomorphic slender cells (Samuel Dean, 
unpublished observations).  However, as a stumpy form specific protein, it may be 
that PAD1 expression is the determinant that enables stumpy form cells to become 
hypersensitive to cis-aconitate in response to cold shock. 
Two possibilities were investigated in the experiment described below: (i)  that 
upregulation of PAD1 is necessary and sufficient for the cold shock effect; thus by 
upregulating PAD1 we would predict that the trypanosomes would exhibit increased 
sensitivity to cis-aconitate at 37°C, and (ii) that upregulation of PAD1 is necessary, 
but not sufficient, for hypersensitivity to cis-aconitate; thus upregulation of PAD1 
causes increased sensitivity to cis-aconitate at 20°C, but not at 37°C.  The second 
hypothesis relies on a cold shock inducible factor being expressed in monomorphic 
cells, which may or may not be the case. 
In order to investigate these possibilities, a cell line was generated using the 
expression vector pHD617 that had been modified to contain a puromycin resistance 
cassette in place of a hygromycin cassette (see Materials and Methods for details, 
and Appendix A for a plasmid map).  The expression vector pHD617 is optimised for 
expression in blood form trypanosomes and was expected to give higher expression 
than pHD451 (Biebinger et al. (1997)).  The cell line was engineered such that PAD1 
could be inducibly expressed from the ribosomal spacer region of the genome when 
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the cells were cultured in the presence of tetracycline.  These cells were cultured with 
and without tetracycline to induce expression of PAD1; parental trypanosomes 
containing only pHD449 were treated equivalently as a negative control.  After 5 
days of induction at 37°C, half of each of the four cultures was incubated overnight 
at 20°C so that the following conditions existed for both the PAD1-expressing cell 
line, and the parental control: 
• + tetracycline: 37°C 
• - tetracycline: 37°C 
• + tetracycline: 20°C 
• - tetracycline: 20°C 
After the overnight incubation, each of the 8 cultures was induced to differentiate 
using different concentrations of cis-aconitate: 6 mM, 1 mM, 10 µM and no cis-
aconitate. The 32 cultures were incubated at 27°C and samples were taken at 0, 24, 
48 and 72 hours for FACS analysis to assay their progression through differentiation.  
Additionally, cell lysates were prepared prior to the addition of cis-aconitate for 
Western analysis to determine the relative levels of PAD1 expression. 
Figure 6.1-1A shows that cells induced to express PAD1 respond slightly better than 
non-induced cells to 1 mM cis-aconitate at 37°C after 24 hours (22% procyclin 
positive, versus 11% respectively), but this was not observed at later time-points or at 
10 µM cis-aconitate and was probably experimental variation unrelated to PAD1 
expression.  The cell line containing the ectopic copy of PAD1 differentiated at 
slightly higher efficiency than the untransfected cell line when exposed to 6 mM cis-
aconitate at 37°C irrespective of the presence of tetracycline (82% differentiation 
after 48 hours, compared with approximately 62% for the untransfected), but this 
was not inducible and was also probably unrelated to the expression of PAD1. 
When these cells were subjected to cold shock prior to addition of cis-aconitate, the 
cell lines transfected with ectopic PAD1 appeared to be inhibited in their ability to 
differentiate in response to 6 mM cis-aconitate when compared with the 427 control 
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(approximately 30% of cells have differentiated compared with the untransfected cell 
line).  However, there was no inducible effect related to PAD1 expression and so the 
differences between the cell lines were probably unrelated to expression of the trans-
gene.  Moreover, neither of the cell lines were able to differentiate in response to less 
than 6 mM cis-aconitate, indicating that PAD1 expression did not confer enhanced 
sensitivity to cis-aconitate. 
A Western blot using the α-PAD1 antibody was performed on protein samples to 
determine PAD1 expression prior to the addition of cis-aconitate.  No PAD1 
expression was detected in any of the monomorphic cell lysates from cells 
maintained at 37°C.  This is despite the earlier inducible expression of PAD1-Ty (see 
Section 4.5).  This may be due to a less efficient expression of PAD1 in this 
construct (despite its optimisation for blood form expression), or could be due to the 
α-PAD1 antibody being less sensitive than the BB2 antibody.  Interestingly, PAD1 is 
detectable at low levels in the cold shocked cells.  Expression is leaky, but analysis 
of PAD1 signal using the LI-COR Odyssey system shows that addition of 
tetracycline causes 3 fold increased expression.  However, expression is far lower 
than in stumpy forms, whereby PAD1 is 10 fold more highly expressed than even the 
induced cells. 
The detection of PAD1 in only the cold shocked cells may be due to an accumulation 
of protein unrelated to a specific biological mechanism.  The vector pHD617 utilises 
the aldolase 3’ UTR  to confer mRNA stability, and has not been reported to show 
any effect of cold shock.  It is possible that the upregulation is mediated at the post-
translational level, possibly through molecular chaperones conferring enhanced 
folding and therefore translation.  However, the most likely explanation for this 
effect is probably that cell division was greatly inhibited at 20°C (data not shown), 
thus expressed protein was not diluted as quickly through cell division. 
Nonetheless, no convincing effect of PAD1 ectopic expression was observed upon 
differentiation efficiency at 37°C or 20°C. 
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Figure 6.1-1  The effect of ectopic expression of PAD1 in combination with cold 
shock upon the sensitivity to cis-aconitate. (A) Monomorphic cells were assayed for 
their sensitivity to cis-aconitate using ectopic expression of PAD1 and cold shock as 
variables.  Differentiation was assayed by flow cytometry analysis of EP expression over 
72 hours.  (B) PAD1 protein expression was compared with stumpy form cells by Western 
blot using the α-PAD1 antibody.  PAD1 was not detected in monomorphic cells at 37°C in 
any of the conditions.  When cold shocked, expression was detected in the PAD1:617 cell 
line, and shown to be 3 fold upregulated in induced cells, but nonetheless 10 fold lower 
than was detected in stumpy form cells. ± refers to tetracycline induction, St = stumpy 
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6.1.2 The affect of incubating cells with different concentrations of cis-
aconitate during cold shock and ectopic expression of PAD1 
Hitherto, the detection of cis-aconitate has been limited to observations of 
differentiation after cells have been subjected to cold shock (as described by Engstler 
et al.(2004)).  However, in this context it was possible that incubating the 
trypanosomes with different concentrations of cis-aconitate during cold shock would 
be more revealing.  It may be that the cold shock effect is rapidly reversible and as 
such hypersensitivity would not be observed by subsequent incubation at 27°C. 
To investigate this possibility, cells ectopically expressing PAD1 were incubated 
with different concentrations of cis-aconitate at 27°C and under cold shock 
conditions; non-induced cells and cells that did not have the ectopic expression 
cassette were included as experimental controls (see Figure 6.1-2A).  The level of 
differentiation was measured after 24 hours by assaying for the expression of EP 
procyclin using flow cytometry (see Materials and Methods). 
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Figure 6.1-2  The effect of incubating cis-aconitate with cells ectopically expressing 
PAD1 during cold shock.  (A) Parental cells and PAD1:pHD617 cells were incubated 
with, or without, tetracycline for 5 days prior to the addition, or not, of different 
concentrations of cis-aconitate at either 37°C or 20°C.  (B)  Differentiation was assayed 
by flow cytometry analysis of EP procyclin expression after approximately 24 hours.  
There was a mild, inducible, increase in differentiation capacity at 6 mM, and a non-
inducible increase in differentiation capacity at 1 mM cis-aconitate. A reduced capacity for 
differentiation was observed at 37°C.  Interestingly, cells responded better to cis-
aconitate at 20°C irrespective of PAD1 induction. 
Parental (427) and cells inducibly expressing
ectopic PAD1 protein (PAD1:617)
5 days, 37 °C
(protein samples collected)
5 days, 37 °C
(protein samples collected)
After 24 hours incubation with 6mM, 1mM, 10 µM and 0mM  cis -aconitate, the extent of
differentiation was determined by assaying for EP procyclin expression using flow
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Figure 6.1-2B shows that, in cells pre-incubated at 37°C, parental Lister 427 cells 
appear to differentiate better in response to 6 mM cis-aconitate than cells undergoing 
the ectopic expression of PAD1.  However, this effect was not inducible and so may 
be unrelated to PAD1 expression.  Similarly, no enhanced sensitivity to cis-aconitate 
was observed for the PAD expressing line and only background levels of EP 
expression were detected at 1 mM, 10 µM and in the absence of cis-aconitate. 
Differentiation was more efficient at 20°C than 37°C for both of the cell lines.  
Surprisingly, both the parental cell line and the cell line containing the ectopic copy 
of PAD1 respond to cis-aconitate at 1 mM well above background levels - this effect 
was not observed when cis-aconitate was added after cold shock (see Figure 6.1-1).  
Additionally, the cell line containing the ectopic PAD1 has higher differentiation 
capacity than control cells at 6 mM and 1 mM; however, at 1 mM, where any effect 
of PAD1 expression upon the sensitivity to cis-aconitate should have been most 
noticeable, this effect was not inducible and was probably unrelated to PAD1 
expression.  Moreover, no increase in differentiation was observed at 10 µM, 
showing that these cells did not become hypersensitive to the low concentrations of 
cis-aconitate reported by Engstler et al. (2004). 
Note that this experiment was performed alongside that described in 6.1.1, and that 
expression of PAD1 was not detected in the cell lines maintained at 37°C  (see 
Figure 6.1-1B, 37°C, - and + PAD1), but was detected in those that were 
equivalently cold shocked. 
Thus we can conclude that, although monomorphic cells may respond to  cis-
aconitate more efficiently under cold shock conditions, hypersensitivity to cis-
aconitate was limited to stumpy form cells and that increased expression of PAD1 
has not conferred this stumpy form characteristic.  Nonetheless, in this experiment, 
PAD1 expression combined with cold shock may have stimulated a mild, enhanced 
sensitivity to cis-aconitate at 1 mM and 6 mM.  It would be interesting to repeat this 
experiment with ectopic expression of PAD2; however, the upregulation of PAD2 in 
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response to cold shock was shown relatively late in this study, and time constraints 
prevented a repeat of this analysis. 
6.2 Using RNA interference to ablate PAD1 in monomorphic slender 
cells 
RNAi in Trypanosoma brucei was originally discovered by accident when 
trypanosomes were transfected with a construct capable of forming a hairpin loop 
with tubulin RNA (Ngo et al. (1998)).  Since then, the technology has matured and 
inducible, heritable RNA interference of essential genes is possible (Shi et al. 
(2000)) (LaCount et al. (2000)) (Wang et al. (2000)) (DaRocha et al.(2004)).  Two 
types of RNAi construct are in use.  The first contain opposing promoters whereby a 
nucleotide sequence homologous to the target mRNA transcript is cloned between 
the two opposing promoters such that, when both promoters initiate transcription, 
double stranded RNA will be synthesised.  The second type are stem loop vectors, 
whereby two duplicate homologous sequences are cloned either side of a non-
specific spacer sequence downstream of a promoter such that they are inverted. 
When transcription is initiated at the promoter, a stem-loop structure is synthesised 
whereby the stem is double stranded RNA specific to the target mRNA transcript.  
Several variants of these constructs are in use, whereby the type of promoter (i.e. 
procyclin, ribosomal RNA, VSG and T7) and the site of genomic integration 
(commonly the ribosomal spacer or the minichromosome) have been modified.  
Additionally, the promoter driving transcription usually contains a tetracycline 
repressor protein (TetR) binding sequence (tetracycline operator) such that when the 
TetR is expressed, expression of double stranded RNA is only possible in the 
presence of tetracycline. 
6.2.1 Generating the RNAi construct 
The stem loop RNAi construct has been noted to cause more efficient knock down of 
target transcripts as well as having tighter regulation (Professor James Bangs, 
University of Wisconsin, personal communication).  Due to the homologous nature 
of the PAD array, there were very tight restrictions on which regions of PAD1 could 
be used as a target.  The theoretical minimal requirement for the RNAi process to 
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work is predicted to be 21 nucleotides (Zamore et al. (2000)) (Elbashir et al. (2001)); 
indeed, synthetic 21 nucleotide dsRNA  corresponding to the size of small interfering 
RNA (siRNA) has been shown to ablate a target transcript (Elbashir et al. (2001)).  
However, the minimal size of target sequence homology within an RNAi stem loop 
vector for efficient gene ablation to occur has not been experimentally determined. 
Nonetheless, a 76 base-pair nucleotide sequence was amplified from trypanosome 
genomic DNA by the polymerase chain reaction.  The forward primer (primer #108) 
contained HindIII and BclI (5’ – 3’) restriction enzyme recognition sites at the 5’ 
end, and the reverse primer (primer #109) contained XhoI and NdeI sites.  The 
amplicon was purified and digested in two different restriction digest reactions: (1) 
XhoI and BclI, and (2) HindIII and XbaI, and re-purified.  Number 1 insert was 
ligated with XhoI and BamHI digested pALC14 and used to transform XL1Blue 
cells; colonies were screened by restriction digest with BamHI and XhoI (plasmids 
containing insert number 1 did not release an insert because the BamHI recognition 
site was destroyed).  A positive colony was cultured and a small scale preparation of 
DNA was made for subsequent HindIII and XbaI restriction digestion and ligation 
with digested insert number 2.  After transformation of XL1Blue cells, resulting 
colonies were screened for the presence of both inserts in inverse orientation by the 
polymerase chain reaction with the forward primer only. 
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Figure 6.2-1  Making the PAD1:pALC14 RNAi DNA construct. (A)  Primers #108 and 
109 were used to generate a 76 nucleotide amplicon (5’  3’ directionality is indicated by 
the arrow). The amplicon was digested with either XhoI and BclI, or HindIII and XbaI, and 
cloned into either XhoI and BamHI, or HindIII and XbaI digested pALC14 respectively. (B)  
A schematic of the relevant regions of PAD1:pALC14 plasmid to knock down PAD1 is 
shown.  Note that the plasmid BamHI and the amplicon BclI sites were destroyed upon 
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6.2.2 The effect of inducing RNAi upon PAD1 
The monomorphic S16 SMB cell line (Wirtz et al. (1998)) expressing T7 polymerase 
and the tetracycline repressor was transfected with the PAD1 RNAi plasmid 
PAD1:pALC14.  Cells were induced, or not, to knock down PAD1 mRNA with 
tetracycline for 4 days and subsequently exposed to cis-aconitate and a drop in 
temperature to 27°C.  Induced and non-induced untransfected S16 cells were 
included as negative controls.  RNA and protein samples were made prior to cis-
aconitate treatment to determine the extent of knock-down of PAD1. 
Figure 6.2-2A shows that there did not appear to be detectable RNA ablation in 
response to tetracycline in the PAD1:pALC14 cell line.  Although the RNA was 
slightly degraded, there was a band corresponding to PAD1 in cells incubated with or 
without tetracycline.  As expected, the PAD1 transcript was present in far higher 
levels in the stumpy form positive control.  An overexposure is shown because the 
PAD1 transcript is present at very low levels in monomorphic cells. 
It appears that RNAi on PAD1 was unsuccessful in this experiment.  The reasons for 
this are unclear; it may be that knockdown of PAD1 was lethal such that generating a 
cell line containing PAD1:pALC14 selects for cells that are unable to execute RNAi.  
However, given that PAD1 mRNA is present in very low levels, and that PAD1 
protein is undetectable in monomorphic slender cells, this is unlikely.  It is more 
likely that 76 base-pairs of nucleotide sequence was insufficient to generate effective 
RNA ablation. 
Although there was no clear evidence of PAD1 mRNA ablation, differentiation 
capacity was assayed at 0, 24, 48 and 72 hours post cis-aconitate treatment by FACS 
analysis of EP procyclin expression in PAD1 RNAi and parental cell lines with and 
without incubation with tetracycline (see Figure 6.2-2B).  As expected, no 
differentiation phenotype was observed in response to tetracycline. 
6 - An Analysis of PAD Family Function 226 
Figure 6.2-2   The effect of targeting PAD1 by RNAi for differentiation in 
monomorphic cells. (A) A Northern blot to determine if PAD1 mRNA ablation was 
successful.  No ablation of the low level PAD1 transcript was detected. The blot was 
overexposed to allow visualization of the of the low level PAD1 mRNA in monomorphic 
S16, SMB cells.  (B)   The effect of PAD1 RNAi induction upon the capacity of 
monomorphic slender cells to respond to 6 mM cis-aconitate at 27°C.  No effect upon 
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6.3 Using RNA interference to ablate the PAD array 
Discounting technical issues, there are some potential biological caveats associated 
with phenotypic analysis of PAD1 mRNA ablation.  PAD1 shares its RNA 
expression profile with PAD5 and PAD7 and there is a strong likelihood of 
functional overlap between the PAD proteins due to their high degree of homology.  
Thus, ablation of one member in the PAD array may be compensated for by the 
presence of other PAD proteins resulting in no observable phenotype.  For this 
reason it was of interest to ablate every member of the PAD array at once.  The high 
degree of homology allows all eight genes in the PAD array to be ablated when the 
entire coding sequence of PAD1 was expressed as double stranded DNA.  Moreover, 
this was predicted to overcome possible issues of insufficient length of double 
stranded RNA that may have been associated with the PAD1 RNAi (see 6.2).  
6.3.1 Generating the RNAi construct 
The entire PAD1 coding region (approximately 1800 base-pairs) was amplified from 
trypanosome genomic DNA by the polymerase chain reaction using a forward primer 
(primer #106) containing HindIII and BclI (5’ – 3’) restriction enzyme recognition 
sites at the 5’ end, and a reverse primer (primer #109) containing XhoI and NdeI 
sites.  Cloning followed the same strategy as cloning PAD1:pALC14 (see Figure 
6.2-1) except for the screening steps:  successful insertion of the first insert was 
screened by restriction enzyme digestion with BamHI and HindIII, this releasing a 
346 base-pair fragment due to the internal BamHI site, whereas BamHI digestion of 
the final construct released a 1.1 Kb fragment. The resulting plasmid was named 
“array:pALC14”.  All primer sequences are listed in Appendix A. 
6.3.2 The affect of inducing RNAi upon PAD protein and RNA 
Monomorphic slender S16 SMB cells were transfected with array:pALC14.  The 
resulting cell line was cultured in HMI9 media in the presence, or absence, of 
tetracycline for 5 days prior to preparation of protein and RNA (see Materials and 
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Methods for details).  The parental S16 SMB cells with and without tetracycline 
were included as controls. 
A Northern analysis was performed on the RNA using a DIG labelled riboprobe 
designed to detect every member of the PAD array.  The RNA appeared to have 
degraded somewhat, probably due to RNase mediated deterioration, but there was a 
clear reduction of signal detection in the cell line transfected with array:pALC14 
when incubated with tetracycline (see Figure 6.3-1A) in comparison with those with 
no tetracycline, and the S16 SMB parental cell line. This indicated that the RNAi 
was likely successful. 
A Western analysis was not thought to be necessary as previous Western blots using 
both the α-PAD1, α-PAD2 and the α-PAD-array antibodies did not detect any PAD 
family protein expression in monomorphic slender cells (see Sections 5.4, 5.5 and 
5.6). 
6.3.3 The affect of inducing RNAi upon capacity for differentiation 
Subsequent to tetracycline induction, the four cultures were induced to differentiate 
by supplementing HMI9 media with 6 mM cis-aconitate and a reduction in 
temperature from 37°C to 27°C.  Flow cytometry samples prepared at 0, 24, 48 and 
72 hours post cis-aconitate addition for analysis of differentiation by EP procyclin 
expression (see Materials and Methods for details). 
Figure 6.3-1B shows that no difference was detected in differentiation capacity 
between the different cell lines, irrespective of the presence of tetracycline.  Thus it 
appears that ablation of PAD transcript did not affect the capacity of cells to 
differentiate.  If any of the PAD genes have a role in differentiation in monomorphic 
slender cells it would appear that they are able to exert their effect at very low levels 
of protein.  However, given the lack of detectable PAD family protein expression in 
monomorphic slender cells, and the lack a differentiation phenotype in response to 
RNAi mediated ablation of the PAD family transcripts, it appears likely that 
monomorphic slender cells do not respond to cis-aconitate through a PAD protein 
mediated mechanism.
6 - An Analysis of PAD Family Function 229 
Figure 6.3-1  The effect of ablating the mRNA transcripts of the entire PAD array.  
Cell lines were generated that would ablate all of the PAD mRNA transcripts upon 
induction with tetracycline and the affect upon differentiation was assayed.  (A) A 
Northern analysis to determine if PAD1 mRNA ablation was successful.  Note that the 
mRNA is partially degraded, and that the blot was overexposed in order to detect the low 
level PAD family transcripts clearly.  (B)  The differentiation capacity of RNAi and parental 
cell lines was assayed in the presence and in the absence of tetracycline over a 72 hour 
timecourse.  There did not appear to be any differentiation phenotype in response to 
RNAi induction, and the RNAi cell line differentiated with similar kinetics to the 
untransfected parental cell line. 
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6.4 Generating transgenic knockout cell lines without the PAD1 gene 
RNAi ablation of PAD1 was unsuccessful, and RNAi ablation of the array transcripts 
was not complete.  Therefore, a gene knockout strategy was undertaken. 
The most desirable cell line in which to perform this knock out is a pleomorphic cell 
line capable of forming all stages of the trypanosome lifecycle.  PAD1 is highly 
expressed in the stumpy form, thus it is logical to determine the affect upon 
differentiation of removing PAD1 in stumpy form cells.  However, pleomorphic cells 
are notoriously difficult to culture and although initial attempts were successful, 
sustained culturing failed.  For these reasons the knockout was attempted in 
monomorphic cells.  This is far from ideal; monomorphic cells are a laboratory 
artefact that does not differentiate synchronously, as is the case with stumpy form 
cells.  Moreover, as shown earlier, PAD protein was undetectable when 
monomorphic cells were analysed using either the α-PAD1 antibodies or the α-array 
antibodies, and no upregulation was detected in response to cis-aconitate or at any 
point through differentiation.  This raises the possibility that either (A) PAD proteins 
do not play an essential role in the differentiation of monomorphic cells or (B) the 
PAD proteins exert their effect at levels undetectable by Western blot.  If deletion 
mutants exhibited a differentiation phenotype, this would form a strong argument in 
favour of PAD proteins transmitting the signal to differentiate in monomorphic cells. 
6.4.1 Making the constructs to remove PAD1 
Generating knockout cell lines has some technical differences in the design of the 
DNA construct when compared to other types of genetic manipulation.  DNA 
constructs designed to integrate into the genome use regions homologous to the 
target site (for example the ribosomal spacer).  Upon transfection into T. brucei, the 
cellular machinery recognises the homologous, double stranded ends, and aligns the 
ends of the fragment with their target sequence to ‘repair’ the break and integrate the 
construct; the region of homology is therefore duplicated and the DNA construct is 
inserted in the reverse orientation.  A gene knockout, however, is designed such that 
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a linear fragment of DNA is generated that contains a resistance cassette flanked by 
terminal regions of homology to sequences flanking to the gene to be removed.  The 
DNA repair mechanism of the cell aligns the terminal regions of homology, and 
replaces the target gene with resistance cassette.  Transgenic cells can be selected for 





 wild type cells.  T. brucei is a diploid organism meaning that both 
alleles of a gene must be removed and, conventionally, a conditional rescue copy of 
the gene is inserted under the control of an inducible promoter to verify that any 
phenotype observed is due to the removal of the target gene.  Hence, the DNA 
manipulations involved are quite complex. 
The DNA constructs to remove the PAD1 gene were designed using 2 regions of 
homology upstream of the PAD1 gene, and 2 regions downstream such that 2 of the 
sequences were nested within the other two (see Figure 6.4-1A).  Each region of 
homology was designed to be approximately 250 – 300 nucleotides long and was 
designated A, B, F and E (starting from the most upstream region).  Region A and E 
were amplified and cloned into the cloning sites flanking the neomycin and TetR 
cassettes (referred to as AE-neo), and B and F were cloned into restriction sites 
flanking a hygromycin resistance cassette (referred to as BF-hygro).  The resulting 
DNA constructs were verified by PCR and sequencing to confirm that the regions of 
homology were present in the correct orientation (the cloning primers, a schematic of 
the deletion constructs, and the genomic regions targeted by the deletion constructs, 
are shown in Appendix A). 
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Figure 6.4-1  Design of the PAD1 knockout constructs and the differentiation 
capacity of a cell line containing them.  (A)  DNA constructs were designed using 
regions of homology flanking the PAD1 gene.  (B) Cell lines that had been transfected 
with these constructs were assayed for their differentiation capacity.  5 semi-independent 
cell lines all show impaired differentiation analysed by immunofluorescence analysis of 
cell expressing EP procyclin.  This analysis was repeated using cell line 1 and assaying 
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6.4.2 Analysing the transgenic cell lines 
T. brucei strain Lister 427 was transfected with AE-neo and the resulting cell lines 
were pooled prior to being transfected with BF-hygro.  The resulting 5 semi-
independent cell lines were subsequently assayed for a differentiation phenotype by 
culturing at 27°C in the presence of 6 mM cis-aconitate.  Differentiating cells were 
fixed in methanol at 0, 24, 48 and 72 hours post-differentiation, and stained with EP 
procyclin to assay the percentage of cells that had differentiated by UV 
immunofluorescence microscopy (see Materials and Methods for details).  The single 
knockout transgenic cell line showed no differentiation phenotype until 72 hours 
when compared with the parental Lister 427 cell lines; however, all 5 of the semi-
independent double transgenic cell lines showed a strong differentiation phenotype in 
comparison with the parental Lister 427 strain.  ‘KO1’ attains a maximum 
differentiation of approximately 12%, compared with  more than 60% of the parental 
cells.  Subsequent differentiation experiments using flow cytometry to assay EP 
procyclin expression re-capitulated this result (data not shown). 
These data suggest that PAD1 does indeed have a role in differentiation of 
monomorphic slender cells, despite undetectable levels of PAD1 protein.  This might 
lead one to speculate that PAD1 functions under these conditions at very low protein 
concentrations, thus explaining the lack of any differentiation phenotype when RNAi 
mediated ablation is induced.  The differentiation that was observed must therefore 
have been due to entry of cis-aconitate into the cell by other means. 
In order to introduce a rescue copy of PAD1 into the hygromycin and G418 resistant 
KO1 cell line, pHD617(hygro) was modified to replace the hygromycin cassette with 
a puromycin resistance cassette.  Briefly, the 5’ end of the hygromycin open reading 
frame, along with the upstream rRNA promoter and the actin 5’ UTR was removed 
by restriction enzyme digest with XhoI and NdeI.  An amplicon containing the rRNA 
promoter with a 5’ XhoI site and a 3’ NdeI site was then inserted into the agarose 
purified vector backbone to facilitate subsequent insertion of an amplicon containing 
the puromycin cassette; the puromycin cassette was PCR amplified from pHD1034 
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(Quijada et al. (2002)) and inserted into the NdeI and NheI restriction sites of the 
backbone, thus creating pHD617(puro).  This analysis was performed prior to the 
availability of the α-PAD1 antibody, and therefore a Ty epitope tag was incorporated 
into the C terminus of PAD1, to make pHD617(puro):PAD1Ty. 
Figure 6.4-2A shows that the introduction of an ectopically inducible rescue copy of 
PAD1-Ty into cell line KO1 was able to partially rescue the differentiation 
phenotype, but, surprisingly, did not restore full parental differentiation capacity and 
was not inducible.  The lack of inducibility may have been due to leaky expression 
allowing production of low, but functional, levels of PAD1.  However, the lack of 
complete rescue was more difficult to explain, but one explanation was that the 
presence of the Ty epitope tag was interfering with PAD1 function. 
A Western blot was performed using the BB2 antibody to determine whether 
expression of the epitope tagged PAD1 was leaky, thus explaining the partial rescue 
of the phenotype in the absence of tetracycline. Figure 6.4-2B shows that 2 strong 
bands were detected in the rescue cells when they were incubated with tetracycline, 
and 1 much weaker band was detected when no tetracycline was added.  However, 
this weaker band may have been a cross reactive band, as this was also detected in 
the knockout cells that had not been transfected with the epitope tagged gene.  This 
blot was difficult to interpret fully as some of the signal was obscured. 

































Figure 6.4-2  Rescue of PAD1 knockout cell lines.  An epitope tagged rescue copy of 
PAD1 was integrated into the PAD1 knockout cell line in order to rescue the phenotype.  
(A) Rescue of the phenotype was successful, but incomplete and not inducible.  (B)  A 
Western blot using the BB2 anti-Ty antibody shows that there did appear to be an 
inducible band.  However, several unidentified bands were also detected. 
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A cleaner Western blot than Figure 6.4-2B would have been desirable.  However, in 
the process of verifying the PAD1 null mutants, a PCR reaction using genomic DNA 
from the KO1 cell line as template and primers specific to PAD1 showed a strong 
amplicon at the size expected if PAD1 was still present within the genome.  Further 
experiments showed this band in the other null mutant cell lines (see Figure 6.4-3).  
These bands were cloned into pGEM T easy and sequenced to verify that the PCR 
reaction has indeed amplified PAD1 and not another member of the PAD array; 
sequence data confirmed the presence of PAD1.  Subsequent PCR reactions verified 
the presence of the hygromycin and neomycin cassettes, demonstrating that these 
cassettes have indeed integrated into the genome (see Figure 6.4-3). 
Thus it appears that these cell lines retained the PAD1 gene and were therefore, in 
fact, not PAD1 deletion mutants.  The reasons for this are unclear; it may be that the 
repetitive nature of the PAD array intergenic regions has resulted in a mal-integration 
of the DNA constructs, possibly into another area of the array.   
Alignments of the targeting sequences with the PAD array intergenic regions (see 
Appendix A) showed that target sequence (TS) B contains 67 nucleotides of 
sequence from intergenic element I at its 3’ end, which is present in the 5’ UTR of all 
of the PAD genes.  Nonetheless, it was not thought that this would interfere with the 
removal of PAD1 because there are 148 nucleotides upstream of this that are not 
present elsewhere within the array; moreover, the 3’ TS in this construct,  F, is 
entirely specific to PAD1 and does not contain sequence that is repeated elsewhere in 
the PAD array.  Thus, the target construct BF-hygro was predicted to remove PAD1. 
The 5’ region of homology (‘A’) in AE-neo is entirely specific to upstream of PAD1 
and does not contain sequences homologous to other region of the array.  However, 
the TS ‘E’ in this construct contains 25 nucleotides of sequences of intergenic 
element VI, which is present in the PAD5/7 3’ UTRs, thus giving rise to the 
possibility that ‘E’ may target to these regions.  However, in the event of this 
occurrence, we would expect that all of the DNA sequence between PAD1 – 5 or 
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PAD1 – 7 to be removed; this was clearly not the case as PAD1 was shown to still be 
present in these cell lines.  Thus, the construct AE-neo was predicted to work. 
A previous analysis of a 28 kb region of genome (Kramer et al.(2006)) showed that 
there were major differences between homologous regions of genome in different T. 
brucei isolates, especially when these regions contained repetitive elements.  The 
authors show that that a 14.7 kb fragment of DNA containing 4 genes was duplicated 
in an isolate of MITat.1.2 that had undergone serial passage in culture, and speculate 
that the duplication event occurred during unequal crossing over between repetitive 
DNA sequences on homologous chromosomes.  Another study concluded the 
variation in DNA content in chromosome I between the genome reference 927/4 
strain, STIB247 and Lister 427 was concentrated in the sub-telomeres and tandemly 
repeated genes (Callejas et al. (2006)).  Furthermore, the authors report that all 
tandemly repeated gene arrays on chromosome I showed variation in the number of 
duplicated genes between the strains used, and speculate that the amplification and 
reduction in size of these arrays is an ongoing process.  Thus, the evidence shown in 
this paper would lead one to predict that the 427 strain of T. brucei does not contain 
the same number of PAD genes as the genome reference strain.  Furthermore, the 
genome reference database annotation states that the ‘Number of repeated genes in 
array uncertain, region may contain misassembly’.  This may explain the failure to 
remove PAD1 from the genome. 






Figure 6.4-3  A PCR showing that PAD1, hygromycin resistance and neomycin 
resistance genes were still present in the PAD1 'null' mutants.  A PCR reaction was 
preformed on PAD1 ‘null mutant’ genomic DNA.  Bands were obtained using primers 
specific to the hygromycin and neomycin resistance genes, as well as to PAD1.  The 
bands from the PAD1 PCR reaction were subsequently cloned into pGEM T easy for 
sequencing to confirm they were indeed PAD1, and not a related PAD gene. 
6 - An Analysis of PAD Family Function 239 
 
6.5 Generating transgenic  PAD array null mutants 
The homologous nature of the PAD genes makes it likely that there may be some 
overlap in function between the PAD genes.  Thus, removing PAD1 may not show a 
phenotype due to rescue by other PAD members.  For this reason it was decided to 
attempt to remove all 8 genes from the genome.  This involved the replacement of 
approximately 27 kb of genomic DNA with a resistance cassette, making this the 
largest attempted knockout in a trypanosomatid.  It may be that removing a segment 
of this size is not feasible by homologous recombination, so to maximise the chances 
of success, transfection efficiency was increased using the Amaxa nucleofector 
machine and buffers.  The AMAXA protocol was reported to increase stable 
transfection efficiency by a factor of approximately 1000 fold (Burkard et al. (2007)) 
and has been used frequently with high success rates. 
6.5.1 Generation of PAD array deletion constructs 
The previously described constructs AE-neo and BF-hygro (see Section 6.4.1) were 
modified to replace the PAD1 3’ target sequences E and F with regions downstream 
of PAD8 (designated ‘C’ and ‘D’, where D is upstream of C), such that two 
constructs were made that were made designed to remove the entire array (‘AC-neo’ 
and ‘BD-hygro’).  The BF-hygro target sequences were nested within the AC-neo 
target sequences, such that transfection of a cell line where 1 copy of the array has 
been removed by AC-neo with BF-hygro will remove the other copy of the array.  
Attempts to obtain transfectants with these constructs were unsuccessful, however, 
possibly due to the size of the region of genomic DNA to be replaced. 
It was decided to make DNA constructs with larger regions of homology in order to 
increase the chances of success.  A region of approximately 2.8 kb upstream of 
PAD1 (designated ‘G’) was cloned in place of A, and a region 1.6 kb downstream of 
PAD8 (designated ‘H’) was cloned in place of E in the AE-neo DNA construct, thus 
generating a construct (designated GH-neo) with very large regions of homology to 
the regions flanking the PAD array.  Due to the large nature of these regions of 
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homology, a nested knockout was not possible.  Therefore, the construct designed for 
the second round transfection was identical to GH-neo except that the neomycin 
resistance cassette was replaced with a hygromycin resistance cassette, thus 
generating ‘GH-hygro’.  Schematics of the deletion constructs are shown in 
Appendix A. 
Lister 427 cells were transfected with GH-neo using the Amaxa nucleofection 
protocol (see Materials and Methods).  Resulting cell lines were pooled and re-
transfected with the GH-hygro cassette. 
6.5.2 Analysing the transgenic cell lines 
Given the failiure to generate PAD1 deletion mutants, it was a priority to verify the 
presence of the PAD genes in cells transfected with GH-neo and GH-hygro.  
Genomic DNA from the cell line containing GH-neo and GH-hygro was used as 
template in a PCR reaction to determine the presence of PAD genes.  The primers 
used in the reaction were designed to bind to any of the PAD genes and generate a 
400  nucleotide amplicon if PAD genes were still present within the genome.  A band 
corresponding to the expected size of a PAD specific amplicon was generated by this 
PCR reaction; cloning and sequencing determined that this band was in fact PAD 
specific, thus the cell lines still retain PAD genes and are therefore not PAD array 
knockout cell lines (data not shown).  Differentiation assays were not performed as 
the data would have been impossible to interpret. 
It was suspected that there was a common reason for the failure to remove both 
PAD1, and the PAD array from the genome.  It may be that 1 or more of the PAD 
genes is essential in monomorphic slender cells; however, this would appear unlikely 
as PAD-array RNAi cell lines did not show a growth phenotype (data not shown), 
and PAD protein was not detected in these cells.  As discussed (see Section 6.4.2), it 
appears likely that this was associated with possible differences between the genome 
reference strain and the 427 cell line used for this study, or a genome mis-assembly 
in the genome reference data. 
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It was of interest to perform further analyses on the ‘pseudo’ PAD1 and PAD array 
deletion mutants.  For example, determining the integration sites of these constructs 
may help to determine whether they have integrated into the predicted position, and 
thus allow us to infer the presence of multiple copies of PAD1, and the PAD array.  
However, it was decided that it was of higher priority to implement an alternative 
strategy that would allow the role of the PAD genes in differentiation to be 
determined.  This involved implementing an RNAi strategy in pleomorphic cells. 
6.6 RNAi mediated ablation of PAD family transcripts in pleomorphic 
cells 
It was considered of primary importance to continue with further functional studies 
in a naturally occurring, pleomorphic cell line using an RNAi based approach.  This 
had the dual advantage of (A), being independent of genome data mal-assembly and 
PAD gene copy number and (B), analysing the effect of PAD gene ablation in a cell 
type where PAD proteins were detectable. 
6.6.1 RNAi mediated ablated transfection of PAD family transcripts using 
transient transfection 
The vast majority of functional studies in Trypanosoma brucei are performed in 
monomorphic slender cell lines due to their ease of culture and genetic tractability.  
Pleomorphic cell lines can be very difficult to culture adapt and maintain in culture, 
possibly due to their tendency to enter cell cycle arrest at high culture densities.  For 
this reason, initial PAD family functional analyses in stumpy form cells were 
performed by transient transfection of pleomorphic trypanosomes with a PAD array 
RNAi construct (see 6.3.1), such that expression of a stem loop structure was driven 
by an EP procyclin promoter and the PAD family mRNA transcripts were targeted 
for degradation. 
Figure 6.6-1 shows a diagram depicting the design of the experiment.  A mouse was 
inoculated with a pleomorphic parasites, and the cells harvested from the infection by 
DEAE cellulose anion exchange after several days (see Materials and Methods for 
details).  Once harvested, the cells were transfected with either the stem loop PAD 
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array RNAi construct, or with water.  After 24 hours recovery at 37°C to allow 
expression of the stem loop vector and slender to stumpy form differentiation, the 
cells were either maintained at 37°C, or incubated at 20°C overnight.  Cells were 
subsequently incubated at 27°C in different concentration of cis-aconitate to assay 
their sensitivity to cis-aconitate and the effect of PAD array RNAi (see Materials and 
Methods for details). 
A number of variables were considered in the design of this experiment.  In 
particular, it was necessary to decide at what point in the slender to stumpy form 
transition to harvest cells from a parasitaemia and transfect with the RNAi 
constructs.  If the cells were harvested too early during the transition, there may be 
insufficient time for them to subsequently differentiate to the stumpy form before the 
addition of cis-aconitate.  However, if stumpy form parasites were transiently 
transfected, then PAD protein may have already been made prior to the initiation of 
RNAi thus preventing useful phenotypic analysis. 
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Figure 6.6-1  Transient RNAi in pleomorphic trypanosomes.  Parasites from a mouse 
parasitaemia were harvested and transfected with the PAD array RNAi construct, or a 
water control.  After 24 hours recovery, cells were either maintained at 37°C, or cold 
shocked at 20°C overnight.  Cells were subsequently incubated at 27°C in different 
concentrations of cis-aconitate, and samples were prepared for flow cytometry over a 
timecourse to assay differentiation by expression of EP procyclin. 
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6.6.1.1 Transient transfection of trypanosomes from a mid-stage parasitaemia 
An AnTat 1.1 mouse parasitaemia was closely monitored for the presence of slender, 
intermediate and stumpy form trypanosomes by taking blood smears from tail snips 
and observing the morphology of the parasites by light microscopy.  At 5 days post-
inoculation, an equal proportion of slender and intermediates was observed, with a 
small proportion (>10%) of stumpy forms, and the cells were transfected and assayed 
for their sensitivity to cis-aconitate at 37°C and 20°C as described (see Section 6.6.1 
and Figure 6.6-1). 
Figure 6.6-2A is a Western blot performed on protein prepared prior to the addition 
of cis-aconitate using the α-array antibody.  There was a clear reduction in the levels 
of PAD protein in those cells that have been transfected with the RNAi construct; 
however, there remained a significant amount of PAD protein left in the cells. 
Figure 6.6-2B showed that there was no effect on differentiation after RNAi when 
cells were incubated at 37°C before cis-aconitate addition.  In contrast, when cells 
were incubated at 20°C before cis-aconitate addition, a mild reduction in 
differentiation was observed after RNAi at 1 mM cis-aconitate at 6 hours, although 
this was not observed at higher concentrations of cis-aconitate, or at later timepoints 
(Figure 6.6-2C).  This may be due to experimental variation unrelated to PAD array 
RNAi, but it is worth noting that the 6 hour timepoint is most reflective of the level 
of initiation of differentiation, as the 24 hour timepoint is complicated by cell 
outgrowth due to re-entry of the cell into the cell cycle. 
Interestingly, RNAi appeared to inhibit the cold shock induction of EP procyclin 
expression in these cells.  This effect was observed at 0 hours where approximately 
9% of RNAi cells expressed EP procyclin compared with 16% of non-RNAi cells, a 
>40% reduction. 
Although further experiments may add statistical support to this observation, it was 
decided to repeat the experiment using cells from an earlier parasitaemia in order to 
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more completely reduce the PAD protein from the cells (see Section 6.6.1.2). 
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Figure 6.6-2 The effect of PAD family RNAi upon differentiation in morphologically 
pleomorphic cells.  A pleomorphic population of cells were transiently transfected to 
ablate PAD family transcripts. (A) A Western blot shows that PAD RNAi resulted in the 
partial knockdown of PAD protein from transfected cells.  (B) and (C) show the sensitivity 
to cis-aconitate when cells were pre-incubated at 37°C and 20°C respectively, as 
measured flow cytometry detection of EP procyclin expression. No convincing effect was 
observed at 37°C, but there may be an afect of RNAi at 1mM cis-aconitate after 6 hours 
under cold shock conditions.  Interestingly, RNAi reduces induction of EP procyclin in 
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6.6.1.2 Transient transfection of slender forms 
As before (see Section 6.6.1.1) an AnTat 1.1 mouse infection was closely monitored 
for the presence of slender, intermediate and stumpy form trypanosomes by taking 
blood smears from tail snips and observing the morphology of the parasites by light 
microscopy.  At approximately 3 days post-inoculation, the parasites were 
morphologically >99% slender, and the cells were harvested for transfection. RNAi 
treated and control cells were subsequently assayed for their sensitivity to cis-
aconitate at 37°C and 20°C as described previously (see Section 6.6.1 and Figure 
6.6-1). 
Figure 6.6-3A shows a Western blot of RNAi treated and mock transfected cells that 
were incubated at either 37°C or 20°C prior to the addition of cis-aconitate.  
Consistent with stumpy form cell lysates, a 55 kDa and a 57 kDa band was detected 
using the α-array antibody in the mock-transfected cells, showing that these cells had 
differentiated to the stumpy form after treatment.  In the cells subjected to RNAi, no 
PAD protein was detected despite cells becoming morphologically stumpy whilst in 
culture (data not shown), showing that RNAi was successful and highly efficient. 
Figure 6.6-3B shows the analysis of 3 separate experiments.  The average 
differentiation efficiency was assayed by flow cytometry at 0, 6 and 24 hours post 
cis-aconitate addition when cells were not previously cold shocked.  Cells that were 
transfected with the RNAi construct showed an inhibition in their ability to respond 
to cis-aconitate when compared with equivalent negative controls.  For example, at 6 
hours post differentiation, 37°C, and 6 mM cis-aconitate, RNAi cells differentiate 
approximately 33% less efficiently than the negative controls.  This was more 
pronounced at 24 hours (42%), possibly due to blood forms re-entering the cells 
cycle in the RNAi cells, or procyclic form cell death in the RNAi treated cells.  This 
trend was repeated in cells incubated with 1 mM cis-aconitate, whereby cells 
undergoing RNAi differentiated 25% and 43% less efficiently at 6 hours and 24 
hours post differentiation respectively when compared with mock-transfected cells.  
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Figure 6.6-3C shows means for the same experiments when cells were cold shocked 
prior to the addition of cis-aconitate.  In this case, at 6 mM cis-aconitate there was a 
31% and 47% reduction in differentiation at 6 hours and 24 hours, respectively.  At 1 
mM cis-aconitate this was more pronounced, with a 51% and 55% reduction at 6 
hour and 24 hours post differentiation respectively. 
A paired T test shows that cold shocked RNAi treated cells are impaired in their 
ability to respond to cis-aconitate with respect to the mock transfected controls, both 
at 6 hours and at 12 hours (P < 0.005).  Non cold shocked, RNAi treated cells do not 
show statistically significant impairment at 6 hours (P = 0.07), but do at 12 hours (P 
> 0.05) post cis-aconitate treatment. 
Thus, inducing RNAi of the PAD genes was shown to reduce the capacity of 
pleomorphic cells to differentiate in response to cis-aconitate, thus demonstrating 
that they do play a role in the initiation of differentiation.  The residual 
differentiation observed in these cells was presumably due to incomplete 
knockdown, or other routes of cis-aconitate entry into the cells when exposed to high 
extracellular concentrations of cis-aconitate 
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Figure 6.6-3  Transient RNAi on slender AnTat 1.1 cells.  Slender form AnTat 1.1 cells 
were transiently transfected with an RNAi construct to ablate all the PAD family 
transcripts.   (A) The Western blot shows that RNAi ablated the PAD transcripts such that 
no PAD proteins were detected in the RNAi cells at 37°C or 20°C. Transfected cells were 
allowed to recover for 24 hours and subsequently incubated overnight at either (B) 37°C 
or (C) 20°C prior to the addition of different concentrations of cis-aconitate.  Thereafter, 
cells were assayed for differentiation by flow cytometry analysis of EP expression at 0, 6 
and 24 hours post cis-aconitate addition.  Cold shocked RNAi treated cells were 
significantly impaired in their ability to differentiate in response to cis-aconitate at both 
timepoints (P < 0.005), and non-cold shocked RNAi treated cells show statistically 
significant impairment only at 12 hours (P < 0.05).  The error bars show the standard 
error of the data. 
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6.6.2 Stable RNAi of the PAD array 
The data from the transient RNAi showed that ablating PAD transcripts impaired the 
ability of cells to differentiate in response to cis-aconitate.  It was therefore of 
interest to determine whether this effect was recapitulated in a stable, pleomorphic, 
PAD array RNAi cell line. 
To this end, 90:13 AnTaT 1.1 pleomorphic cells containing the T7 polymerase and 
the Tet repressor protein (a kind gift of Markus Engstler and Michael Boshart) were 
harvested from an early mouse infection and transfected with the linearised 
array:pALC14 RNAi construct (see Section 6.3.1).  The cells were recovered 
overnight in methyl cellulose containing media, and transgenic parasites were 
selected using 0.5 µg ml
-1
 puromycin (see Materials and Methods for details).  
Eventually, 1 clonal cell line was obtained, which was subsequently inoculated into 
immunosuppressed mice to generate blood stocks.  The generation of this cell line 
was an important step in determining the function of the PAD proteins. 
To determine the affect of PAD mRNA ablation upon the ability of cells to 
differentiate, 2 immunosuppressed mice were inoculated with the PAD RNAi cell 
line, and 1 mouse with the 90:13 (parental) cell line.  The parental cell line-
inoculated mouse, and 1 of the RNAi cell line-inoculated mice, were provided with 
doxycycline in their drinking water to induce RNAi, and the remaining mouse was 
provided with normal water.  The infections were then monitored for the presence of 
stumpy forms, and harvested when the population became >90% stumpy in 
morphology.  The cells were subsequently incubated overnight in HMI9 media at 
either 20°C, or 37°C in the presence or absence of tetracycline as appropriate, such 
that 6 conditions existed: 
• Parental, 37°C +tetracycline (+dox) 
• Parental, 20°C +tetracycline (+dox) 
• RNAi PAD array, 37°C -tetracycline (-dox) 
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• RNAi PAD array, 37°C +tetracycline (+dox) 
• RNAi PAD array, 20°C -tetracycline (-dox) 
• RNAi PAD array, 20°C +tetracycline (+dox) 
Protein samples were made at this point to determine the extent of PAD protein 
knockdown.  The cells were then treated with differing concentrations of cis-
aconitate, and differentiation was assayed by flow cytometry analysis of EP 
procyclin expression at 0, 6 and 24 hours post treatment. 
Figure 6.6-5A shows a typical Western blot when samples from 0 hours were 
analysed using the α-array antibody.  It was clear that knockdown had occurred in 
these cell lines, although did not appear to be clearly inducible, presumably due to 
leaky RNAi.  Analysis of PAD expression using the LI-COR Odyssey system 
showed that knock down was approximately 6 fold at 37°C, and 7 fold at 20°C with 
respect to the parental line.  The addition of doxycycline did not appear to result in 
an increased knockdown at 37°C, and only resulted in an increase of approximately 
30% ablation in cold shocked cells.  Nonetheless, it was clear that the RNAi cell line 
was reduced in its ability to synthesis PAD array proteins. 
Figure 6.6-5B shows representative cells subsequent to the overnight incubation at 
37°C or 20°C.  The cells showed clear stumpy morphology, demonstrating that the 
RNAi cells did not have a reduced pleomorphism, either as a consequence of 
passaging, or RNAi ablation of the PAD array. 
Supporting this, Figure 6.6-5C shows that the 6 populations of cells had similar 
kinetoplast and nucleus configurations (KN), with high percentages of 1K1N cells, 
such that each population would be expected to contain similar numbers of stumpy 
form cells, and would therefore be predicted to differentiate with similar efficiencies 
unless PAD ablation had an effect. 
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Figure 6.6-4  The effect of stably inducing RNAi upon pleomorphic cells. A stable 
pleomorphic PAD array RNAi cell line was generated and inoculated into mice that were 
given, or not, doxycycline.  The cells were allowed to progress to the stumpy form, 
harvested, and allowed to incubate at 37°C or 20°C overnight in HMI9 containing 
tetracycline, or not.  Parental 90:13 cells were also included, and were inoculated into 
mice fed with doxycycline.  The analysis described here is representative of the 3 repeats 
of this experiment.  (A)  A Western blot shows that the RNAi cell line was impaired in its 
ability to synthesise PAD protein.  Analysis using the LI-COR Odyssey system showed 
that RNAi cells exposed to doxycycline/ tetracycline produced 6 and 7 fold less PAD 
protein than parental cells at 37°C and 20°C respectively.  RNAi was not affected by 
doxycycline at 37°C, but at 20°C doxycycline treated cells had approximately 30% 
reduced PAD protein compared untreated RNAi cells.  (B) Subsequent to an incubation at 
37°C or 20°C, cells were visualised by phase contrast microscopy.  All cell lines show a 
strong stumpy morphology, therefore PAD RNAi did not reduce the capacity for 
pleomorphism.  (C)  The  different cell line populations were analysed for their nucleus 
and kinetoplast configuration to confirm that they exhibited similar levels of stumpy form 
cells. 
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Figure 6.6-5 shows the data on the capacity for differentiation from 3 repeats of the 
experiment described above.  At 37°C, the RNAi cell lines both showed an inhibition 
of differentiation at all concentrations of cis-aconitate at 6 and 24 hours post 
differentiation.  This effect was subtle, but clear, particularly at lower concentrations 
of cis-aconitate. 
The same effect was seen when cells were pre-incubated at 20°C, but the extent was 
more dramatic and appeared to be inducible, in keeping with the Western blot of 
PAD protein expression (see Figure 6.6-4A).  At 6 mM cis-aconitate, cold shocked 
RNAi cells exposed to tetracycline/ doxycycline differentiated  almost 3 fold less 
efficiently than parental cells at 6 hours.  The same effect was observed at 1 mM cis-
aconitate, and was even more pronounced at 0.1 mM cis-aconitate. 
A paired t test shows that doxycycline/ tetracycline treated PAD array RNAi cells 
maintained at 37°C were significantly impaired in their ability to respond to cis-
aconitate with respect to the parental control cells, both at 6 hours and at 12 hours (P 
< 0.005 for both timepoints).  Doxycycline-treated versus non doxycycline-treated 
RNAi cells, and parental versus non- doxycycline treated cells, do not show 
significant difference when maintained at 37°C (P = 0.437 and 0.101 respectively).  
Under cold shock conditions, PAD array RNAi cell lines were significantly impaired 
in their ability to differentiate in response to cis-aconitate compared with parental 
cells, both in the presence and the absence of doxycycline, and at 6 and 24 hours post 
cis-aconitate (P < 0.0005).  The cold shocked doxycycline-treated RNAi cells were 
not significantly impaired in their ability to differentiate compared to untreated RNAi 
cells at 6 hours (P = 0.095), but were at 24 hours (P < 0.05). 
Interestingly, less EP procyclin expression was observed under cold shock conditions 
at 0 hours, and at 0 mM cis-aconitate 6 and 24 hours post differentiation.  This had 
also been seen with the transient assays carried out previously (see Figure 6.6-2), and 
was thus investigated further. 
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Figure 6.6-5 The effect of stable PAD RNAi upon the differentiation of cells in 
response to cis-aconitate.  The average differentiation of RNAi (induced and non-
induced with doxycycline) cells and parental cells was assayed by flow cytometry 
analysis of EP procyclin expression 0, 6 and 24 hours subsequent to the addition of 
different concentrations of cis-aconitate.  Cells were pre-incubated at either (A) 37°C or 
(B) 20°C prior to differentiation induction.  Error bars show the standard error of the data. 
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6.6.3 The effect of PAD RNAi upon cold shock induced EP procyclin 
upregulation 
As discussed, the RNAi cell lines appeared to have reduced cold shock-induced EP 
procyclin.  This suggested that an effect of PAD proteins may be to facilitate 
expression of EP procyclin in response to cold shock.  To dissect this interesting 
attribute further, the flow cytometry traces of EP expression were compared between 
the RNAi cell line and the parental cells. 
Figure 6.6-6 supports the summary of EP expression shown in Figure 6.6-5B.  Thus, 
the parental cells (red trace) expressed EP procyclin in response to cold shock, 
showing a proportion of cells highly fluorescent in the FL1 channel (corresponding 
to EP expression).  This matches the findings of Engstler and Boshart (2004).  
However, the EP induction was greatly reduced in the RNAi cells, and appeared to 
be inducible, being further reduced in cells treated with doxycycline/ tetracycline. 
Thus, it would appear that PAD protein expression is linked to the two attributes of 
cold shock, (a) hypersensitivity to cis-aconitate, and (b) induction of EP procyclin 
expression. 
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Figure 6.6-6 The effect of PAD ablation upon cold shock induced EP procyclin 
expression.  Parental cells and RNAi cells were grown in mice provided with and without 
doxycycline treated water.  The stumpy form cells were harvested from the mouse, and 
were incubated overnight at 20°C in HMI9 media, whereby doxycycline exposure was 
replaced with 1 µg ml-1 tetracycline.  The extent of EP upregulation was then determined 
by flow cytometry analysis (FL1 channel).  The RNAi cell lines consistently showed a 
reduced induction of EP in response to cold shock, with the doxycycline/ tetracycline 
treated cells showing a more pronounced effect than the non-doxycycline/ tetracycline 
treated cells.  Indeed, here the effect was reduced to levels observed when cells were 
incubated at 37°C. 
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6.7 Response of the RNAi cell line to an alternative differentiation 
trigger 
The data presented in Sections 6.6.1.1 and 6.6.1.2 show that PAD protein reduction 
inhibited differentiation in response to cis-aconitate.  However, this effect was only 
subtly inducible in response to doxycycline and may represent a cell line defect 
unrelated to PAD array ablation.  This was unlikely because the data from the 
transient RNAi was consistent with the data from the stable cell line.  Nonetheless, it 
was important to determine whether these cells were inhibited in their ability to 
differentiate per se, and whether the effect was cis-aconitate specific. 
As discussed (see Section 1.5), a number of differentiation triggers exist in 
trypanosomes.  Pronase was chosen because it has been shown to stimulate 
differentiation in stumpy form cells with very high efficiency (Hunt et al. (1994)) 
(Sbicego et al. (1999)).  Therefore, the PAD RNAi cell lines and the parental 90:13 
cells were inoculated into immunosuppressed mice and maintained with doxycycline 
treatment (as described in Section 6.6.2).  Stumpy form cells were then harvested and 
allowed to recover in HMI9 media for 2 hours.  Subsequently, the cells were washed 
in PSG, and treated with, or not, 4 U µl
-1
 of Pronase for 10 minutes at 25°C.  Cells 
were subsequently washed in PSG and re-suspended in SDM79 media at 27°C.  
Differentiation was then assayed by flow cytometry analysis of EP expression at 6 
hours post differentiation. 
Figure 6.7-1 shows that the PAD RNAi cell line was not inhibited in its ability to 
differentiate in response to cis-aconitate.  Rather, in this experiment it differentiated 
slightly more efficiently than the parental cells.  This probably reflects experimental 
variation, but it does nonetheless demonstrate that the PAD RNAi cell line is fully 
able to differentiate when induced by a cis-aconitate independent trigger.  Hence, 
PAD proteins mediate cis-aconitate dependent signalling.
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Figure 6.7-1  The ability of PAD RNAi and parental cells to respond to Pronase.  To 
determine whether the reduced differentiation observed in PAD RNAi cells in response to 
cis-aconitate was a cell line specific defect unrelated to the ablation of PAD genes, cells 
were treated with Pronase, or not, and the differentiation efficiency was observed after 6 
hours at 27°C.  RNAi cells were not inhibited in their ability to differentiate in response to 
Pronase.  P = 90:13 parental.  + = PAD RNAi cells.  Both cell lines were harvested from a 
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6.8 Expression of PAD1 in Xenopus laevis oocytes to determine 
citrate transport activity 
The substrate specificity of a transporter molecule can be tested using the Xenopus 
laevis expression system.  Synthetic mRNA coding for the protein of interest is 
microinjected into freshly harvested Xenopus oocytes.  The oocytes are allowed time 
to express the protein and localise it to the surface membrane of the cell, and are then 
assayed for transport activity through incubation with the radio-labelled putative 
substrate.  There are a number of potential problems associated with this strategy: 
• the mRNA may not be expressed by the cell 
• the protein may not be localised to the cell surface membrane 
• the protein may prove toxic to the cell, thus killing the cell before the protein 
is fully expressed 
• the quality of the oocyte must be good in order to achieve reproducible data 
• each transporter has different characteristics that require optimisation for the 
assay to work (e.g. pH, presence of appropriate ions etc) 
• some radio-labelled substrates are not commercially available 
• the oocyte may contain endogenous transporters that give high background; 
in addition, endogenous transporters an be upregulated through expression of 
the exogenous transporter 
Despite these issues, this system has been successfully used to identify many 
transporter substrates, and to investigate the kinetics, and mechanisms of transport 
(Bröer et al. (1997)) (Saliba et al. (2006)). 
Therefore, PAD1 was cloned into the eukaryotic expression vector pGem-He-Juel 
(pGHJ) such there was a Kozak sequence adjacent to, and upstream from, the initial 
ATG start codon in order to enhance ribosome binding, and subsequent protein 
translation in the oocyte.  After sequence verification, a small scale DNA preparation 
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of pGHJ:PAD1 was used in an in vitro mRNA synthesis reaction to generate 
synthetic PAD1 mRNA (see Materials and Methods).  Oocytes were microinjected 
with the PAD1 cRNA, incubated to allow expression of the protein, and assayed for 
radio- labelled citrate uptake. 
6.8.1 Optimisation of assay 
Initial attempts to show PAD1 transport activity suggested that there may be some 
transport above basal levels, but was not convincing due to high levels of 
background transport (see Figure 6.8-1A.  A number of variables were investigated, 
including the pH of the transport buffer and the amount of time allowed for the 
oocytes to express the PAD1 protein.  Additionally, the concentration of cold, carrier 
substrate was varied; cells incubated with no carrier substrate and 5 µM radio-
labelled citrate appeared to transport marginally better than those incubated with 5 
µM or 50 µM carrier citrate or cis-aconitate, suggesting that transport did occur in 
the µM range.  Increasing the pH from pH 7 to pH 9 did not affect the levels of 
radioactive transport, but did appear to reduce background levels of endogenous 
transport. 
6.8.2 PAD1 is able to transport citrate when expressed in Xenopus laevis 
Finally, the quantity of PAD1 cRNA injected into the oocytes was varied.  
Surprisingly, when the quantity of cRNA injected was titrated from 50 – 5 ng, the 
levels of PAD1 transport levels rise correspondingly to approximately 3 fold 
background levels at 5 ng of PAD1 cRNA (see Figure 6.8-1B).  An unpaired t test 
showed that this was statistically significant (P < 0.0005).  One explanation for this 
inverse correlation was that excessive intracellular cRNA concentration interfered 
with endosomal trafficking of transmembrane protein through the endoplasmic 
reticulum, thus preventing localisation of PAD1 protein to the cell surface 
membrane. 
Further optimisation may increase transport levels further, and competition 
experiments may help to determine substrate specificity.  For example, it would be of 
interest to determine whether PAD proteins are able to transport cis-aconitate (which 
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is not commercially available as a radio-labelled chemical) as well as citrate.  
Furthermore, given that T. brucei is unable to differentiate in response to isocitrate, it 
may be revealing to determine whether PAD proteins are also able to transport this 
tri-carboxylate.  Unfortunately these assays could not be completed in the timescale 
of the project, although they are being pursued in collaboration with Kiaran Kirk’s 
laboratory.  Nonetheless, it was clear that the PAD1 protein was able to induce 
transfer of citrate in Xenopus laevis oocytes. 
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Figure 6.8-1  Transport of 14C citrate in Xenopus laevis oocytes micro-injected with 
PAD1 synthetic mRNA.  Synthetic PAD1 mRNA was microinjected into Xenopus 
oocytes and their ability to transport 14C citrate was assayed.  (A)  Oocytes injected with 
PAD1 RNA transport 14C citrate at higher levels than non-injected oocytes.  Transport 
levels are low, although above background.  (B)  14C citrate transport increased when 
less PAD1 RNA was injected.  Transport of citrate when 5 ng of PAD1 RNA was 
microinjected was approximately 3 fold above background levels (P < 0.0005).  Further 
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6.9 Conclusion 
The data presented here demonstrates that the PAD genes play an important role in 
the initiation of differentiation in response to cis-aconitate.  The hypothesis that the 
PAD genes promotes differentiation by transporting cis-aconitate into the cell is 
strongly supported.  Furthermore, the interesting, and unexpected, observation that 
PAD ablation reduces cold shock-induced upregulation of EP procyclin adds further 
support to the role of PAD proteins in cis-aconitate mediated differentiation, their 
link with hypersensitivity to cis-aconitate.  It would be interesting to dissect in future 
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7 Discussion 
This study has set out to test the hypothesis that the PAD proteins act as 
environmental sensors by importing citrate/ cis-aconitate, thus enabling cells to 
differentiate. 
7.1 Bioinformatics evidence 
Although an important and useful analysis, the bioinformatics data did not provide 
direct evidence of PAD gene function.  The PAD proteins contain both of the motifs 
characteristic of members of the Major Facilitator Superfamily (MFS) (see Section 
3.3.3), and contain 14 predicted trans membrane helices (TMS) (see Section 3.6), 
making these genes members of a little characterised MFS subset, and thus of 
intrinsic interest.  Almost all of the characterised PSI-BLAST hits were carboxylate 
transporters (see Section 3.8), supporting the hypothesis that PAD genes are cis-
aconitate/ cis-aconitate transporters.  Interestingly, the majority of these carboxylate 
transporters were anti-porters, suggesting that the PAD proteins may facilitate export 
of one substrate, and the import of a different substrate. 
An analysis of the PAD array locus showed that there were several repetitive 
elements within the intergenic regions (see Section 3.3.3) and allowed the PAD 
genes to be grouped based on the homology in their 3’ UTRs: PAD1/5/7, PAD2, 
PAD3, PAD4/6/8.  This 3’ UTR grouping was reflected in mRNA expression, as 
PAD1, 5 and 7 have similar expression pattern during the parasite lifecycle (see 
Section 5.1). 
7.2 Analysis of the DiD1 defect 
As described (see Section 1.8 and Tasker et al. (2000)), DiD1 cells do not 
differentiate in response to citrate/ cis-aconitate.  Although, the basis of this defect 
was not resolved by this study, PAD1 and PAD2 were implicated in this phenotype 
as both transcripts were found to be highly expressed in DiD1 cells with respect to 
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the parental cell line (see Section 4.1).  This was also reflected in protein levels, 
whereby PAD1 (and probably PAD2) protein was found to be expressed in DiD1 
cells, but not in the parental strain (see Section 4.6).  This raised a clear disparity; 
two proteins that were hypothesised to import citrate/ cis-aconitate were found to 
have elevated expression in a cell line that is unable to differentiate in response to 
cis-aconitate.  Moreover, no gene sequence differences were found between PAD1 
and 2 in the different cell lines (see Section 4.4), and ectopic expression of PAD1 did 
not inhibit differentiation (see Sections 4.5.1 and 6.1.1), ruling out the possibility of a 
dominant negative effect. 
Therefore, the evidence suggested that the DiD1 phenotype was not due to PAD1 
and PAD2 expression per se.  To investigate the mechanism of PAD1 and PAD2 
enrichment in DiD1 cells, a sequence analysis of the PAD1 3’UTR, and a Southern 
blot analysis of the PAD array locus, was performed, but showed no differences 
between the DiD1 cells and the parental cells (see Sections 4.3 and 4.2).  This 
demonstrated that the elevated expression of PAD1 and 2 that was observed in the 
DiD1 cells was not due to a mutated PAD1 3’ UTR, nor due to these gene being 
moved to a more highly transcribed genomic locus.  Rather, it was likely that it was 
due to unidentified trans regulatory differences. 
As PAD array genes were found to be expressed in stumpy forms (see Section 5.1), 
other stumpy-enriched transcripts were investigated in DiD1 cells.  Of these, PTP1 
was the most interesting; it was reported that reduced levels of active PTP1, caused 
by either RNAi-mediated ablation or pharmacological inhibition, caused blood form 
cells to spontaneously differentiate to procyclic form cells (Szöor et al (2007)).  
Thus, if elevated levels of PTP were found, this would neatly explain the phenotype.  
However, none of these genes was found to be aberrantly expressed in DiD1 cells 
and there did not appear to be a global enrichment of stumpy transcripts (see Section 
4.7). 
In conclusion, the mechanism underlying the DiD1 defect was not resolved, and it is 
unlikely that the PAD proteins are directly involved.  Therefore, it seems that if 
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interrogated properly, the DiD1 cell line may have more information to yield.  
Further work focused establishing the role of the PAD proteins in differentiation. 
7.3 Expression of PAD1 in Xenopus laevis oocytes 
The working hypothesis of this study has rested upon the ability of either PAD1 or 
PAD2 to transport citrate/ cis-aconitate.  To investigate this, PAD1 cRNA was 
micro-injected into Xenopus laevis oocytes and tested for enhanced citrate uptake.  
The data show that PAD1 cRNA injected oocytes were significantly enhanced in 
their citrate uptake, demonstrating that PAD1 is able to transport citrate (see Section 
6.8).  The uptake seen was approximately 3 fold that of the control oocytes, and 
therefore not comparable with the dramatic increases shown by some adenosine 
transporters (Chiang et al. (1999)).  This was probably due to the presence of 
endogenous tri-carboxylate transporters within Xenopus oocytes, resulting in high 
background.  Nonetheless, it is likely that with further optimisation transport levels 
could be increased.  Indeed, as potential anti-porters (see Section 3.8), efficient 
citrate transport may depend upon the presence of a specific, intracellular, substrate. 
The possibility remains, however, that the transport observed by PAD1 represents 
non-specific transport, and that the in vivo substrate may not be citrate or cis-
aconitate.  Further work by Rosa Marchetti in Kiaran Kirk’s lab (Australian National 
University, Canberra, Australia) will focus on determining the substrate specificity of 
the PAD proteins.  Nonetheless, these data clearly show that PAD1 is able to 
transport citrate. 
7.4 Expression of PAD genes 
As discussed previously (see Section 1.8), macroarray data showed that PAD1 and/ 
or PAD2 were highly expressed in DiD1 cells with respect to the parental cell line 
(Pamela Davies, University of Manchester, unpublished data).  This study has 
extended this observation to give a more complete picture of the PAD genes’ 
expression profile. 
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7.4.1 PAD lifecycle expression and localisation 
PAD1 mRNA and protein were shown to be strongly upregulated in stumpy forms, 
and almost undetectable in monomorphic slender forms and procyclic forms (see 
Sections 5.1 and 5.4).  The identification of a stumpy form-specific protein 
represents a significant advance as there are currently no molecular markers able to 
distinguish slender from stumpy forms that are not associated with mitochondrial 
activation (Matthews and Gull (1994)).  Further applications of a stumpy marker are 
described in Section 7.6.1. 
PAD2 mRNA was shown to be expressed predominantly in procyclic forms, but was 
also detected in stumpy forms (see Section 5.1).  Similarly, protein expression of 
PAD2 increased within 2 hours of differentiation from stumpy to procyclic forms, 
where it was maximally expressed (see Section 5.5.2 and 5.8).  As with PAD1, 
PAD2 protein was not detected in monomorphic slender forms. 
PAD5 and 7 mRNA (which are indistinguishable) was shown to be stumpy form 
enriched (see Section 5.1).  However, a Western blot using a α-array PAD generic 
antibody did not detect PAD5/7 protein.  Instead, two bands of 55 kDa and 57 kDa 
were detected, but were subsequently  shown to be PAD1 and PAD2 respectively 
(see Section 5.6).  This indicated that either PAD5/7 is translationally repressed in 
stumpy forms (as has been shown with EP isoforms in epimastigotes (Urwyler et al. 
(2005)), or that PAD5/7 proteins resolve at precisely the same size as PAD1 or 
PAD2, and therefore contribute to either of these bands.  This issue could be resolved 
by either reacting stumpy form protein with a PAD5/7 specific antibody in a Western 
blot, or by ablating PAD5/7 mRNA in stumpy forms and determining whether the 
bands detected by the α-array antibody have reduced intensity. 
PAD3 was not detected by Northern blot, and PAD4, 6 and 8 were not investigated 
in this study.  Western blots using the α-array PAD generic antibody did not reveal 
any unaccounted for bands (see Section 5.6), suggesting that PAD family proteins 
other than PAD1 and 2 are not expressed in slender, stumpy or procyclic forms cells.  
Interestingly, however, a recent study showed that an RNA binding protein, 
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TbDRBD3, may regulate PAD4, 6 and 8 transcripts in procyclic forms (Estévez 
(2008)). 
PAD1 was shown to localise to the cell surface membrane of stumpy form cells (see 
Section 5.2.2.2), which supports the hypothesis that PAD1 promotes differentiation 
by importing citrate/ cis-aconitate into the cell.  The localisation and the affect of 
cold shock upon PAD2 is discussed in Section 7.4.2. 
7.4.2 The affect of cold shock upon PAD2 
The discovery that citrate/ cis-aconitate is able to efficiently induce differentiation to 
procyclic forms (Brun and Schönenberger (1981)) (see Section 1.5.2) was somewhat 
perplexing: the differentiation response was specific to these tri-carboxylates, but the 
high concentration required for this effect excluded them from being an in vivo 
trigger.  However, in 2004 Engstler et al. reported that when stumpy, but not slender 
form, cells were subjected to a temperature decrease from 37°C to 20°C, they 
became sensitive to micromolar concentrations of cis-aconitate.  The cis-aconitate 
concentration in the tsetse was reported to be 15.9 µM (Hunt et al. (1994)), but this 
analysis use whole tsetse homogenate, rather than determining the concentration in 
the midgut specifically.  However, the concentration of citrate found in the blood that 
accompanies the trypanosome into the tsetse midgut is approximately 130 µM 
(Jacobs and Lee (1964)) (Taylor et al. (1998)), and is therefore within the range 
reported to induce differentiation.  Thus, citrate/ cis-aconitate is a potential 
physiological trigger of differentiation. 
Importantly, when stumpy forms were subjected to cold shock conditions, PAD2 
protein was shown to be upregulated 3 to 6 fold (see Section 5.16), with some 
experiments showing expression of up to 32 fold that of cells maintained at 37°C 
(see Figure 5.15-3).  This raises the intriguing possibility that the upregulation of 
PAD2 enables hypersensitivity to cis-aconitate.  However, it could be argued that a 4 
fold upregulation of protein expression is unlikely to result in a 1000 fold increase in 
cis-aconitate sensitivity. 
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There are two responses to this argument.  The first is that PAD2 upregulation is 
unlikely to be the only molecular change that the cell undergoes in order to become 
hypersensitive to cis-aconitate, and there are likely to be a number of intracellular 
molecules of the cis-aconitate reception pathway affected by cold shock.  Hence, 
PAD2 upregulation may be one part of a system optimised for hypersensitivity.  The 
second is that the data presented here show that, in addition to increased levels of 
PAD2, cold shock causes a re-localisation of PAD2, such that stumpy form cells 
maintained at 37°C hold PAD2 in intracellular storage vesicles until a temperature 
drop, whereupon PAD2 is rapidly trafficked to the cell surface membrane (see 
Section 5.17).  The combined effect of the upregulation and the re-localisation would 
be to vastly increase the number of PAD2 molecules that are present on the cell 
surface membrane, thus enabling much more efficient import of cis-aconitate at low 
extra-cellular concentrations. 
There are examples of similar characteristics shown by other transporters.  For 
example, a mammalian kidney cell aquaporin is held in intracellular vesicles until it 
is re-localised to the surface membrane in response to a diuretic signalling hormone; 
this causes an increase in cell permeability to water with much faster kinetics than 
would be possible if the aquaporin had to be synthesised de novo (Kamsteeg et al. 
(2007)).  Importantly, this effect is dependent on the presence of another membrane 
bound protein that modulates intracellular aquaporin retention (see also model in 
Figure 7.7-1). 
Moreover, a pleomorphic PAD array RNAi cell line was impaired in its ability to 
express EP procyclin in response to cold shock.   It is tempting to speculate that cell 
surface access of procyclin in blood forms is dependent upon the presence of PAD 
proteins, which may also explain the flagellar pocket checkpoint control of procyclin 
surface access in slender form cells (Engstler et al. (2004)).  There is precedence for 
this type of mechanism; the cell surface localisation of the monocarboxylate 
transporters MCT1 and MCT4 is dependent upon another membrane bound protein, 
CD147, in COS cells (Wilson et al. (2005)).  To investigate this further, one could: 
firstly determine whether ablation of procyclin eliminates PAD2 surface access in 
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response to cold shock and, hence, cis-aconitate hypersensitivity and secondly 
determine whether the cold shock induced procyclin surface expression is prevented 
in cells where PAD genes are ablated individually. 
7.5 Phenotypic analyses 
7.5.1 PAD ablation 
Initial attempts to generate PAD gene deletion mutants focused on monomorphic 
cells.  Although PAD proteins were not detected in monomorphic cells, this was 
strategy was pursued because (a) the PAD array was originally identified using the 
monomorphic DiD1 cell line, (b) monomorphic cells do respond to cis-aconitate 
(albeit only at high concentrations), and may therefore have low levels of PAD 
proteins undetectable by Western blot, and (c) monomorphic cells are amenable to 
genetic manipulation.  However, these efforts were unsuccessful (see Sections 6.4 
and 6.5).  Further analysis showed that although gene deletion constructs had 
integrated into the genome, they had failed to remove the PAD1 gene.  This was 
thought to be a consequence of a genome miss-assembly in this region of the 
database, differences between the genome reference strain and the 427 cell line that 
was used in this study or a combination of both. 
It is revealing to note that a study of a 28 kb region of chromosome 9 reported that a 
sub-clone of MITat 1.2 that had been serially passaged showed duplication of a 14.7 
kb genomic fragment in a region containing tandemly repeated genes (Kramer et al. 
(2007))  Additionally, another study to compare the chromosome 1 sequence of the 
genome reference strain with Lister 427  showed that, in addition to subtelomeric 
VSG gene duplications, all arrays of tandemly repeated sequences showed significant 
copy number differences between the 927 reference strain, and the Lister 427 cell 
line (Callejas et al. (2006)).  Thus, irrespective of technical difficulties associated 
with gene knockouts, it is highly likely that there are PAD gene copy number 
differences between different cell lines of T. brucei, making targeted gene deletion 
difficult. 
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Therefore, further work focused on pleomorphic cells.  This had the advantage that 
both PAD1 and PAD2 protein were highly expressed in the stumpy form, and that 
these cells differentiate synchronously in response to cis-aconitate.  However, 
transgenic studies using pleomorphic cell lines have been largely unsuccessful, and 
very few groups have successfully achieved this.  This is probably due to the 
combined effect of two principal factors.  Firstly, pleomorphic cells differentiate to 
the terminally arrested stumpy form in response to SIF (Vassella et al. (1997)); thus 
if cells are not closely monitored in culture then they enter cell cycle arrest and 
subsequently die.  Secondly, as with other trypanosome isolates, a period of 
adaptation to culture conditions may be required before successful growth in vitro.  
Despite these caveats, it was clear that it was not going to be possible to obtain useful 
data on PAD function without using pleomorphic cells. 
Prior to the successful cloning of a stable, pleomorphic PAD array RNAi cell line, a 
transient transfection was used to abate all 8 PAD genes in pleomorphic cells.  This 
strategy had the advantage that it (a) did not require accurate genome sequence 
covering the PAD array locus on chromosome 7, (b) avoided the technical issues 
associated with generating stable transgenic pleomorphic cells described above, and 
(c) avoided difficulties of inducibility, the effects of parasitaemia stage and the 
inherent possibility of a founder effect associated with cloning cell lines.  This 
strategy ultimately gave reproducible and statistically significant inhibition of 
differentiation in response to cis-aconitate. 
To verify this result in stable RNAi cell lines, we made use of a pleomorphic cell line 
that expressed the tetracycline repressor protein and the T7 polymerase (a kind gift of 
Markus Engstler and Michael Boshart).  In accordance with the transient RNAi data, 
differentiation was shown to be clearly inhibited when PAD array gene expression 
was silenced.  Interestingly, the most profound inhibition was observed at low 
concentrations of cis-aconitate, at which differentiation was completely abrogated 
(see Section 6.2.2).  This has the implication that, at high concentrations, cis-
aconitate is transported into the cell via other, lower affinity, transporters, or possibly 
via non-carrier mediated diffusion across the cell surface membrane.  This would 
explain the efficient differentiation of monomorphic cells at 6 mM cis-aconitate in 
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the absence of detectable PAD array protein expression (for further discussion on 
this see Section 7.7). 
There are two potential caveats associated with this phenotype.  Firstly, PAD gene 
ablation was associated with reduced procyclin expression in response to cold shock 
(see Sections 6.6.3 and  7.4.2), and this could account for the differentiation 
phenotype.  However, differentiation was also reduced when cells were not 
previously cold shocked (see Section 6.6.2). Further analysis of differentiated cells 
could resolve this; for example, analysis of the cells with other procyclic specific 
markers, such as CAP5.5. 
Secondly, PAD2 was shown to be expressed in procyclic forms; if PAD2 is essential 
in these forms then the differentiation phenotype could be due to non-viability of 
these cells.  This second caveat is unlikely, however, as the timepoints taken for the 
differentiation assay were too early (6 hours and 24 hours post-differentiation) for an 
affect on cell growth to complicate the analysis (Brun and Schönenberger (1981)) 
(Ziegelbauer et al. (1990)) (Matthews and Gull (1994)). 
Nonetheless, both of these caveats were addressed when these RNAi cell lines were 
shown to differentiate as efficiently as parental cells in response to proteolytic stress 
(see Section 6.7).  Moreover, this assay also addressed the concern that the stable 
RNAi cell line had a reduced capacity for differentiation unrelated to PAD gene 
ablation. Interestingly, this suggests that cis-aconitate operates via a different 
pathway to proteolytic stress induced differentiation. 
Thus, it would appear that PAD gene expression is necessary for the initiation of 
differentiation in response to cis-aconitate under physiologically relevant conditions. 
7.5.2 PAD ectopic expression 
As discussed (see Section 7.5.1), the PAD proteins appeared to be necessary for 
hypersensitivity to cis-aconitate in stumpy form cells.  As monomorphic slender cells 
did not appear to express PAD1 protein (see Section 5.4), it was of interest to 
determine whether ectopic expression of PAD1 would increase their sensitivity to 
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cis-aconitate.  Further, if cis-aconitate import was the limiting factor in the initiation 
of differentiation, one would expect an increase in differentiation capacity, i.e. at a 
given cis-aconitate concentration, cells expressing PAD1 would be expected to 
initiate differentiation at a higher frequency than those that do not.  Ectopic 
expression of PAD1 at the cell surface membrane was achieved, albeit at levels 
lower than on stumpy form cells (see Section 6.1).  However, neither of these effects 
was clearly observed, even under cold shock conditions (see Section 6.1). 
It is difficult to draw many firm conclusions from these observations.  One would 
expect that cold shock stimulates a number of molecular changes in stumpy forms, 
including parts of the intracellular signalling pathway associated with cis-aconitate 
reception.  These stumpy attributes or pathways are unlikely to be functional in the 
serially passaged monomorphic Lister 427 cell line.  Additionally, it should be noted 
that ectopic expression experiments were performed only for PAD1, whereas it was 
PAD2 that was most clearly linked with hypersensitivity (i.e. PAD2 has increased 
cell surface membrane expression in response to cold shock).  This was unavoidable 
as these experiments were performed prior to any of the analyses on PAD2. 
Nonetheless, it would appear that simply expressing PAD1 was not sufficient to 
either increase differentiation efficiency or sensitivity to cis-aconitate in 
monomorphic cells.  It would be interesting to repeat these ectopic expression 
experiments in pleomorphic cells to determine whether PAD array expression is both 
necessary and sufficient for hypersensitivity to cis-aconitate. 
7.6 Future directions 
7.6.1 Applications of a stumpy specific protein 
The identification of a stumpy specific protein will be a valuable tool in dissecting 
the biology of trypanosome transmission.  Currently, the only stumpy specific 
characteristics that have been identified are morphology and mitochondrial 
activation.  Both have been successfully used (Matthews and Gull (1994)) (Matthews 
(1999)), but both have their limitations.  Specifically, morphology can be very 
ambiguous in a pleomorphic population that contains intermediate forms, and 
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mitochondrial activation is associated with oxidative stress and cell death in 
eukaryotes (Giffin et al. (1986)). (McCann et al. (1986)) (Giffin et al. (1989)).  
Hence, it would be interesting and informative to use PAD1 as a marker for stumpy 
forms and to correlate this with other stumpy form characteristics.  For example, the 
presence of low numbers of dividing, PAD1 positive  cells suggests that commitment 
to the stumpy form often occurs prior to the final ‘differentiation-division’, and 
precedes morphological change.  A cytological marker for stumpy forms may yield 
new insights into the stumpy transformation, and its underlying molecular events.  
A further use of a stumpy form marker would be to generate a bioassay for stumpy 
formation.  For example, expressing a reporter gene fused to the PAD1 3’ UTR in 
pleomorphic cells would allow the rapid and objective quantitation of stumpy form 
cells within the population.  This would allow the population dynamics of the slender 
to stumpy transition to be analysed in a natural infection, potentially providing new 
insights into trypanosome biology, and the interaction of different cell forms with the 
mammalian immune system.  The development of a reporter cell line will therefore 
be addressed by Paula MacGregor, University of Edinburgh. 
A reproducible and robust bioassay would allow a large number of compounds to be 
screened for stumpy induction activity, thus facilitating purification of the, so far, 
unidentified SIF molecule (Reuner et al. (1997)) (Vassella et al. (1997)).  Previous 
work has been hindered by the absence of a quantitative stumpy bioassay (Saville 
and Seed (2004)) (MacGregor and Matthews (2008)). 
As described (see Section 1.4), a number of chemicals have been reported to bypass 
the normal route of SIF signalling, and induce slender to stumpy formation (Vassella 
et al. (1997)), even in monomorphic slender cells (Giffin et al. (1986)) (Laxman et 
al. (2006)) (Denninger et al. (2007)).  A stumpy specific marker and a reporter cell 
line would enable validation of these chemicals. 
7.6.2 Further dissection of the role of PAD proteins in promoting differentiation 
It would be of further interest to dissect the PAD proteins’ relative contribution to 
differentiation by ablating each gene individually.  Initial data on this using transient 
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transfection was encouraging (data not shown), but further work could make use of 
existing pleomorphic cell lines that have RNAi constructs stably integrated that 
target the genes individually.  There was insufficient time to analyse these cells in 
this study. 
All of the work in this study has been performed in vitro.  It would therefore be of 
great interest to repeat some of these analyses in vivo, and determine the ability of 
PAD RNAi stumpy forms to generate tsetse midgut infections.  This would 
potentiate the quantitative study of the contribution of cis-aconitate mediated 
differentiation with respect to some of the other triggers of differentiation that have 
been identified.  However, it is worth noting that DiD1 cells, although unable to 
respond to cis-aconitate in vitro, were able to establish a tsetse midgut infection 
(Maria Tasker, University of Manchester, unpublished observations). 
7.6.3 The roles of PAD family members in other lifecycle stages 
The PAD family consists of 8 members, 2 of which have been characterised in some 
detail, and the mRNA expression profile of 2 more is also known.  Thus, the 
expression and function of other PAD members is also of interest.  The expression 
profile of PAD4, 6 and 8 was not investigated, and the expression of any of the genes 
in the mesocyclic, epimastigote or metacyclic forms was not tested.  Staining cells 
from these lifecycle stages with the α-array PAD generic antibody could be 
informative.  Analysis of mRNA transcripts using RT-PCR from these lifecycle 
stages has been described (Urwyler et al. (2005)) and could be applied to the PAD 
transcripts. 
7.6.4 Further analysis of the cis-aconitate mediated differentiation pathway 
It has become increasingly clear that temperature reduction to 20°C is an integral part 
of cis-aconitate mediated differentiation in vivo (Engstler et al. (2004)).  Further 
work could ablate EP procyclin transcripts to determine whether this inhibits (a) 
hypersensitivity to cis-aconitate and (b) upregulation and re-localisation of PAD2.  
Furthermore, a mutational analysis of PAD2 could help to identify sequences 
important for re-localisation, and thus elucidate this interesting phenomenon. 
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The data presented here suggest that the PAD proteins have an important role to play 
in the hypersensitivity to cis-aconitate; however, they are very unlikely to be the only 
cellular factors affected by cold shock.  A proteomic analysis of cold shocked versus 
non-cold shocked cells may help to identify other, intracellular, factors that are part 
of the hypersensitivity system.  A microarray may also be revealing, although cold 
shock may not operate via regulation of mRNA transcripts. 
7.6.5 Citrate/ cis-aconitate uptake assays 
Previous work (Hunt et al. (1994)) reported that blood form cells do not import 
significant levels of citrate.  Given the putative role of the PAD genes this is 
somewhat surprising, and it would be interesting to determine whether cold shocked 
stumpy forms have increased citrate import activity.  This analysis could be extended 
to include cis-aconitate and to determine whether tri-carboxylate import is reduced in 
the PAD RNAi cell lines. 
Furthermore, an analysis to mutate charged residues in the PAD proteins’ TMS could 
determine which residues are important for substrate binding and substrate 
translocation. 
7.7 Insights into trypanosome biology from this work 
This study has convincingly shown that cis-aconitate induced differentiation under 
physiologically relevant conditions is dependant on the presence of the PAD family 
of transporters.  This has a number of interesting implications.  The first is that cis-
aconitate acts intracellularly, and does not bind to a cell surface receptor in order to 
exert its effect.  This is an unexpected addition to the field as it has long been 
supposed to exert its effect outside the cell.  The findings of Hunt (Hunt et al. 
(1994)) have generally been interpreted to mean that blood form trypanosomes do 
not transport citrate.  The authors showed that pleomorphic trypanosomes exposed to 
3 mM extracellular citrate had undetectable levels of intracellular citrate within the 
first 60 minutes of differentiation, approximately 18 µM after 72 hours, and to 50 
µM in established procyclic forms.  However, it was not clear from that study 
whether the cells were taken from a late stage parasitaemia (and hence contained a 
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stumpy form population expressing PAD family proteins).  Importantly, this study 
was performed prior to the work of Engstler et al. (2004), and uptake experiments 
were therefore not performed under cold shock conditions, i.e. those reported to 
induce hypersensitivity to cis-aconitate. 
Monomorphic slender cells are capable of differentiating in response to high levels 
of cis-aconitate.  The data presented in this study suggest that this may in fact be due 
to non-specific tri-carboxylate uptake, either through non-specific carrier mediated 
transport, or diffusion though the cell membrane. However, expression of PAD1 to 
the cell surface membrane does not appear to increase transformation efficiency or 
sensitivity (see Section 6.1).  It was therefore speculated that perhaps an intracellular 
molecule is also affected by cold shock; however, cold shock of these cells in 
combination with PAD1 expression did not enhance differentiation (see Section 6.1).  
This supports the hypothesis proposed by Engstler et al. that stumpy form specific 
factors are affected by cold shock and enable hypersensitivity to cis-aconitate.  
Identification of one of these factors is described in this study (i.e. PAD2 expression 
and localisation), clearly there are other, intracellular factors still to be identified. 
Our understanding of trypanosome lifecycle biology has advanced much in the last 4 
years.  The observations regarding the affect of cold shock upon sensitivity to cis-
aconitate reported by Engstler et al. (2004) has meant that this chemical has become 
a physiologically relevant candidate for stimulating transformation, rather than 
simply a useful tool.  The subsequent discovery of a PTP phosphatase that acts as a 
break upon differentiation when active (Szöor et al. (2007)) and a putative PTP1 
interacting protein (currently termed PTPInt) that is cold shock induced, and may 
have citrate specificity (Szöor, unpublished data), allows us to propose a model of 
tri-carboxylate induced differentiation into which the PAD story fits neatly (see 
Figure 7.7-1).  Hence, stumpy form trypanosomes are taken up into the tsetse upon 
feeding, and are subsequently exposed to a low temperature of 20°C.  This causes the 
upregulation and re-localisation of PAD2, which, in concert with PAD1, allows the 
transport of very low levels of citrate and cis-aconitate that are present in the blood 
meal, and possibly the tsetse midgut.  Subsequent binding of citrate to the cold 
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shock-induced PTPInt causes inactivation of PTP1, thus allowing differentiation to 
proceed, assisted by the activity of gene regulators, such as the CCCH zinc finger 
family of proteins (Paterou et al. (2006)) (Walrad, unpublished data).  Clearly, much 
of this model is speculation, and some parts have more support from the data than 
others.  Nonetheless, the field has progressed to a point whereby these models can be 
proposed and therefore tested experimentally. 
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Figure 7.7-1  A model of citrate/ cis-aconitate mediated differentiation 
Down-stream signaling pathway
Citrate/ cis-aconitate binds to PTPInt,
allowing PTPInt to inactivate TbPTP.
TbPTP no longer acts as a break upon
differentiation, and stumpy forms initiate





PAD2 protein is upregulated, and
expressed on the cell surface.  Citrate/
cis-aconitate is transported into the cell
with high efficiency even at very low
extra-cellular concentrations.
Intracellular signaling proteins (such as
PTPInt) may also be upregulated in




PAD1 and PAD2 are not expressed in
slender forms, therefore citrate cannot
enter the cell at physiologically relevant





PAD1 is expressed on the cell surface of
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intracellular vesicles.  Differentiation can
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Northern blot solutions 
[10x] MOPS 
MOPS 46.26 g/l 
Na-Acetate (pH 7.0) 50 mM 
EDTA 10 mM 
Autoclaved and stored in the dark at 4 °C.  Made up to 1× with dH2O 
RNA Gel Loading Buffer 
Formamide 30 % 
Formaldehyde 6.1 % 
Bromophenol blue 0.01 % 
MOPS 1 × 
glycerol 10 % 
Maleic Acid Buffer 
Maleic acid 100mM 
NaCl 150mM 
pH7.5 with NaOH, autoclaved  
10% Block Solution  
Blocking reagent 10 % (w/v) 
Maleic Acid 1 × 
Wash Buffer 
Maleic Acid Buffer 1 × 
Tween 20 0.3 % 
Detection Buffer  
Tris-HCl 100 mM 
NaCl 100 mM 
pH 9.5  
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Southern blot solutions 
TELT 
TrisCl, pH 8.0 50 mM 
EDTA, pH 9.0 62.5 mM 
LiCl 2.5 M 
Triton X-100 4% (v/v) 
Denaturing Solution 
NaCl 1.5 M 
NaOH 0.5 M 
Neutralizing solution 
NaCl 1.5 M 
Tris 1 M 
pH to 7.4 with HCl  
20xSSC 
NaCl 3 M 
Tri Sodium Citrate 0.3 M 
Hybridization/ pre-hybridization buffer 
Dextran sulphate (dissolved in water first) 5 % 
SSC 5 x 
Liquid block 10 % 
SDS (added last) 0.1% 
Buffer A 
Tris pH9.5 100 mM 
NaCl 300 mM 
Blocking buffer 
Liquid block 10% 
Tris pH9.5 100 mM 
NaCl 300 mM 
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Western blot solutions 
[10x] Running Buffer 
Tris-HCl, pH8.3 0.25 M 
Glycine 1.92 M 
SDS 1% 
Laemmli Sample Buffer 
Tris-HCl, pH6.8 62.5 mM 
SDS 2 % 
Glycerol 10 % 
Bromophenol blue 20 µg 
Coomassie Blue Stain 
Methanol 50% 
Acetic Acid 10% 
Coomassie Brilliant blue R250 0.1 % w/v 
Destain Solution 
Methanol  40% 
Acetic Acid 10% 
Water  50% 
[10x] Blot Transfer Buffer Stock 
 Tris (do not pH) 0.025 M 
Glycine  0.15 M  
1× Completed Transfer Buffer 
SDS 0.2 % 
[10x] Transfer Buffer Stock 10 %  
Methanol 20 % 
Ponceau Stain  
Ponceau S 0.4% 
TCA 3% 
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Immunofluorescence solutions 
DAPI working stock 
4',6-diamidino-2-phenylindole (DAPI) 10 µg ml-1 
MOWIOL Mounting Medium 
Glycerol 25 % w/v 
MOWIOL 10 % w/v 
Tris pH8.5 0.1 M 
Medium required heating at 50 °C to dissolve MOWIOL.  Aliquots were stored at -20 °C. 
Voorheis’s modified PBS (vPBS) 
NaCl 137 mM 
KCl 3 mM 
Na2HPO4 16 mM 
KH2PO4 3 mM 
Sucrose 46 mM 
Glucose 10 mM 
pH7.6  
Phosphate Buffer Solution (PBS) 
NaCl 137 mM 
KCl 3 mM 
Na2HPO4 16 mM 
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Miscellaneous solutions 
TAE 1×  
Tris-Acetate 40 mM 
EDTA 1 mM 
pH 8.0  
TBS 10x  
NaCl 140mM 
Tris  10mM 
ND96  
NaCl 96 mM 
KCl 2 mM 
CaCl2 1.8 mM 
MgCl2 1 mM 
HEPES 5 mM 
pH 7.4  
TE  
TrisCl 10 mM 
EDTA 1 mM 
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Small scale plasmid preperation solutions 
Solution I  
glucose 50 mM 
EDTA 10 mM 
Tris-HC1 (pH 8.0) 25 mM 
Solution II  
NaOH 0.2 M 
Sodium dodecyl sulfate (SDS). 1% 
Solution III  
Potassium acetate 3 M 
pH 5.2  
 
 
Appendix A 290 
Antibody concentrations 
Immunofluorescence 
α-EP procyclin 1:500 
α-PAD1 antibodies 1:100 
α-PAD2 antibodies 1:100 







α-PAD1 antibodies 1:1000 
α-PAD2 antibodies 1:1000 
α-array antibodies 1:1000 
α-mouse-HRP 1:5000 
α-rabbit-HRP 1:5000 
IRDye 800CW Goat Anti-Rabbit IgG (LI-COR, 
red) 
1:5000 
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A list of primers used in this study 
Primer 
Number 
Primer name Primer Sequence Comment 
























































GCAGAAGGTTCCGAGAACCAAGAG Binds to PAD2 
    









Amplifies PAD1 open reading 
frame for cloning into pGHJ 
    









When annealed, generates a 
duplex containing XhoI 
    
Primers for cloning PAD genes into expression vectors 
26 
Gene 1 FOR - 
PHD451 
(HindIII) 
TAAAAGCTTATGAGCGCACCCGTCGACAACG A generic PAD forward primer 
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27 
Gene 1 REV - 
PHD451 (XhoI) 
TAACTCGAGTTGCGGAGCAGCCTCACGGGC 
For cloning PAD1 into 
pHD451-TY 
28 
Gene 1 REV - 
STOP (XhoI) 
TAACTCGAGTCATTGCGGAGCAGCCTCACGG 
For cloning PAD1 into pHD451 
(no tag) 
    












Generates a 76 nucleotide 
amplicon for cloning into 






Amplifies the entire PAD1 open 
reading frame for cloning into 
pALC14 (in combination with 
#109) 
    
Primers for making knockout constructs 
67 




68: A REV 
(XhoI) 
AAActcgagAAAATTTATTGACTCCGAGAG 
Generates target sequence A 
46 
5’ array hyg 
(SacI) KO FOR 
CCCGAGCTCCTCACAAAACGCCGCAAGTAATAAAG 
45 
5’ gene 1 inner 
KO (NotI) REV 
AAAGCGGCCGCGTTAGTCTGTGGTATTGTTCAAAGGTTC 
Generates target sequence B 
69 




70: C REV 
(SacI) 
CCCGAGCTCCCTGCTGTCAACCATTCACCTGCC 
Generates target sequence C 
61 




62: D REV 
(KpnI): 
CCCGGTACCACCGTACACTGCAGTCAACGCC 
Generates target sequence D 
    
71 




72: E REV 
(SacI) 
CCCGAGCTCGGGCGGATATAATGCTATTGATGTGTG 
Generates target sequence E 
    
65 




66: F REV 
(KpnI): 
CCCGGTACCGTGAAGAATTTAACGATATAAGTTGGTGTG 
Generates target sequence F 
75 
75: PAD array 
5' FOR (KpnI) 
CCCGGTACCccgatattggtgagttagacaggtg 
Generates target sequence G (in 
combination with #68) 
76 
76: PAD array 
3' REV (SacI): 
CCCGAGCTCaagatgccttaggcgcgacctgc 
Generates target sequence H (in 
combination with #69) 
    
Replacing pHD617 Hygromycin cassette with puromycin cassette 
 






































































HindIII XhoI BamHI TY tag
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An alignment of PAD1 with the closest ortholog in Trypanosoma cruzi. 
 




A clustalW alignment of PAD1 with the closest ortholog in Leishmania major. 
 





Gene Accession number Gene description E value 
Tc00.1047053506551.10 Hypothetical protein, conserved|. 4.70E-168 
Tc00.1047053508799.270 Hypothetical protein, conserved. 1.30E-167 
Tc00.1047053510069.20 Hypothetical protein, conserved|. 1.80E-166 
Tc00.1047053509713.30 Hypothetical protein, conserved|. 6.40E-156 
Tc00.1047053510103.24 Hypothetical protein, conserved|. 2.10E-155 
Tc00.1047053510811.20 Hypothetical protein, conserved|. 5.00E-154 
Tc00.1047053508799.260 Hypothetical protein, conserved. 1.10E-151 
Tc00.1047053509707.10 Hypothetical protein, conserved|. 2.20E-151 
Tc00.1047053508065.70 Hypothetical protein, conserved|. 2.80E-151 
Tc00.1047053509713.20 Hypothetical protein, conserved|. 3.30E-147 
Tc00.1047053510811.10 Hypothetical protein, conserved|. 9.50E-147 
Tc00.1047053509713.10 Hypothetical protein, conserved|. 2.90E-146 
Tc00.1047053508799.280 Hypothetical protein, conserved. 6.60E-143 
Tc00.1047053510103.30 Hypothetical protein, conserved . 2.90E-140 
Tc00.1047053506725.70 Hypothetical protein, conserved|. 2.40E-124 
Tc00.1047053507089.110 Hypothetical protein, conserved. 8.10E-124 
Tc00.1047053508801.10 Hypothetical protein, conserved|. 9.20E-94 
Tc00.1047053506947.10 Hypothetical protein, conserved|. 2.80E-93 
Tc00.1047053509107.9 hypothetical protein, conserved|T. 5.30E-92 
Tc00.1047053511639.20 Hypothetical protein, conserved|. 3.60E-91 
Tc00.1047053510605.10 Hypothetical protein, conserved|. 6.60E-90 
Tc00.1047053509669.160 Hypothetical protein, conserved. 9.70E-85 
Tc00.1047053506175.100 Hypothetical protein, conserved. 1.20E-84 
Tc00.1047053509537.90 Hypothetical protein, conserved|. 1.60E-80 
Tc00.1047053504765.20 Hypothetical protein, conserved|. 2.80E-73 
Tc00.1047053509431.10 Hypothetical protein, conserved . 8.00E-70 
Tc00.1047053508799.290 Hypothetical protein, conserved. 2.70E-64 
Tc00.1047053402857.10 Hypothetical protein, conserved|. 6.00E-52 
Tc00.1047053510001.20 Hypothetical protein, conserved|. 1.40E-49 
Tc00.1047053507529.20 Hypothetical protein, conserved|. 2.60E-48 
Tc00.1047053504149.100 Hypothetical protein, conserved. 3.80E-36 
Tc00.1047053506505.30 Hypothetical protein, conserved|. 1.90E-35 
Tc00.1047053506175.110 Hypothetical protein, conserved. 2.40E-35 
Tc00.1047053509669.170 Hypothetical protein, conserved. 1.00E-34 
Tc00.1047053510001.31 Hypothetical protein, conserved|. 3.00E-34 
Tc00.1047053507677.160 Hypothetical protein, conserved. 4.50E-34 
Tc00.1047053507529.30 Hypothetical protein, conserved|. 6.60E-33 
Tc00.1047053503837.10 Hypothetical protein, conserved|. 3.80E-32 
Tc00.1047053507707.20 Hypothetical protein, conserved|. 3.80E-32 
Tc00.1047053507383.10 Hypothetical protein, conserved|. 1.70E-09 
Tc00.1047053508397.70 Transporter, putative|Trypanosom. 0.993 
Tc00.1047053509875.240 Hypothetical protein, conserved. 0.9995 
A list of T. cruzi PAD1 orthologs. 
PAD1 was used in a TBLASTX search against the Trypanosoma cruzi genome.  The 
closest matches are shown.  
 








An alignment of the PAD intergenic elements.  The PAD intergenic repetitive elements 
(A) 1, (B) 2 and (C) 4 were identified by multiple sequence alignments of the PAD 
intergenic regions. 
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An alignment of the PAD intergenic elements The PAD intergenic repetitive element 3 
was identified by multiple sequence alignments of the PAD intergenic regions.  Note that 
element 3 is truncated downstream of PAD8 (PAD8-DOWN-element-3). 
 




An alignment of the PAD intergenic elements The PAD intergenic repetitive elements 
(A) 5 and (B) 6 were identified by multiple sequence alignments of the PAD intergenic 
regions. 
 









PAD protein secondary structures.  The secondary structures of the PAD proteins 
were predicted as described in chapter 3.  Note that all proteins share a similar predicted 
topology, with 14 trans-membrane spanning regions, and 2 large, intracellular loops. 
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A PAD array protein alignment.  The PAD proteins were aligned using Multalin to 
determine the conservation of amino acids between the proteins.  Red indicates perfect 
conservation, blue indicates high conservation, and black indicates low conservation.  
Note that the C terminal end is the most heterogeneous 
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